HUMAN BODY PARTS FOR SALE TO THE HIGHEST BIDDER Inside a Creepy Global Body Parts Business

SPIEGEL ONLINE - News - International ~~ August 28 2009

42.90 Euros Per Arm

Inside a Creepy Global Body Parts Business By Martina Keller and Markus Grill

The German company Tutogen's business in body parts is as secretive as it is lucrative. It extracts bones from corpses in Ukraine to manufacture medical products, as part of a global market worth billions that is centered in the United States.

Anatoly Korzhak, a pensioner and former engineer, died in Kiev on August 5, 2004. His body was picked up at 2 a.m. and taken to the forensic medicine institute in the Ukrainian capital. That same night, Korzhak's daughter, Lena Krat, received a telephone call and was asked to come to the institute immediately in the morning, where she was told she would receive further information.

It was the first time Krat was confronted with the death of a close relative. "I was so upset that I couldn't think clearly," she recalls. When she arrived at the institute in the morning, a man there said something to her about skin transplants. He was an employee of a Ukrainian company that works hand-in-hand with forensic medicine experts. She said to the man: "Leave me alone. I don't understand what you're talking about, and I don't want to listen to you."

But the employee was persistent and eventually gave her a form to sign. He told her that if she consented to skin removal, she would be helping pediatric burn victims who needed transplants. Krat signed the form. "It was as if I had been hypnotized," she says.

But now Krat, a mother of two young girls, has learned from SPIEGEL that the Ukrainian company in question sends the body parts to a German company, Tutogen Medical GmbH, which in turn apparently supplies large numbers of such parts to the American tissue market.

In addition to strips of skin, tendons, bones and cartilage are removed from the bodies. "This shocks me," says Krat. "If I had known that so much is cut out, I would never have given my consent."

A Lucrative Industry The incident in the Ukrainian capital is part of the secretive daily routine of a little-known but highly lucrative branch of the medical industry, in which companies use corpses to make medical spare parts. In doing so, they reuse almost everything the human body has to offer: bones, cartilage, tendons, muscle fascia, skin, corneas, pericardial sacs and heart valves. In the jargon of the profession, all of this is referred to as tissue.

Bones and tendons, the parts that interest Tutogen the most, are subjected to complex processing. The company degreases and cleans bones, cuts, saws or mills them into the desired shapes, then sterilizes, packages and sells the finished product in more than 40 countries around the world. With a prescription, it is even possible to order Tutogen's products through online pharmacies.

Photo Gallery: Tutogen's Global Business in Body Parts 1. HQ: Tutogen headquarters in Neunkirchen am Brand, a town of 8,000 people in northern Bavaria. Body parts extracted in Ukraine are shipped by are to Frankfurt or Nuremberg before being taken here. 2. A photo of the rundown pathology department where autopsies are conducted in the Ukrainian city Dnipropetrovsk. 3. Assistant District Attorney Josh Hanshaft holds a photograph of an X-ray showing the pelvic area of a deceased person with PVC plumbing pipe inserted where bones should have been at a Feb. 23, 2006 press conference in New York. Prosecutors allege four individuals including the head of Biomedical Tissue Services illegally extracted body parts of the deceased and sold them for profit. The case is still pending.

The market for tissue products is still small in Germany. When it comes to bones, for example, experts estimate that only about 30,000 transplants a year are used in hospitals nationwide, mainly for use in bone reconstruction for hip surgery and in spinal column surgery.

It's a completely different story in the United States. According to the American Academy of Orthopedic Surgeons, more than a million bone parts are used in transplants every year. In no other country is it possible to make so much money with body parts. If a body were disassembled into its individual parts, then processed and sold, the total proceeds could amount to $250,000 (€176,000). For a single corpse! The US tissue industry generates total revenues of about $1 billion a year, says journalist Martina Keller, a co-author of this article and the author of the German book, "Cannibalized: The Human Corpse as a Resource."

Legal and Ethical Questions

This raises the question of just how legal the process of obtaining raw materials is. And are bone products made from corpses even medically necessary? According to Klaus-Peter Günther, president of the German Society of Orthopedics and Orthopedic Surgery, they are often "not the first choice" in operations. "For us, the gold standard is still tissue taken directly from the patient in question."

Alternatives are only an option, says Günther, when the material from the patient's body is insufficient. Those alternatives include animal bones and artificial replacement parts made of ceramic material, for example -- or human donor bones.

Many hospitals collect and reuse bone fragments removed from patients who have received artificial hips. "For this reason," says Günther, "we have not had to resort to dead donors so far."

In the United States, doctors have far fewer qualms about using body parts from corpses than their German counterparts -- in such areas as spinal surgery, sports injuries and cosmetic surgery. For instance, doctors used pulverized skin particles to enhance lips and smooth out wrinkles.

Should corpses be butchered to make cosmetic procedures possible? Ingrid Schneider is decidedly opposed to the practice. For the past 15 years the Hamburg political scientist, a former member of the Investigative Commission on Law and Ethics in Modern Medicine in the German parliament, has been involved in the subject of recycling body substances. Schneider argues that the body is not a source of raw materials that can be sold at will. Given such concerns, it is not surprising that many people are deeply opposed to allowing the body of a family member to be reused, even for medical purposes.

Even if it is unrealistic to expect that all commercialization of the body could be ruled out in modern medicine, says Schneider, it is important to set boundaries. For that reason, she insists that human tissue ought to be used sparingly -- that is, only when such use is medically necessary and clearly superior to other forms of treatment.

The conviction that the body is much more than an object has also shaped the policies of the World Health Organization (WHO), the European Parliament and the European Council, the EU's body representing the leaders and ministers of the 27-member bloc. All of these bodies condemn the practice of trading in human body parts to turn a profit.

In Germany, the country's organ transplant act regulates the removal of tissue. Only those who have consented to organ and tissue harvesting are considered as donors. If a person dies and is not already a donor, his or her closest relatives can consent to donation. Paragraph 17 of the transplant act explicitly states: "Trading in organs or tissue intended for use in the medical treatment of others is prohibited." Physicians who remove tissue can only be paid suitable compensation for their efforts. The law calls for prison sentences of up to five years for violation of the trading prohibition.

Part 2: A Booming Tissue Market Tutogen paid its Ukrainian partners a fixed price for each body part. In January 2002, the company paid €42.90 for a complete femur, €42.90 for a humerus and €13.30 to €16.40 for a pericardial sac, depending on its size. Graduated prices were also arranged with the Ukrainians. Take, for example, the removal of patellar tendons with bone segments, known as "bond-tendon-bone," or BTB. When coroners supplied less than 40 BTBs on-site, Tutogen paid €14.30 apiece. For larger numbers of BTBs, the price went up: to €23 apiece for 40 or more BTBs and to €26.10 for 60 or more. For a coroner, who makes about €200 ($287) a month in Ukraine, such graduated prices must have been an incentive to remove as much body material as possible.

Thousands of pages of internal memos, faxes, supply lists and documents from the years 2000 to 2004, which SPIEGEL has obtained, suggest that not only did Tutogen process the Ukrainian body parts itself, but it also supplied the US tissue market.

Florida-based RTI Biologics, one of the US market leaders in the industry, generated $147 million in sales in 2008. The company describes itself as the "leading provider of sterile biological implants for surgeries around the world."

To that end, RTI acquired Tutogen Medical, Inc., the American parent company of the German company Tutogen Medical GmbH, last year. The acquisition was good news for RTI shareholders, because of Tutogen's large international donor network, says CEO Brian Hutchison. Put differently, Tutogen is a company that knows the ins and outs of gaining access to as many body parts as possible.

The body parts from Ukraine are shipped by air to Frankfurt or Nuremberg. From there, they are taken to Tutogen headquarters in Neunkirchen am Brand, a town of 8,000 people in northern Bavaria.

Tutogen's facilities in Neunkirchen, just a few kilometers north of Nuremberg, comprise several low, warehouse-like buildings, where about 140 employees work. All in all, it is an inconspicuous place for visitors who fly in regularly from Ukraine and the United States.

Company President Karl Koschatzky refused to respond to requests for an interview, and the company declined to answer a list of questions sent to its offices.

The Middleman Tutogen uses a middleman to organize its deliveries from Ukraine. Dr. Igor Aleshenko, a coroner by training, manages the company's relationships with the various local forensic medicine institutes. He has been working for Tutogen in Ukraine for about 10 years.

In that time, Aleshenko has become a wealthy man, and he now divides his time between his two residences, one in Kiev and one in Moscow. In 2002, Tutogen described Aleshenko as a "cost-intensive person." He too was unavailable for an interview in Kiev, nor did he respond to written questions.

In Ukraine, Aleshenko is far more than Tutogen's local contact. He is the director of Bioimplant, a company that manages tissue removal. Because of its close ties to the Ukrainian Health Ministry, Bioimplant is practically immune to overly probing government inspections of bone shipments crossing the border.

Ukrainians are kept somewhat in the dark when it comes to Bioimplant's true business dealings. According to the company's Web site, its "primary activity" is the "production of bio-implants" for use in Ukrainian patients. But what does Bioimplant really do?

Kiev, on a summer's day in 2009. Anyone seeking to pay a visit to Bioimplant's headquarters would be inclined to head to the company's official address at Patrice Lumumba Street 4/6, an office building with a number of tenants -- where Bioimplant doesn't even have its own mailbox.

A guard and a doorman greet visitors and send them to the fourth floor, where Bioimplant's offices are supposedly located. Room 305 is in a long hallway of closed doors. There is not even a sign to identify the room as being associated with Bioimplant. A young man in a pinstriped suit opens the door. He says that he hasn't been working for Bioimplant for very long, and that most of his work consists of photocopying.

According to the young man, the company leases three rooms in the office complex, but Dr. Aleshenko is not in today. Tutogen brochures and packets of sterilized corpse bones are stacked in the next room. Instead of the expected production facility, the offices are nothing but a distribution site.

Tutogen developed its business relationship with Aleshenko about 10 years ago. During a trip to Tutogen headquarters in the Bavarian countryside in November 2001, Aleshenko met with Koschatzky at the Bayerischer Hof Hotel in Erlangen, near Nuremberg. The minutes of the meeting contain a list of "new pathologies" working for Tutogen in the eastern Ukrainian cities of Dnipropetrovsk, Poltava and Zhytomyr.

Aleshenko had apparently brought along a wish list to the meeting, and his German business partners were eager to comply. According to the minutes, "TTG (Tutogen) agreed to provide 5,000 deutsche marks for investment costs in Dnipropetrovsk (Ukraine). Dr. Aleshenko will send us the necessary payment instructions."

Unkosher Discussions Some of the issues discussed at the meeting were less than kosher. For instance, the minutes state, "TTG is testing whether depilation of the corpse prior to skin removal could alleviate the hair problem (perhaps using the hot wax or cold wax method)."

A list of "pathologies currently providing (parts)," dated November 2001, already included abbreviations for 15 facilities in Ukraine. In the 2000-2001 fiscal year alone, 1,152 bodies in Ukraine were used to provide tissue for Tutogen.

But it still wasn't enough for the company, which needed more cooperating institutions, more donors and more bone parts to supply a booming tissue market.

According to an internal planning document dated June 17, 2002 (the file is titled "Raw Tissue Requirements"), Tutogen needed the following parts for the coming fiscal year:

* 2,920 shafts of the femur,

* 3,000 iliac crests,

* 1,190 patellar tendons,

* 3,750 kneecaps,

* 10,200 femoral muscle fascia (or fascia lata),

* 50 cranial bones,

* 70 Achilles tendons.

Aleshenko, who Tutogen apparently paid directly for the tissue parts, is believed to have funneled part of the money to coroners in Dnipropetrovsk, Kiev, Kharkiv and other Ukrainian cities. According to an internal list of "paid incoming goods," Tutogen's Ukrainian partner received roughly €350,000 between January and August 2001.

The investment must have paid off. Online pharmacies charge between €367 and €854, depending on the size, for a Tutoplast Spongiosa Block (Bone Substance). According to the price lists used at the time, the Ukrainians received between €23 and €26.10 for the original body part, again depending on the size. Even if Tutogen were paying twice as much for the raw material today, it would still be a bargain.

Part 3: Tissue and Organ Harvesting

Not surprisingly, Tutogen could afford to be generous to its Ukrainian partners. That generosity included large quantities of equipment the company routinely sent to its hardworking coroners.

According to the internal documents, in the 2000-2001 fiscal year Tutogen shipped 6,000 scalpels, 2,600 pairs of sterile gloves, 500 surgical gowns, 15 hacksaw blades for autopsies and many other items to Ukraine -- at a total cost of €40,000 in "donor expenses without tissue," as the Tutogen bookkeepers noted fastidiously. Tutogen paid its Ukrainian partners roughly €500,000 for the body parts during the same period.

The US Food and Drug Administration (FDA) currently lists 20 facilities in Ukraine that are authorized to supply body parts for the US market. But no matter which of these facilities one clicks on in the FDA database, all share the same contact information: the telephone number of Tutogen Medical GmbH in northern Bavaria.

One of the facilities on the list is the forensic medicine institute in Krivoy Rog, an industrial city in southeastern Ukraine, with a population of about 700,000. According to the FDA database, the Krivoy Rog site is authorized to supply bones, cartilage, fascia, ligaments, pericardial sacs, sclera (the white of the eye), skin and tendons.

Tissue and Organ Harvesting The whitewashed, Spartan structure housing the forensic medicine institute is on the edge of the hospital grounds. Frosted glass windowpanes behind latticed windows discourage prying eyes. Visitors immediately notice the cloying odor of corpses upon entering the building. The director of the institute is unavailable, even though his car is parked on the hospital grounds. A doctor wearing a denim jacket assumes the task of getting rid of anyone inquiring about the institute's collaboration with the German company.

Instead, he tells the reporters to contact the district attorney's office and points to a sign above the door, which reads: "No Admittance without Authorization." Does that include Tutogen, the reporters ask? "No, Tutogen is not unauthorized here," the man says, indicating that the conversation is over.

The former director of the city's forensic medicine department, Vladimir Bondarenko, is slightly more forthcoming. A retiree, he meets with visitors at a street café. Tissue harvesting began at his department about 10 years ago, says Bondarenko.

"It was illegal," he says. "The family members should have been told about what was happening with the bodies," but they had no idea. "When the deceased is lying in the coffin, the family members see nothing but the face. What they don't see is that the bones of the legs or arms have been removed."

The Ukrainian tissue transplant act includes a provision stating that family members must consent to tissue donation if the deceased did not already do so while still alive. However, there are indications that this was often not the case. Ukrainian authorities in Krivoy Rog and several other cities are conducting investigations into suspected illegal tissue and organ harvesting.

The case of the deceased father of Kiev resident Lena Krat, for example, was examined in connection with an investigation identified by the file number 50-3793, begun on Jan. 4, 2005. The investigation included all incidents that took place between May and September 2004. The names of 10 deceased persons are listed in the files. Their family members stated that they "did not consent to the removal of anatomical material."

According to the court order authorizing the proceedings, "family members were deceived, in that they were told that only a small part of the deceased would be removed, such as a bone or tissue fragment. In actual fact, almost all bones and tissue were removed. ... All of the material is taken to Germany."

A Legal Twist Despite the evidence, the Kiev district attorney's office closed the proceedings in July 2005, "for lack of a statutory offense." Curiously, the document states, as grounds for dropping the case, that the Bioimplant employees had not violated the transplant act, because they had not transplanted material from corpses, but had merely removed it so that it could be processed into "bio-implants." As a result of this legal twist, the recycling of corpses has been allowed to continue to this day.

Kiev, the forensic medicine institute on Orangery Street: A long, brick building, from which doctors wearing light-green aprons occasionally emerge to smoke cigarettes outside the front door. Family members stand next to the entrance, waiting for the release of their dead relatives. There is a display of coffins and wreaths in front of a funeral parlor across the street.

Vladimir Yurchenko is the director of the institute. He points to the room where bodies are processed for Tutogen. It is on the ground floor and sealed off to outsiders. Why? "Because that's what the US health authorities require," says Yurchenko.

Kiev's senior forensic pathologist explains the process. Bioimplant obtains the relatives' consent, and company employees also come to the institute to harvest the body parts. Yurchenko's staff members assist in the process, for which they receive additional compensation. Once bones and other parts have been removed, wooden sticks are inserted into the body so that it retains its shape until the funeral.

The harvested bones, tendons and pieces of cartilage are stored in zinc-plated metal boxes in a refrigerated room in the basement. "The tissue parts are brought up once every few weeks, when a truck comes and takes them away," says Yurchenko. Karl Koschatzky, the secretive Tutogen executive from Bavarian, also turns up occasionally.

Part 4: 'A Source of Raw Materials' According to Yurchenko, about 8,000 corpses a year are delivered to the forensic medicine department. Of that number, more than 5,000 are potential bone donors, but family members only consent to harvesting from about 150 bodies. If the two facilities in the capital already provide parts from about 150 bodies each, as Yurchenko says, and if a total of 20 facilities in Ukraine are registered with the FDA -- and, therefore, are collaborating with Tutogen -- it can be assumed that the German company obtains its body parts from large numbers of Ukrainian corpses. "All we are for the rich countries is a source of raw materials," says Yurchenko.

In May 2004, Tutogen signed a five-year contract with Bioimplant, which describes the process as follows: The Ukrainians transfer harvested tissue to Tutogen in Germany to have it processed into products. But this processing is costly. How does the Ukrainian company pay for the expensive processing? The answer is deceptively simple: with the bones, from Ukrainian corpses, that have been processed into products in Germany. This is the currency accepted by both parties to the arrangement.

What the agreement does not state is that the Germans were not producing products for Bioimplant, but were ordering substantial amounts of raw material from the Ukrainians every month.

At times, much larger numbers of body parts from Ukraine and other countries were arriving in Neunkirchen than Tutogen could even process. A document titled "Inventory, Raw Material Storage 1," dated March 2000, reveals the scope of this excess material. According to this inventory document, Tutogen warehouses already contained 688 patellar tendons, 1,831 kneecaps, 1,848 fibula, 2,114 fascia and 1,196 foot bones, or a total of more than 20,000 body parts.

In June 2002, Tutogen employees wrote the following comments in the minutes of a meeting: "Warehouse problems. More tissue than necessary continues to be delivered. Solutions are needed to address this problem."

The company documents also include references to the kinds of solutions Tutogen had in mind. According to an internal memo dated April 2002, a Ms. R. noted "that there is no longer any storage capacity in the deep freezers. Efforts must be stepped up to ship tissue to the USA."

According to a document dated June 2002, which lists the "Raw Tissue Requirements for USA Needs," the US partners required the following monthly supply:

* 119 iliac crests,

* 667 pieces of fascia lata,

* 267 kneecaps,

* 243 shafts of the femur.

Did Tutogen Break the Law? Apparently, the deliveries to the United States were not only sent to the parent company in Florida, Tutogen Medical Inc., which could have been explained as a way of shifting the problem within the company, but also to RTI, the company's US competitor at the time.

In a table detailing a shipment from Lugansk in Ukraine, delivered on Dec. 7, 2001, a sum of €62,000 is quoted, but the recipient is identified as "TM/RTI."

If Tutogen was indeed shipping unprocessed tissue to the United States, this could constitute an act of engaging in illegal tissue trade, provided a profit was generated as a result.

In a memo dated April 4, 2002, a Tutogen employee issued the following cautionary statement: "We should avoid shipping unprocessed raw material to TMUS (Tutogen USA), so as not to create the impression of engaging in the tissue trade."

The German Institute for Cell and Tissue Replacement, another major bone producer, categorically rejects such practices. Director Hans-Joachim Mönig insists that "obtaining raw tissue from one country and passing it on to third parties is against the law. In our view, this constitutes the crime of trading in tissue."

To date, its collaboration with Aleshenko and the Kiev Health Ministry has worked exceedingly well for Tutogen. All investigations against Tutogen's Ukrainian partners in Krivoy Rog, Kiev and Dnipropetrovsk have been suspended.

But that could change. Last year, the public prosecutor's office in Krivoy Rog launched a new investigation.

Once again, forensic medicine employees, as the public prosecutor's office states in response to SPIEGEL's inquiry, are suspected of "having used coercion and fraud to obtain the consent of family members for the removal of tissue and other anatomical material for purposes of transplantation." Seventeen family members of the deceased have already testified.

On Jan. 9, 2009, the district attorney's office submitted the case to the relevant district court, where the case is still underway.

Lena Krat, the Kiev woman who was persuaded to release her father's body for tissue harvesting in 2004, would be pleased to see those responsible finally brought to justice. "Those people are truly guilty," she says, "and I am outraged that these terrible things are still taking place."


http://www.spiegel.de/international/europe/0,1518,645375,00.html





DER SPIEGEL (9/2001) - 24.02.2001 (9397 Zeichen)USA: Loch in der MauerDie BSE-Angst erreicht Amerika: Trotz strikter Auflagen gelangte in Texasverbotenes Tiermehl ins Rinderfutter - die Kontrollen der Aufsichtsbehördensind lax. Link auf diesen Artikel im Archiv: http://service.spiegel.de/digas/find?DID=18578755"

Its as full of holes as Swiss Cheese" says Terry Singeltary of the FDA regulations. ...



http://service.spiegel.de/digas/servlet/find/DID=18578755





http://usdameatexport.blogspot.com/2008_01_01_archive.html




2001


Last, but not least. The illegal/legal harvesting of body parts and tissues will come back to haunt you. Maybe not morally, but due to NO background checks and human TSEs, again it will continue to spread.



http://www.fda.gov/ohrms/dockets/ac/01/slides/3681s2_09.pdf






Tutogen Medid,U.S.,Inc.

December 9, 2002

Dockets Management Branch (HFA-305)
Food and Drug Administration5630 Fishers Lane,Rm. 1061Rockville, MD 20852

RE: Docket No. 02D-0266, CBER 150. Draft Guidance for Industry: Preventive Measures toReduce the Possible Risk of Transmission of Creutzfeldt-Jakob disease (CID) andVariant Creutzfeldt-Jakob Disease (vCJD) by Human Cells, Tissues, and Cellular andTissue-Based Products (HCT/Ps); Availability. Pages 42789--42790 FR Dot. 02-158981

Tutogen Medical Inc. (“Tutogen”) appreciates the opportunity to comment on the draft documentissued by the FDA in June 2002 entitled: “Preventive Measures to Reduce the Possible Risk ofTransmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease(vCJD) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) ” Inparticular, we wish to use this venue to respond to your request for data assessing the impact ofthe recommendations contained therein to reduce the risk of CJD and vCJD on the availability ofHCT/P.


snip...


1. # of Tissue Banks reporting 63

2. # of tissue donors recovered (HCT/P domw population) 18,021

3. # of Bone allografts dlstributed in U.S. 675,370

4. Volume of Skin grafts distributed in U.S. 11,222 ft2

1Excerpt Corn “Background” statement contained in the American Association of Tissue Banks MembershipDirectory 2001-2002.


snip...


II. Impact of donor deferral upon the availability of HCT/ps: During the year 2001, Tutogenprocessed 3,500 donors recovered by our contract recovery agencies from various locationsincluding Europe. In the 12 months from July 1, 200l to June 30, 2002, Tutogen distributed atotal of 21,639 musculoskeletal allograft products to patients in the U.S. Based upon the dataabove, this represents approximately 3% of the total number of bone allograft productsdistributed by AATB accredited Banks in the United States.
The implementation of the FDA’s proposed guidance would immediately reduce the number ofavailable HCT/P donors by approximately 10% in the U.S. due to country of origin exclusion.The direct impact to Tutogen would be an approximate 50% reduction in our donor base orapproximately 10,820 musculoskeletal allograft products. Therefore, the impact of this proposalfrom the FDA upon Tutogen would be greater than upon any other U.S. based tissue bank.Among the remaining 16,271 HCT/P donors (approximately) recovered by other AATBaccredited organizations annually, a large percentage would be eliminated under the proposedFDA rule that would disqualify any donor who has visited a listed country for a cumulativeperiod of 6-months or more. Not only would frequent travelers be considered deferred donors,but a large share of military veterans and their immediate family members due to being stationedoverseas. Tutogen does not have verifiable data concerning these figures, however, it is notinconceivable that this would adversely impact the donor pool by at least an additional 6% ormore, based on the blood bank industry experience, this would translated to a 976 HCT/P donors.The combination of Tutogen’s and the rest of the tissue banks would total approximately 2,726HCT/P donors. .

III. Musculoskeletal allografl tissue has been scientijiiaUy classified as low risk forCVZWCJD transmission. As with other AATB certified organizations, Tutogen allograftproducts are used across a multitude of medical applications. Currently, none of TutogenHCT/Ps in the United States are so-called high-risk tissue such as dura mater or corneas (refer toAppendix 1).
Not all tissue has the same infectivity risk. The HCT/Ps utilized by Tutogen in allografiproducts, distributed in the US, are classified as Category IV tissue (i.e., “No detectible @Jo-)infectivity”) by the World Health Organization in its March 19972 study.Tutogen has not processed or distributed in the United States high-risk Category II tissue such asdura mater since June 2000. Tutogen has never processed or distributed comeal tissue.Therefore the effect of any donor deferral ruling by the FDA on HCT/Ps limited to high-riskCategory II tissue, will not have any effect upon Tutogen’s ability to continue providing HCT/Psin the United States as shown in the table above.

2 World Health Organization, Emerging and other Communicable Diseases Report of a WHO consultation onmedicinal and other products in relation to human and animal transmissible Spongiform Encephalophathies.

2


IK Tutoplast safe@ claims are supported by a long-hktory (25 consecutive years) ofsuccessful allograft implants:

Tutogen HCT/Ps are recovered following a very stringent donor selection criterion in accordancewith AATB standards and FDA regulations. The current industry standard concerning CJDsignificantly reduces the risk of harvesting tissue from a potentially infected HCT/P donor.All Tutogen HCT/Ps are processed using a proprietary system known as the Tutophst 8 process.Tutogen’s single donor tissue processing methods (no pooling of donors) have been shown toensure viral/bacterial inactivation in controlled studies. The Tutopht 8 process has beenvalidated, specifically for the inactivation of prions and other transmissible agents. Twoindependent studies have confirmed that the Tutophst 8 process is capable of removinginfectious Prion agents from sol? tissue as a result of treating soft tissue with sodiumhydroxide. ‘4

Recommendations:

Tutogen recognizest hat the spread of bovine spongiform encephalopathy, or mad cow disease,has prompted debate concerning the possible modification of recent deferral criteria Tutogenurges the FDA to continue inviting scientists, physicians and patient groups to participate in thispolicy discussion. Physicians must be given accurate information about the benefits and risks,both real and theoretical associatedw ith HCT/P transplantations o that they can effectivelyeducate every patient when an HCT/P transplant is needed.

While Tutogen also recognizes that studies about the potential for transmission of TSEs inanimal models continue, however, evidence is still lacking of such transmission among patientswho have received human tissues, blood transfusions and clotting factor concentrates. Tutogenrespectfully requests that the Food and Drug Administration, before any final ruling, addressissues sited herein, by limiting its definition of deferred donor to those cases where high-riskCategory II tissue is being implanted (e.g., dura mater, corneas), and/or to those cases wheretissue recovery and processing methods being used pose additional risks.

Conclusion:

The very low incidence of human CJDMXD and our current screening criterion already poses alow risk that an infected donor may enter the process. The Centers for Disease Control andPrevention reports that the incidence of CJD is one case per million people each year.3Robert Koch Institut in Berlin (Department of the German FederalI nstitute of Health) Diringer H, Braig H,Infectivity of unconventional viruses in duramater,The Lancet, February 25, 19894L aboratorieso f RBM, Ivrea, Italy and expert opinion by Dr. Masullo (NurosurgeonM) asullo, 1994, Estimate ofthe theoretical risk of transmission of Creutzfeld-Jacob Disease by human duramater grafts manufactured by theTutoplast process.R MB, Studienbericht1, 994, Determination of the clearance factor for unconventional slowviruses during the processing of duramater.

3


Based upon the track record of safety, quality, and clinical effkacy of mhtml:%7B33B38F65-8D2E-434D-8F9B-8BDCD77D3066%7Dmid://00000055/!x-usc:mailto:TutopZast@%20and theproduct approval protocols adhered to by Tutogen, and already audited by the FDA, relating tothe import of HCT/Ps into the U.S. from Europe, we do not believe that there is any additionalrisk associated with HCT/Ps recovered and processed by Tutogen. Given the scientific dataavailable today, Tutogen does not believe that a blanket ruling to defer HCT/P donors fromspecific counties would reduce CJD and vCJD risk in cases where a validated recovery andprocessing procedure is being used. Indeed, the impact of a deferred donor ruling as presentlyproposed would significantly reduce the availability of HCT/Ps in the United States (up to 20%or more based upon the data contained herein) without a commensurate and measurable riskreduction in CJD and vCJD transmission.

Very truly yours,
Wade S, Tetsuka
Tutogen Medical U.S., Inc.General Manager
P.J. PardoTutogen Medical U.S., Inc.Director,Regulatory Affairs/ Quality Management



Appendix 1: mhtml:%7B33B38F65-8D2E-434D-8F9B-8BDCD77D3066%7Dmid://00000055/!x-usc:mailto:Tutoplast@P rocessedA llografks Distributed
Spinal / TraumaSulzer SpineTech,Minneapolis MNOphthalmologyIOP, Inc., Costa Mesa, CAENTUrologyMentor Corp., SantaBarbara, CADentalSulzer Dental, Carlsbad, CASpinal Fusion, ACL,Rotator Cuff repairGlaucoma patch, eyebrowslings, enucleationwraps, poterior segment,eyelid spacersTymp~oplasty,CholesteomaR esectionPelvic Floor repair,urinary incontinencePeridontal implantsFemur, Ulna, Radius,Humurous with cuff,anterior cruciateligament.Sclera, Pericardium,Fascia LataSclera, Pericardium,Fascia TemporalisFascia Lata,Pericardium,D ermisCancellousb onec hipsfrom femur, ulna, radius4,000 grafh8,000 grafts2,000 grafls9,000 grafts17,000 grafts


http://www.fda.gov/ohrms/DOCKETS/dailys/02/Dec02/121002/02d-0266.pdf





From: TSS
Subject: Possible body parts theft ring uncovered (spreading TSEs from stolen body parts perfectly legal in Texas after 4 hours)Date: December 24, 2005 at 7:36 am PST
Dec. 23, 2005, 11:44PMPossible body parts theft ring uncoveredSkin and bones are alleged to have been sold secretly

By TOM HAYSAssociated Press

NEW YORK - Michael Bruno's life had been uncomplicated: He was an immigrant who worked hard, spoke his mind and succumbed to kidney cancer two years ago at 75.

"Typical Italian cab driver," recalled his son, Vito. "He had an opinion about everything."
It's only after death that his story became ghoulish.

Authorities believe his body and those of hundreds of other people — including famed British broadcaster Alistair Cooke — were secretly carved up in the back rooms of several funeral parlors citywide to remove bone, skin and tendons, without the required permission from their families. Authorities allege the body parts were then sold for a profit.

Worse, health officials fear some of the stolen body parts were diseased, and could infect patients who received them in skin grafts, dental implants or other orthopedic procedures — a risk concealed by paperwork doctored with forged signatures and false information.

"It's not just disrespectful to my father," said Vito Bruno, who has sued one of the funeral homes. "It's an absolutely hideous crime against other people."

In the Cooke case, authorities confirmed this week that investigators contacted the late broadcaster's family after finding paperwork indicating his bones had been removed and sold by a Fort Lee, N.J., tissue bank, Biomedical Tissue Services, before he was cremated. Cooke, best known as the host of PBS's Masterpiece Theatre, died from cancer last year at 95 in Manhattan.
Violation of FDA rulesThe family insists it never signed off on the procedure, and that someone had falsified documents by changing his cause of death to heart attack, and by lowering his age to 85. Harvesting bones from cancer patients violates rules by the Food and Drug Administration.
A state grand jury in Brooklyn has been hearing evidence against at least a half dozen funeral homes in the borough and against Biomedical Tissue Services. Authorities allege that they illegally profited by conspiring to sell stolen body parts, and say indictments could be handed up early next year.

The scandal's reach extends beyond the New York City area. In the fall, the FDA ordered a recall of products produced by tissue processors in Texas, New Jersey, Florida and Georgia, all customers of Biomedical Tissue Services.

Health officials advised physicians that patients who were implanted with the tissue should be tested for HIV, hepatitis and other infectious diseases. The officials said they believed the health hazards were minimal, and no infections have been reported since the FDA warning.
But past cases have demonstrated dire risks. In 2001, a Minnesota man died after a knee surgery from an infection traced to cartilage from an infected donor. A year later, health officials in Oregon announced that several patients were infected with hepatitis C after receiving donated organs and tissue from a single corpse.

Authorities say the Brooklyn case stems from a deal struck between a dentist who started Biomedical Tissue Services, Michael Mastromarino, 42, of Fort Lee, and Joseph Nicelli, 49, an embalmer and funeral parlor operator from Staten Island.

Alleged harvesting schemeInvestigators suspect Nicelli helped secure access to tissue and bones from funeral directors for $500 to $1,000 a body. Mastromarino allegedly would remove the body parts, then ship them to processors paying thousands of dollars per order.

Attorneys for Nicelli and Mastromarino did not respond to numerous phone messages left by the Associated Press, but have previously denied that their clients did anything wrong. A phone number listed for Biomedical Tissue Services was disconnected.


http://www.chron.com/disp/story.mpl/nation/3545690.html


Dec. 23, 2005, 11:05AM

Authorities Probe Theft of Body Parts

By TOM HAYS Associated Press Writer© 2005 The Associated Press

NEW YORK — Authorities are investigating allegations that hundreds of bodies were illegally carved up in funeral homes around New York City and sold for parts without the permission of the families of the deceased.

Corpses _ including that of famed British broadcaster Alistair Cooke _ were used to harvest human bone, skin and tendons which were then sold for a profit, authorities allege.
Worse, health officials fear some of the stolen body parts were diseased, and could infect patients who received them in skin grafts, dental implants or other orthopedic procedures _ a risk concealed by paperwork doctored with forged signatures and false information.
"It's not just disrespectful to my father," said Vito Bruno, who has sued one of the funeral homes after his father Michael's corpse was desecrated. "It's an absolutely hideous crime against other people."

In the Cooke case, authorities confirmed this week that investigators contacted the late broadcaster's family after finding paperwork indicating his bones had been removed and sold by a Fort Lee, N.J., tissue bank, Biomedical Tissue Services, before he was cremated. Cooke, best known as the host of "Masterpiece Theatre," died from cancer last year at 95 in Manhattan.
The family insists it never signed off on the procedure, and that someone had falsified documents by changing his cause of death to heart attack, and by lowering his age to 85. Harvesting bones from cancer patients violates rules by the Food and Drug Administration.
A daughter, Susan Cooke Kittredge, said the family was "shocked and saddened" by the news.
"That people in need would have received his body parts, considering his age and the fact he was ill when he died, is appalling to the family, as is that his remains were violated," she said.
The probe _ first reported by the Daily News in October _ has generated other gruesome stories. In one instance, the corpse of a Queens grandmother that investigators exhumed last month had nearly all the bones removed below the waist and replaced with PCV pipes.
A grand jury in Brooklyn has been hearing evidence against at least a half dozen funeral homes in the borough and against Biomedical Tissue Services that they illegally profited by conspiring to sell stolen body parts. Authorities say indictments could be handed up early next year.
The brewing scandal's reach extends far beyond the New York City area.

In the fall, the FDA ordered a recall of products produced by tissue processors in New Jersey, Florida, Georgia and Texas, all customers of Biomedical Tissue Services. Since the announcement, authorities in Canada have determined that about 300 potentially tainted products were imported there, and used for dental surgery on at least two patients.
Health officials advised physicians that patients who were implanted with the tissue should be tested for HIV, hepatitis and other infectious diseases. The officials said they believed the health hazards were minimal, and no infections have been reported since the FDA warning.
But past cases have demonstrated dire risks.

In 2001, a Minnesota man died after a knee surgery from an infection caused by a bacterium traced to cartilage from an infected donor. A year later, health officials in Oregon announced that several patients were infected with hepatitis C after receiving donated organs and tissue from a single corpse.

Authorities say the Brooklyn case stems from a deal struck between a dentist who started Biomedical Tissue Services, Michael Mastromarino, 42, of Fort Lee, and Joseph Nicelli, 49, an embalmer and funeral parlor operator from Staten Island.

Investigators suspect Nicelli helped secure access to tissue and bones from funeral directors for $500 to $1,000 a body. Mastromarino allegedly would remove the body parts, then ship them to processors paying thousands of dollars per order.

Attorneys for both Nicelli and Mastromarino did not respond to numerous phone messages left by The Associated Press. A phone number listed for Biomedical Tissue Services was disconnected.

The Brooklyn case demonstrates the potential pitfalls of allowing funeral homes and tissue banks to do business without stricter oversight, said Annie Cheney, author of the upcoming book, "Body Brokers: Inside America's Underground Trade in Human Remains."

"The fact that these people were supposedly able to get away with this for so long is shocking," she said.

http://www.chron.com/disp/story.mpl/ap/nation/3544706.html


Dec. 23, 2005, 10:35AM

Allegations of body part sales investigated

Associated Press

NEW YORK — Authorities are investigating allegations that the body of British broadcaster Alistair Cooke — among hundreds of others — was illegally carved up in the back room of a funeral home and sold so its parts could be used in transplants.

Officials confirmed this week that investigators found paperwork indicating Cooke's bones had been removed and sold by Biomedical Tissue Services, a Fort Lee, N.J., tissue bank, before he was cremated.

Cooke, longtime host of PBS' "Masterpiece Theatre" and known around the world for his "Letter From America" shows on the BBC, died from cancer last year at age 95 in New York.
His family said it never agreed to the bone removal and that someone falsified documents by changing Cooke's cause of death to heart attack and by lowering his age to 85.

A day after his death, Cooke's bones were allegedly sold for about $7,000 to two transplant companies. The family was supplied with what they were told were his ashes, and scattered them in Central Park.

A daughter, Susan Cooke Kittredge, said the family was "shocked and saddened" by the news.
"That people in need would have received his body parts, considering his age and the fact he was ill when he died, is appalling to the family, as is that his remains were violated," she said.
A phone number listed for Biomedical Tissue Services was disconnected.


http://www.chron.com/disp/story.mpl/nation/3544620.html


TSS


----- Original Message -----

From: "Terry S. Singeltary Sr."
To:
Sent: Tuesday, December 20, 2005 4:25 PM
Subject: Re: THE LEGAL TRADING AND SELLING OF BODY PARTS AND HUMAN TSEs IN THE USA


----- Original Message ----- From: "Terry S. Singeltary Sr." To: Sent: Tuesday, December 20, 2005 4:25 PM Subject: Re: THE LEGAL TRADING AND SELLING OF BODY PARTS AND HUMAN TSEs IN THE USA

##################### Bovine Spongiform Encephalopathy #####################

Subject: Biomedical Tissue Services (BTS) THE BODY SNATCHERS and mad cow disease i.e. CJD and other dangerous pathogens Date: December 20, 2005 at 2:05 pm PST

Greetings BSE-L et al;

well, the 'dear unlucky john recipient' letters are in the mail, while these company's are laughing all the way to the bank. ...TSS

Biomedical Tissue Services (BTS) THE BODY SNATCHERS and mad cow disease i.e. CJD and other dangerous pathogens

Body snatchers tied to allograft firms? Alleged New York-area ring investigated for selling parts to corpse tissue harvesters. October 7, 2005: 2:54 PM EDT By Aaron Smith, CNN/Money staff writer

NEW YORK (CNN/Money) - A Brooklyn funeral home and a New Jersey company that harvests body parts from corpses are being investigated for their alleged roles in a body snatching ring that sold parts to companies specializing in medical grafts, sources close to the investigation said Friday.

The Brooklyn district attorney's office declined to comment on the investigation. But sources close to the investigation acknowledged that it has been going on for about one and a half years, focusing on Michael Mastromarino of Biomedical Tissue Services Ltd. of Fort Lee, N.J., who allegedly harvested body parts illegally from the Daniel George funeral home in Brooklyn.

The firms that bought the allegedly black-market tissue have not been accused of any wrongdoing. Human tissue is usually obtained from non-profit tissue banks. In the U.S., it's illegal to buy and sell human tissue.

Wendy Crites-Wacker, spokeswoman for Regeneration Technologies (down $0.66 to $7.28, Research), a company in Alachua, Fla., said her company has severed all ties with Biomedical Tissue Services, their former source for some of the body parts used to make medical grafts, or allografts.

"We had previously terminated the relationship with Biomedical Tissue Services and we are cooperating with the appropriate authorities on this issue," said Crites-Wacker, who declined to say when the termination took place.

Crites-Wacker also said that her company's BioCleanse process, in which bones and tendons are sterilized through a melange of chemicals, temperature and pressure, ensures that its products are safe.

Two other allograft companies have been identified as customers of Biomedical Tissue Services: LifeCell Corp. (down $2.82 to $17.33, Research), of Branchburg, N.J. and Tutogen Medical Inc. (down $0.15 to $4.06, Research) of West Paterson, N.J.

LifeCell Corp. had issued a Friday statement saying it had voluntarily recalled some human tissue products after questions were raised about Biomedical Tissue Services.

"Specifically, the company recalled all lots of product that were produced using tissue from Biomedical Tissue Services (BTS)," LifeCell said in a release.

LifeCell, which markets products made from human tissues that are used in surgical procedures, said it recalled certain AlloDerm, Repliform and GraftJacket products on Sept. 30.

LifeCell's stock price slid about 5 percent this morning, and a Piper Jaffray analyst attributed the slump to a New York Daily News story that first reported on the investigation.

"We believe this morning's weakness in LifeCell's shares is related to a news article that alleges LifeCell inadvertently received tissue from an illegal body-snatching ring," said Raj Denhoy of Piper Jaffray, in a written report.

LifeCell said in the statement all other tissues supplied by Biomedical Tissue Services remain "on hold until the discrepancies in the donor documentation can be resolved."

Denhoy said that LifeCell did not appear to do anything illegal and that "LifeCell itself was the victim of fraud," referring to allegations that Biomedical Tissue Services forged death certificates and family consent forms.

Denhoy said that LifeCell receives tissue from 30 sources, "so the loss of one will likely not impact the underlying business," though increased regulatory scrutiny could drive down the stock price.

"While LifeCell and the other tissue companies appear to have done nothing wrong, this event could increase regulatory and media scrutiny of the business," said Denhoy, who rates the company market perform. "We recently downgraded LifeCell shares on competitive concerns and today's revelations may pressure the stock further."

Eric Franz, the attorney representing funeral home owners Debora Johnson and Robert Nelms, said his clients "did not participate in any criminal conduct whatsoever."

Attempts to reach Mastromarino and his company Biomedical Tissue Services were unsuccessful. The Daily News reported that Mastromarino declined to comment.

Regeneration Technologies produces heart valves, bone and tendon implants and bone paste, which is used to plug holes. LifeCell specializes in AlloDerm, a "dermal matrix" made from human skin that is used in grafts. Tutogen focuses on bone and dental implants.

--from staff and wire reports

http://money.cnn.com/2005/10/07/news/midcaps/corpse/?section=money_latest


FDA News FOR IMMEDIATE RELEASE P05-77 October 26, 2005 Media Inquiries: Julie Zawisza, 301-827-6242 Consumer Inquiries: 888-INFO-FDA

FDA Provides Information on Investigation into Human Tissue for Transplantation The Food and Drug Administration (FDA) is notifying the public of its investigation of human tissue recovered by Biomedical Tissue Services, Ltd. (BTS) of Ft. Lee, NJ, and sent to tissue processors. Some of this tissue may have been implanted into patients from early 2004 to September 2005. The tissue was recovered by BTS from human donors who may not have met FDA donor eligibility requirements and who may not have been properly screened for certain infectious diseases. At this time, the implicated tissues from BTS include human bone, skin, and tendons. These products represent only a small percentage of the overall U.S. tissue supply.

While no adverse reactions related to these tissues have been reported to FDA at this time, because of the potential lack of proper screening of the tissue donors, some recipients of the tissues may be at increased risk of infections that could potentially be transmitted through tissues. FDA and the Centers for Disease Control and Prevention (CDC) believe the risks from these tissues are low because the tissues were routinely processed using methods that help to reduce the risk of infectious disease; however, the actual infectious risk is unknown.

FDA's requirements to determine donor eligibility include important steps to ensure that donors do not harbor infections that could be transmitted to recipients. These steps include reviewing the donor's medical history and other factors, physically assessing the donor, and testing for relevant communicable diseases that may place the donor at an increased risk of infections that could then unintentionally be transmitted to recipients through the tissues.

The following tissue processors received tissue from BTS:

LifeCell Corporation of Branchburg, NJ Lost Mountain Tissue Bank of Kennesaw, GA Blood and Tissue Center of Central Texas in Austin, TX Tutogen Medical, Inc., of Alachua, FL Regeneration Technologies, Inc., of Alachua, FL These firms already have voluntarily recalled all unused tissue remaining in inventory and are working cooperatively with FDA to ensure that the implanting physicians whose patients may have received the products are properly notified. Physicians who implanted tissue from BTS should have been contacted at this time by the receiving health care facility.

FDA and CDC recommend that implanting physicians inform their patients that they may have received tissue from a donor for whom an adequate donor eligibility determination was not performed. While the overall infectious risk is likely low, FDA and CDC recommend that physicians offer to provide patients access to appropriate infectious disease testing. The relevant communicable diseases for which a tissue donor is required to be tested are HIV-1 and 2 (the viruses that cause AIDS), hepatitis B virus, hepatitis C virus, and syphilis. Physicians who still have concerns or questions about the source of the tissue should contact the health care facility where the procedure was performed. FDA will continue its investigation into this matter and will issue further public health updates, as needed.

Patients and physicians should report any infectious disease possibly related to a tissue transplant to the processing firms, who then should notify FDA. Patients and physicians who wish to notify FDA directly of such infectious disease should report via FDA’s MedWatch reporting program at http://www.fda.gov/medwatch.

http://www.fda.gov/bbs/topics/NEWS/2005/NEW01249.html


Recall of Human Tissue

DATE RECALL INITIATED:

October 13, 2005

PRODUCT:

Human Tissue for Transplantation

MANUFACTURER:

Biomedical Tissue Services, Ltd Fort Lee, New Jersey

REASON:

Biomedical Tissue Services (BTS) was recently made aware that there is the possibility that tissue has been procured from donors without proper medical/social histories. BTS is performing a voluntary recall of any unused tissue from its consignees.

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

Updated October 18, 2005

http://www.fda.gov/cber/recalls/btstis101305.htm


Tutogen Medical Tissue Recall

Frequently Asked Questions and Answers

Q: What prompted this recall?

A: Tutogen was unable to verify donor consent for certain tissue provided by one of its recovery agency suppliers (BioMedical Tissue Services of Fort Lee, NJ). Tutogen, along with several other tissue processing companies, received allograft material from BioMedical Tissue Services. One of these other processing companies notified Tutogen that they were having difficulty in reaching persons taking the consent information or next of kin for BioMedical tissue donors. Upon receiving this notification, Tutogen immediately initiated a review and investigation of all donor consents received from BioMedical Tissue Services. Tutogen also experienced problems in contacting consent takers, witnesses and next of kin shown on the documentation provided by BioMedical Tissue Services. We further attempted to contact Dr. Michael Mastromarino, CEO and Executive Director of BioMedical Tissue Services, to assist in this matter, but without success. Although Tutogen does not believe that there are any safety concerns related to this tissue, the company elected to initiate a voluntary recall of products incorporating the BioMedical tissues, on ethical grounds.

Q: What tissue products are being recalled?

A: Specific serial/lot numbers of Tutogen’s Puros® Allograft Cancellous Particles (marketed by Zimmer Dental) and a small quantity of Tutoplast® Fascia Lata (marketed by Mentor Corporation and Innovative Opthalmic Products, Inc.) are involved in this recall.

Q: How much allograft tissue did BioMedical Tissue Services provide to Tutogen?

A: The quantity of tissue received from BioMedical represents a small fraction (about 2%) of all tissue processed by Tutogen.

Q: What did Tutogen do to notify customers of the recall?

A: Upon completion of its donor documentation investigation, Tutogen notified the FDA of our intent to initiate a voluntary recall. We immediately identified all BioMedical tissue, from raw material stock through finished goods and field distribution, and quarantined all material within our control. Customer shipment information was assembled and a recall letter was prepared and approved by the FDA. Initially, Tutogen alerted all customers of record via telephone, describing the reason for the recall, providing serial numbers of product shipped to them and indicating the process for the return and replacement of affected product.

Simultaneously, copies of the recall letter and distribution information for the affected product was sent to each customer by facsimile. This same information was then provided to customer accounts by certified mail. At the request of the FDA, Tutogen sent a recall follow-up letter to affected customers, including FDA mandated language regarding patient notification and access to disease testing.

An additional letter was prepared and mailed to those customers that had not received any of the products manufactured using BioMedical tissue and were not affected by the voluntary recall. In the interim, the company prepared and issued a press release concerning this recall and participated in numerous conference calls, throughout the U.S. and Canada, with surgeon groups, industry organizations (such as the American Association of Tissue Banks) and professional associations (such as the American Association of Oral and Maxillofacial Surgeons and the American Academy of Periodontology).

These prior communications were supplemented by a scientific dissertation mail-out that described the Tutogen Tutoplast® process, which subsequently led to the preparation of a technical monograph detailing this process and its qualification history. The monograph may be accessed on this website by selecting the link entitled, "The Tutoplast® Process: A Review of Efficacy".

Q: How can I tell whether I received any of the affected product?

A: All customers of record, that received products manufactured utilizing tissue provided by BioMedical, were notified and should have received an individualized list of all product serial numbers shipped to them. Affected product may also be quickly identified by visually checking the alpha-numeric designator beneath the product barcode label (see samples, shown below).

The affected product alpha-numeric code begins with the letters "BM" or "BT".

Q: How should I go about returning affected product that may remain in my inventory stock?

A: Once any affected product has been identified, place it in a shipping container and mark the outside of the container with "BMRECALL". Address the package to:

Tutogen Medical

13709 Progress Boulevard

South Wing

Alachua, FL 32615

Biomedical Tissue Services

Biotissue Recovery Services

Call UPS at (800) PICK UPS and request a package pick-up. Forward the package to Tutogen, via UPS ground, using account number Y6X706. This shipping account number is reserved for the return of recalled items and is for one-way service to Tutogen, from U.S. accounts. Only product affected by this recall will be accepted for return.

Canadian customers should contact Zimmer Dental Corporation Customer Service at (800) 265-0968 or (905) 567-2073 for return instructions.

Q: What is the risk to patients that have already received recalled implants?

A: The FDA and CDC have indicated that they believe the overall risk of disease transmission by these products is low, but unknown. Because Tutogen’ s Tutoplast® tissue preservation and sterilization process is extremely rigorous and has passed significant challenge testing, we believe that all tissue distributed by Tutogen, including that from BioMedical Tissue Services, is safe and effective for its intended use. In addition, comprehensive physical examination and serology testing is routinely performed on all donors processed by Tutogen.

Q: What types of evaluations are performed on donors processed by Tutogen Medical?

A: Consent for donation, along with a detailed medical/social history, is obtained from each donor or their next of kin by hospital, medical examiner, funeral home or recovery agency personnel. The recovery team identifies the donor and conducts a detailed physical evaluation of the body. This examination incorporates an extensive assessment checklist for characteristics that would disqualify a donor from further consideration and addresses tissue appearance and condition during the retrieval process. The recovery team also collects a donor blood sample and forwards it to a third-party CLIA certified laboratory for disease testing, using FDA approved test methodology. The serology test results, along with the previously mentioned donor documentation, is examined by Tutogen’s Quality Assurance Department and a staff Medical Director (a licensed physician). Only after these thorough reviews are completed and release is granted by the Medical Director, is donor tissue allowed to enter the Tutoplast® process.

Q: What testing is done on the donor serology sample?

A: Tutogen requires that the following serology testing be performed and found to be "negative" or "non-reactive", prior to accepting any donor tissue for processing:

Hepatitis B surface antigen (HBsAg)

Hepatitis B core antibody (HBcAb – IgG +IgM)

Hepatitis C Virus antibody (HCV Ab)

Hepatitis B and C Nucleic Acid Testing (HBV and HCV NAT)

Human Immunodeficiency Virus I and II antibodies (HIV I and II Ab)

HIV I – p24

Human T-Lymphotropic Virus I and II (HTLV I and II Ab)

Syphilis – Rapid Plasma Reagin (RPR/STS)

Q: Who will pay for the cost of disease testing for my patients?

A: Although Tutogen does not feel that the products manufactured using BioMedical tissue pose a safety concern, out of respect for your patients’ welfare and as a service to you, Tutogen has elected to bear the cost of the appropriate infectious disease testing.

Q: What process has Tutogen put in place to accomplish the disease testing"?

A: We have made arrangements with ViroMed Laboratories (division of LabCorp), a respected, CLIA and FDA certified organization, to conduct this testing. Should you choose to inform those patients who received the affected implants, we suggest that you offer them the opportunity to be tested for the specified infectious diseases. Additionally, we recommend that you maintain a record of notification for each patient, which would indicate their acceptance or rejection of the testing offered and be signed/dated by that individual. For those patients that elect to undergo testing, both U.S. and Canadian customers should follow the process delineated, below.

1. Provide Tutogen Medical with the name and mailing address of the patient. Only patients that received implants utilizing tissue provided by BioMedical Tissue Services are eligible for this pre-paid testing. This information will be verified in our Tissue Utilization Record (TUR) database, or you may provide documentation confirming the patient’s implant, if no TUR was previously forwarded to Tutogen.

2. Let the patient know that a test kit will be sent to him or her by ViroMed Laboratories within the next few days and will include instructions on how to proceed.

3. Instruct the patient to set up an appointment with and take the test kit to their Primary Care physician. Alternatively, the patient may elect to visit a LabCorp service center as indicated in item # 7, below.

4. Following the instructions provided with the kit, the Primary Care physician or professional healthcare office staff member should obtain a blood sample from the patient and forward it to ViroMed Laboratories in the postage-paid mailer that will be included in the kit.

5. ViroMed Laboratories will perform the appropriate disease testing and forward the results to the patient’s Primary Care physician. If a confirmatory test is necessary, ViroMed Laboratories will automatically perform this additional testing and include those results in the final test report.

6. Upon receipt of the ViroMed data, the Primary Care physician should contact the patient and discuss the final results of the testing with him or her.

7. In the event that your patient does not have a Primary Care physician, he or she may go to a "walk-in" clinic to have a blood sample taken or to be referred to a LabCorp service

center near them and have this blood sample drawn and forwarded to ViroMed Laboratories for testing. The attending physician may call ViroMed Client Services, at (800) 582-0077, to arrange for a test kit or to obtain instructions for handling the sample. These patients must have their eligibility verified by Tutogen. LabCorp or ViroMed will provide all associated test kit supplies. A list of service center locations is available on the LabCorp website (www.labcorp.com ) under the "Patient Service Center Locator" link.

If you have a patient that has already presented for infectious disease testing, a reimbursement request for costs not covered by the individual’s insurance carrier can be made by forwarding the invoice, showing the net responsibility of the patient, or a receipt, marked "Paid" to:

Tutogen Medical, Inc.

Accounts Payable

13709 Progress Blvd., Box 19

Alachua, FL 32615

The invoice should clearly show the name and address of the facility performing the disease testing and be annotated with the name of the patient ’s dentist/oral surgeon and practice name, as well as the identifier, "BMRECALL".

Q: What testing will be performed on each patient’s blood sample?

A: The recommended testing is for HIV I and II, Hepatitis B virus, Hepatitis C virus and syphilis. All test results will remain confidential, between patient and doctor.

Q: Is Tutogen still receiving tissue from BioMedical Tissue Services?

A: No. Upon initiating the voluntary recall, Tutogen suspended the acceptance of any tissues from BioMedical Tissue Services and has officially terminated its relationship with them.

Q: How can a situation such as this be prevented in the future?

A: At this point, there is no simple answer to this question. Tutogen adhered to all of its standard screening, inspection and processing procedures and there was no deviation or departure from its quality assurance systems. All processing companies rely on the FDA registered and state licensed recovery agencies to comply with established regulations and industry guidelines. Tutogen is currently evaluating a number of potential additional safeguards, but no mechanisms have been identified that would provide a foolproof solution. In addition, we are working very closely with the Food and Drug Administration and American Association of Tissue Banks to devise workable options that might preclude recurrence.

http://www.tutogen.com/recallQandA.pdf


Recall of Human Tissue Products

DATE RECALL INITIATED:

October 14, 2005

PRODUCT:

Human Tissue For Transplantation

MANUFACTURER:

Regeneration Technologies, Inc Alachua, Florida

REASON:

Regeneration Technologies, Inc. (RTI) is conducting a voluntary recall of all tissue received from BioMedical Tissue Services (BTS; Ft. Lee, New Jersey) as a result of information regarding the accuracy of donor screening documentation. RTI informed its consignees that a lack of assurance of donor identity as well as the risk of infectious diseases also exists. Consignees are asked to contact the manufacturer to arrange for product return.

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

Updated October 18, 2005

http://www.fda.gov/cber/recalls/rtitis101405.htm


FDA News FOR IMMEDIATE RELEASE P05-77 October 26, 2005 Media Inquiries: Julie Zawisza, 301-827-6242 Consumer Inquiries: 888-INFO-FDA

FDA Provides Information on Investigation into Human Tissue for Transplantation The Food and Drug Administration (FDA) is notifying the public of its investigation of human tissue recovered by Biomedical Tissue Services, Ltd. (BTS) of Ft. Lee, NJ, and sent to tissue processors. Some of this tissue may have been implanted into patients from early 2004 to September 2005. The tissue was recovered by BTS from human donors who may not have met FDA donor eligibility requirements and who may not have been properly screened for certain infectious diseases. At this time, the implicated tissues from BTS include human bone, skin, and tendons. These products represent only a small percentage of the overall U.S. tissue supply.

While no adverse reactions related to these tissues have been reported to FDA at this time, because of the potential lack of proper screening of the tissue donors, some recipients of the tissues may be at increased risk of infections that could potentially be transmitted through tissues. FDA and the Centers for Disease Control and Prevention (CDC) believe the risks from these tissues are low because the tissues were routinely processed using methods that help to reduce the risk of infectious disease; however, the actual infectious risk is unknown.

FDA's requirements to determine donor eligibility include important steps to ensure that donors do not harbor infections that could be transmitted to recipients. These steps include reviewing the donor's medical history and other factors, physically assessing the donor, and testing for relevant communicable diseases that may place the donor at an increased risk of infections that could then unintentionally be transmitted to recipients through the tissues.

The following tissue processors received tissue from BTS:

LifeCell Corporation of Branchburg, NJ Lost Mountain Tissue Bank of Kennesaw, GA Blood and Tissue Center of Central Texas in Austin, TX Tutogen Medical, Inc., of Alachua, FL Regeneration Technologies, Inc., of Alachua, FL These firms already have voluntarily recalled all unused tissue remaining in inventory and are working cooperatively with FDA to ensure that the implanting physicians whose patients may have received the products are properly notified. Physicians who implanted tissue from BTS should have been contacted at this time by the receiving health care facility.

FDA and CDC recommend that implanting physicians inform their patients that they may have received tissue from a donor for whom an adequate donor eligibility determination was not performed. While the overall infectious risk is likely low, FDA and CDC recommend that physicians offer to provide patients access to appropriate infectious disease testing. The relevant communicable diseases for which a tissue donor is required to be tested are HIV-1 and 2 (the viruses that cause AIDS), hepatitis B virus, hepatitis C virus, and syphilis. Physicians who still have concerns or questions about the source of the tissue should contact the health care facility where the procedure was performed. FDA will continue its investigation into this matter and will issue further public health updates, as needed.

Patients and physicians should report any infectious disease possibly related to a tissue transplant to the processing firms, who then should notify FDA. Patients and physicians who wish to notify FDA directly of such infectious disease should report via FDA’s MedWatch reporting program at http://www.fda.gov/medwatch.

Additional information is available on FDA’s web site at http://www.fda.gov/cber/recalls.htm and by calling 1-800-835-4709.

####

http://www.fda.gov/bbs/topics/NEWS/2005/NEW01249.html


Recall of Human Tissue Products

DATE RECALL INITIATED:

October 11, 2005

PRODUCT:

Human Tissue for Transplantation

MANUFACTURER:

The Blood and Tissue Center of Central Texas Austin, Texas

REASON:

Central Texas Regional Blood and Tissue Center is voluntarily recalling tissue products as the firm is unable to confirm information provided by BioMedical Tissue Services (BTS; Ft. Lee, New Jersey). Consignees are asked to contact the manufacturer to arrange for product return.

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

Updated October 18, 2005

http://www.fda.gov/cber/recalls/blotis101105.htm


Recall of Human Tissue Products

DATE RECALL INITIATED:

October 12, 2005

PRODUCT:

Human Tissue for Transplantation

MANUFACTURER:

Tutogen Medical, Inc. Alachua, Florida

REASON:

Tutogen Medical is conducting a voluntary recall of all materials that were manufactured utilizing BioMedical Tissue Services (BTS; Ft. Lee, New Jersey) donor tissue. This action is being taken because Tutogen is unable to satisfactorily confirm that donor eligibility had been properly obtained by BTS. Tutogen informed its consignees that there is a lack of assurance that appropriate donor identification, donor screening, and medical history data collection was performed and, therefore, a risk of infectious disease exists. Consignees are asked to contact the manufacturer to arrange for product return.

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

Updated October 18, 2005

http://www.fda.gov/cber/recalls/tutotis101205.htm


Withdrawal of Human Tissue Products

DATE WITHDRAWAL INITIATED:

October 10, 2005

PRODUCT:

Human Tissue for Transplantation

MANUFACTURER:

Lost Mountain Tissue Bank Kennesaw, Georgia

REASON:

Lost Mountain Tissue Bank, Inc. (LMTB) has initiated consignee notifications for all tissue products processed and/or distributed from donors procured in the New York area by Biomedical Tissue Services (BTS; Ft. Lee, New Jersey). LMTB was informed of some discrepant and possibly fraudulent information in donor documentation. LMTB is notifying all relevant hospitals and medical professionals of the market withdrawal of all tissue products beginning with the letters “GL” or “T” in the tissue identification number (ID#).

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

Updated October 18, 2005

http://www.fda.gov/cber/recalls.htm


DATE RECALL INITIATED:

September 30, 2005

PRODUCT:

AlloDerm, Repliform, and GraftJacket

MANUFACTURER:

LifeCell Corporation Branchburg, New Jersey

REASON:

LifeCell Corporation initiated a voluntary recall of certain AlloDerm, Repliform, and GraftJacket product from the marketplace on September 30, 2005. The recall was prompted when internal quality processes raised questions about the donor documentation received from one tissue recovery organization. Specifically, the company recalled all lots of product that were produced using tissue from Biomedical Tissue Services (BTS). Life Cell promptly notified the FDA and all relevant hospitals and medical professionals. All other BTS inventory remains on hold until the discrepancies in the donor documentation can be resolved. LifeCell works with more than 40 other tissue recovery organizations that are not affected by this recall.

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

Updated October 12, 2005

http://www.fda.gov/cber/recalls/tislife093005.htm


Compliance Program Inspection of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) 7341.002

http://www.fda.gov/cber/cpg/7341002tis.htm


TSS

----- Original Message -----
From: "Terry S. Singeltary Sr."
To:
Sent: Thursday, October 27, 2005 9:55 AM Subject: THE LEGAL TRADING AND SELLING OF BODY PARTS AND HUMAN TSEs IN THE USA

##################### Bovine Spongiform Encephalopathy #####################

From: TSS () Subject: THE LEGAL TRADING AND SELLING OF BODY PARTS AND HUMAN TSEs IN THE USA Date: October 27, 2005 at 8:40 am PST

WASHINGTON FDA investigating human tissue sales WASHINGTON - The Food and Drug Administration said Wednesday that it is investigating a New Jersey-based company that sold human tissue to processors for eventual implantation into people, because it may not have been properly screened for infections. The New York Daily News reported earlier this month that the district attorney's office in Brooklyn, N.Y., is investigating the company, Biomedical Tissue Services of Fort Lee, N.J., on allegations that the company illegally bought body parts from funeral homes to sell to tissue processors. An FDA spokeswoman would not comment on those allegations. The tissues include human bones, skin and tendons and constitute only a small portion of the U.S. tissue supply, the FDA said. They were implanted between early 2004 and September 2005. The Blood and Tissue Center of Central Texas in Austin received some.

http://www.chron.com/cs/CDA/ssistory.mpl/nation/3419112


FOR IMMEDIATE RELEASE P05-77 October 26, 2005 Media Inquiries: Julie Zawisza, 301-827-6242 Consumer Inquiries: 888-INFO-FDA

FDA Provides Information on Investigation into Human Tissue for Transplantation The Food and Drug Administration (FDA) is notifying the public of its investigation of human tissue recovered by Biomedical Tissue Services, Ltd. (BTS) of Ft. Lee, NJ, and sent to tissue processors. Some of this tissue may have been implanted into patients from early 2004 to September 2005. The tissue was recovered by BTS from human donors who may not have met FDA donor eligibility requirements and who may not have been properly screened for certain infectious diseases. At this time, the implicated tissues from BTS include human bone, skin, and tendons. These products represent only a small percentage of the overall U.S. tissue supply.

While no adverse reactions related to these tissues have been reported to FDA at this time, because of the potential lack of proper screening of the tissue donors, some recipients of the tissues may be at increased risk of infections that could potentially be transmitted through tissues. FDA and the Centers for Disease Control and Prevention (CDC) believe the risks from these tissues are low because the tissues were routinely processed using methods that help to reduce the risk of infectious disease; however, the actual infectious risk is unknown.

FDA's requirements to determine donor eligibility include important steps to ensure that donors do not harbor infections that could be transmitted to recipients. These steps include reviewing the donor's medical history and other factors, physically assessing the donor, and testing for relevant communicable diseases that may place the donor at an increased risk of infections that could then unintentionally be transmitted to recipients through the tissues.

The following tissue processors received tissue from BTS:

LifeCell Corporation of Branchburg, NJ Lost Mountain Tissue Bank of Kennesaw, GA Blood and Tissue Center of Central Texas in Austin, TX Tutogen Medical, Inc., of Alachua, FL Regeneration Technologies, Inc., of Alachua, FL These firms already have voluntarily recalled all unused tissue remaining in inventory and are working cooperatively with FDA to ensure that the implanting physicians whose patients may have received the products are properly notified. Physicians who implanted tissue from BTS should have been contacted at this time by the receiving health care facility.

FDA and CDC recommend that implanting physicians inform their patients that they may have received tissue from a donor for whom an adequate donor eligibility determination was not performed. While the overall infectious risk is likely low, FDA and CDC recommend that physicians offer to provide patients access to appropriate infectious disease testing. The relevant communicable diseases for which a tissue donor is required to be tested are HIV-1 and 2 (the viruses that cause AIDS), hepatitis B virus, hepatitis C virus, and syphilis. Physicians who still have concerns or questions about the source of the tissue should contact the health care facility where the procedure was performed. FDA will continue its investigation into this matter and will issue further public health updates, as needed.

Patients and physicians should report any infectious disease possibly related to a tissue transplant to the processing firms, who then should notify FDA. Patients and physicians who wish to notify FDA directly of such infectious disease should report via FDA’s MedWatch reporting program at http://www.fda.gov/medwatch.

Additional information is available on FDA’s web site at http://www.fda.gov/cber/recalls.htm and by calling 1-800-835-4709.

####

http://www.fda.gov/bbs/topics/NEWS/2005/NEW01249.html


a bit of history;

The Eyes have it/CJD * and they could be stealing them from YOUR loved one, hence the spread of CJD (aka MADCOW DISEASE) will spread...

############ Creutzfeldt-Jakob Disease #############

Greetings list members, I was impressed that someone is listening, considering the timing of when I broke the story in Nov. and this was posted in Dec., what a coincidence. Thanks for listening. I find it rather frightening of the fact sporadic CJD as well as vCJD can

transmit infectivity this way. Makes me wonder about blood? Kind Regards, Terry S. Singeltary Sr., Bacliff, Texas USA

http://mad-cow.org/~tom/dec99_news.html#bbb


Testimony of Bess Believeaux, Lions Eye Bank of Central Texas (Submission to the Jan. 18/19 meeting of the TSE Advisory Committee)

http://www.fda.gov/ohrms/dockets/ac/01/slides/3681s2_16.pdf


TSS Submission to the same Committee;

http://www.fda.gov/ohrms/dockets/ac/01/slides/3681s2_09.pdf


Tissue Banks International (TBI), Gerald J Cole

http://www.fda.gov/ohrms/dockets/ac/01/slides/3681s2_13.pdf


re-use contact lenses

http://mad-cow.org/~tom/dec99_news.html#bbb



TSS

Link: Reported by Terry S. Singeltary Sr. son of CJD victim 28 Nov 99 THE EYES HAVE IT, CJD...


#################### https://lists.aegee.org/bse-l.html ####################

#################### https://lists.aegee.org/bse-l.html ####################



http://mad-cow.org/~tom/dec99_news.html#bbb




American, 39, dies of dura mater implant
April 19, 2000
By RONALD CAMPBELL The Orange County Register

A tissue implant in 1992 helped cure Karen Bissell of numbness in her hands and legs. Six years later, it probably killed her. Bissell, 39, died Sept. 21, 1998, of Creutzfeldt-Jakob Disease, or CJD, a rare neurological condition. Scientists believe she was one of about 110 people worldwide who acquired the disease since 1987 from contaminated tissue transplants.

After Bissell's death, the company that provided the tissue launched a voluntary recall, while maintaining there was no conclusive proof the implant killed her.

The disease erupted in June 1998. In her last days, Bissell did not even know that she was being moved from a Denver hospital to a hospice. "The doctor told me she did not know what was happening, and she was not in any pain," said her mother, Eleanor Bissell. "I'm thankful for that." A friend memorialized her as "an angel to everyone she touched when she walked on Earth and now an angel to all as she resides in heaven."

Bissell will get a much-longer epitaph in the medical and legal literature. The scientists who investigated her death are preparing an article for a medical journal � at least the fourth such article tying CJD to transplants of dura mater, the outer lining of the brain. Because of the growing medical evidence, the U.S. Food and Drug Administration issued guidelines last October to prevent the spread of CJD through dura mater transplants.

CJD is a rare disease, striking one person in a million. Most victims are 55 or older. When CJD strikes a younger person, "we try to see if we can find some kind of exposure," said Colorado State Epidemiologist Richard Hoffman, who investigated Bissell's death. "In this case, there was a fairly glaring possibility as to where the person acquired it." Hoffman discussed Bissell's case in general terms, without naming her. The Orange County Register independently verified her identity.

In 1992, Eleanor Bissell recalled, her daughter complained of numbness in her hands as well as numbness and a tingling sensation in her legs. A physician diagnosed Arnold-Chiari malformation, an obstruction of nerves entering her brain. He operated to relieve the obstruction and used a package of dura mater from a German processor to patch the dura he had cut. The surgery bought Bissell six years of good health.

She was the youngest of four daughters. Never married, she remained close to her parents, often sharing their house in a Denver suburb. After 15 years of working at Lowry Air Force Base, however, Bissell decided in the fall of 1997 that she wanted a change. She got a job with the U.S. Department of Agriculture in Miami.

In June 1998, home for vacation, Bissell complained of blurry vision and headaches. The next month, the symptoms worsened, and she began a long round of visits to doctors, in search of answers. Finally, on Aug. 26, she flew to Denver.

"First she was using a cane when she got home," her mother recalled. "Then she was using a walker. Then she was using a wheelchair." From cane to walker to wheelchair was a journey of 10 days. "Day by day, she just went down, down," Eleanor Bissell said. "Each day it got a little bit worse."
The doctors in Miami had not been able to figure out what was h
appening. The Denver doctors while conducting a test saw brain cells literally being destroyed as they watched, and made their diagnosis.

While Bissell lay dying, Hoffman and investigators for the Centers for Disease Control and Prevention and the FDA scoured her medical records. They learned of the 1992 dura mater transplant, traced it to the German manufacturer and to a donor who, Hoffman said, died of a neurological illness. An autopsy had been done, but not a microscopic examination of the brain, which might have revealed CJD.

"I don't think we can conclusively say that the donor did or did not have (CJD)," Hoffman said. But he believes the transplant was "the most likely source of exposure."

The investigation of Bissell's death prompted the American parent of the German dura mater processor, New Jersey-based Tutogen Medical Inc., in mid-1999 to voluntarily recall all dura mater processed in Germany before 1994. Little was returned. In addition, Germany imposed new requirements for dura processing that the company said cost it $350,000 in revenue and $210,000 in profit.

Manfred Kreuger, Tutogen's chief executive, expressed "our deepest sympathy to the woman's family." But, he added, "to suggest that the dura mater was the cause of her condition is, frankly, unfounded." Tutogen was denied access to Bissell's medical records, Kreuger said. But a review of the donor's records showed that while "he certainly had some neurology abnormalities" and depression, he died from heart disease.

He said he believes Tutogen's dura mater "is a very safe product." Tutogen recalled its dura anyway, the company said in a May 1999 report to the Securities and Exchange Commission, because it "cannot rule out with absolute certainty" that its dura killed Bissell.


http://www.mad-cow.org/00/may00_news.html#ccc2



TUTOGEN

http://www.tutogen.com/


TutoplastTM

bone, bone-patellar tendon-bone

* alkaline treatment for prions (tissues are treated with 1N sodium hydroxide for 1 hr at room temperature)

-fascia

-pericardium

-dermis

* because this treatment also affects collagen in a time dependent manner it CANNOT BE USED ON BONES, TENDONS, OR LIGAMENTS WITHOUT A SIGNIFICANT REDUCTION IN BIOMATERIAL PROPERTIES.


http://www.clearant.com/latestnews/im47200211271552.PDF


TUTOGEN MEDICAL INC - Annual Report (Small Business Issuers ...


http://sec.edgar-online.com/tutogen-medical-inc/10ksb-annual-report-small-business-issuers/2001/12/20/Section2.aspx





-------- Original Message --------
Subject: Re: A NEW BRUNSWICKER REPORTED DEAD OF CJD AFTER BRAIN SURGERY (7 CJD cases possible in N.B., officials say)
Date: Fri, 26 Sep 2003 17:11:39 -0500
From: "Terry S. Singeltary Sr." Reply-To: Bovine Spongiform Encephalopathy To: BSE-L@uni-karlsruhe.deReferences: <3f71d32b.5000506@wt.net> <3f72fb5f.5030205@wt.net> 3F743CE8.8070804@wt.net

European Journal of Epidemiology 16 (4) p.353-355 April 2000Kluwer
Creutzfeldt–Jakob Disease in health professionals in SlovakiaMitrová Eva1 and Belay Girma1
1.Institute of Preventive and Clinical Medicine, Limbová 14, 833 01Bratislava, Slovakia


Creutzfeldt–Jakob disease (CJD) is the most important humantransmissible spongiform encephalopathy (prion disease), recognised insporadic, genetic but also iatrogenic forms. The identification of 8health care workers in a group of 114 definitive CJD patients inSlovakia suggested the possibility of professionaly acquired CJD andinduced the investigation of potential endo- and exogenous risk factors.In CJD-affected health professionals special attention was paid to adetailed occupational history, including a possible professional contactwith CJD patient and to the findings characteristic for iatrogenic CJD:early cerebellar symptomatology, long duration of the disease, absenceof typical EEG finding and homozygosity of PRNP gene at codon 129.Analysis of epidemiological, clinical and molecular biological data ininvestigated group of CJD-affected health professionals gave no evidenceof an occupational risk for CJD.

Creutzfeldt–Jakob disease, Health professionals, Iatrogenic
PDF(63K)
BibTex
EndNode
Copyright© 2000 Kluwer Academic Publishers All rights reserved


http://reo.nii.ac.jp/journal/HtmlIndicate/Contents/SUP0000001000/JOU0001000164/ISS0000002345/ART0000025322/ART0000025322_abstract.html




comments from Tom about these cases;

Comment (webmaster): 7% of sporadic CJD in health professionals is waytoo high to occur by chance, despite the tone of the abstract. Now thefirst thing Dr. Mitrova would have done is rule out familial CJD of theform E200K, which has a very extensive cluster in Slovakia, though theabstract does not really say what was sequenced besides codon 129 of theprion gene. Little credence can be given to the idea that acharacteristic pattern exists for iatrogenic CJD, which is a totalhodge-podge after the dominant forms, growth hormone and dura mater, aresubtracted.
One very real possibility in Slovakia is that the high numbers of E200Kcases, prior to diagnosis, has led to a secondary epidemic in healthcare workers. This source would be missed by epidemiology because onlyexposure to clinical E200K (hospice workers) would be considered.
One clear-cut case of a health worker at occupational risk is theorthopedic surgeon who removed dura mater from sheep brain for thecompany in Germany selling dura mater for human transplants.

Until Germany conducts a Prionics-type survey of its sheep, we will haveno real idea of the prevalence of scrapie there. The whole dura matertragedy unfolding in Japan may have resulted from sheep dura mater beingused instead of human cadaver. If so, this unfortunate 'experiment'would prove transmissibility of scrapie to humans (though who woulddoubt this in a scrapie dura mater brain transplant?).

Spinal dura contains elastin and collagen gene products, which wouldallow the species origin of the transplant to be determined even decadeslater (if it is not resorbed). Thus it is still possible to determine iscausing the Japanese dura mater outbreak.

The other related case of a possibly affected caregiver is ahusband-and-wife pair who contracted sporadic CJD within a few years ofeach other:

http://www.mad-cow.org/00/aug00_last_news.html#ddd


i'd say this doctor has seemingly misrepresented medical informationthat was readily available to him from official Health Canada web sites andprominent previous alerts that he and his hospital would have previouslyreceived.

Tutogen Medical, Inc. was formerly known as Pfrimmer-Viggo GmbH+Co,Erlangen, Germany). Their Canadian distributor is listed as CenterpulseDental Canada (hmmm) where in the US it is Tutogen Medical Inc.[Productlines: Dental, Spine, Membrans, Sports Medicine, Bone (more hmmm) ]


http://www.tutogen.de/pages/kontakt/vertreiberadressen.html


what would you call this Health Canada statement ...


"The April 2001, edition of "Neurology" published details of the first case of classical Creutzfeldt-Jakob Disease (CJD) associated with the use of Tutoplast Dura. Following the publication of this news, Health Canada took action to obtain further information on the current surgical need for the use of Tutoplast Dura in Canada. It wrote to orthopaedic, neurosurgical and otolaryngological professional associations seeking advice on the importance to their members of the continued availability of Tutoplast duramater. The Canadian Neurosurgical Society (CNSS) responded by conducting a survey of their members. Of those who replied, 61% supported discontinuing the use of donor dura mater.

On April 10, 2002, Health Canada suspended the medical device licence for Tutoplast Dura. The suspension means that the importation and sale of this medical device is no longer permitted in Canada. Tutoplast Dura manufactured before 1992 was processed with a less concentrated disinfectant solution than material manufactured after October 1992.

The disinfectant used initially, which was in accordance with what was known regarding prion diseases at the time, was a ten times weaker solution of sodium hydroxide than was used starting in 1992. Tutoplast Dura (manufactured by Tutogen Medical GmbH of Germany) was first sold in Canadain January, 1982."

On the company's website in Germany, it seems they have now gone over to Tutomesh ... from bovine pericardium " that is prepared using theTUTOPLAST® procedure thus eliminating antigenic properties"


http://www.tutogen.de/pages/produkte/indikation/detail/tutomeshhernen.html


Some previous experiences in Japan:

"The most recent recipient of a dura mater graft among the 43 graft-associated CJD patients was a woman aged 65 years at the time ofonset of CJD. She had two neurosurgical procedures in 1991 to repair acerebral arterial aneurysm (one in September and one in October); duramater grafts were used during both operations. In February 1994, 28 months after the second operation, she developed progressive dysphagia, dysarthria, and unsteady gait, followed within a few weeks by dementia. In April 1995, she developed generalized myoclonic jerks and akinetic mutism. An electroencephalograph showed a 6- to 10-Hz background rhythm with the periodic synchronized slow activity complexes typical of CJD. Examination of the cerebrospinal fluid revealed a normal protein level and cell count. A magnetic resonance imaging scan showed marked cerebral and cerebellaratrophy. The patient died in October 1995, and no autopsy was performed.

Neither the brand nor year of processing of the dura mater grafts used inthis patient in 1991 could be determined. However, the hospital in which both neurosurgical procedures were performed opened in 1989 and reported using only two brands of dura mater grafts in 1991, LYODURA{Registered} andTutoplast (Pfrimmer-Viggo GmbH+Co, Erlangen, Germany). The investigation suggested that in this patient, the use of LYODURA{Registered} processed before May 1987 was unlikely but could not be ruled out.


http://www.cdc.gov/mmwr/preview/mmwrhtml/00049829.htm


... Even stringent donor screening and processing of each dura separately to avoid possible cross-contamination may not completely eliminate the potential for an infectious graft. In addition, the treatment of dura with NaOH may not inactivate all of the infectious agent that may be present(6). Therefore, surgeons should be aware of the possibly inherent risk for CJD transmission by dura mater grafts and may want to consider the alternative use of autologous fascia lata, fascia temporalis, or synthetic substitutes (4). "


http://www.hc-sc.gc.ca/english/media/releases/2003/cjdbk.htm


September 2003

Information

Tutoplast Dura mater

Health Canada is the national authority that regulates the safety, efficacyand quality of therapeutic products (such as medical devices) used inCanada. It derives its statutory authority over therapeutic products fromthe Food and Drugs Act and Regulations.

Tutoplast Dura mater is a medical device that was available in Canadabetween January 1982 and April 2002 for use in various surgical treatments,including neurosurgery.

The term "medical device" covers a wide range of products used in thetreatment, mitigation, diagnosis or prevention of a disease or abnormalphysical condition. Some examples include pacemakers, artificial heartvalves, hip implants, synthetic skin, medical laboratory diagnosticinstruments, test kits for diagnosis and contraceptive devices.

The Medical Devices Bureau of the Therapeutic Products Directorate (TPD) atHealth Canada is the national authority that monitors and evaluates thesafety, effectiveness and quality of diagnostic and therapeutic medicaldevices in Canada. The Medical Devices Bureau enforces the Medical DevicesRegulations, which aim to ensure to the extent possible, the safety,effectiveness and quality of medical devices in Canada. This is donethrough a combination of pre-market review, post-approval surveillance andquality systems in the manufacturing process.

In Canada, certain medical devices must have a Medical Device Licencebefore they can be sold. To determine which ones need a Licence, allmedical devices have been categorized based on the risk associated withtheir use. This approach means that all medical devices are grouped intofour classes with Class I devices presenting the lowest potential risk(e.g. a thermometer) and Class IV devices presenting the greatest potentialrisk (e.g. pacemakers).

Prior to selling a medical device in Canada, manufacturers of Class II, IIIand IV devices must obtain a Medical Device Licence. Although Class Idevices do not require a Licence, they are monitored through EstablishmentLicences.

What is Tutoplast dura mater?

Dura mater is a tissue that covers and protects the brain and spinal cord.Commercially processed dura mater, obtained from human donors, has beenused in the surgical treatment of many conditions in Canada since the 1970s.

Tutoplast Dura manufactured before 1992 was processed with a lessconcentrated disinfectant solution than material manufactured after October1992. The disinfectant used initially, which was in accordance with whatwas known regarding prion diseases at the time, was a ten times weakersolution of sodium hydroxide than was used starting in 1992.

Processed dura mater is regulated as a class IV medical device. TutoplastDura (manufactured by Tutogen Medical GmbH of Germany) was first sold inCanada in January, 1982.
The April 2001, edition of "Neurology" published details of the first caseof classical Creutzfeldt-Jakob Disease (CJD) associated with the use ofTutoplast Dura.

Following the publication of this news, Health Canada took action to obtainfurther information on the current surgical need for the use of TutoplastDura in Canada. It wrote to orthopaedic, neurosurgical andotolaryngological professional associations seeking advice on theimportance to their members of the continued availability of Tutoplast duramater. The Canadian Neurosurgical Society (CNSS) responded by conducting asurvey of their members. Of those who replied, 61% supported discontinuingthe use of donor dura mater.

On April 10, 2002, Health Canada suspended the medical device licence forTutoplast Dura. The suspension means that the importation and sale of thismedical device is no longer permitted in Canada.

Physicians were advised at the time to place any existing Tutoplast productin a secure location and immediately inform the manufacturer or distributor.

This action was based on the following considerations:

Advice received through Health Canada's consultation with the CanadianNeurosurgical Society The recommendations of a leading Canadian expert onprion illness (Dr. Neil Cashman). The availability of adequate alternativematerials that can be used instead of commercially-processed dura materobtained from human donors.

The Canadian distributor of Tutoplast Dura conducted the recall of theproduct as per Health Canada's request.

The day following the suspension of the licence (April 11, 2002), HealthCanada initiated an Import Alert with Canadian Customs.

Health Canada informed international partners of the suspension and recallaction through the National Competent Authority Report system. HealthCanada forwarded copies of the medical device suspension letter and of theSafety Advisory to the German authorities for information pertaining to themanufacturer Tutogen Medical GmbH in their jurisdiction.

Health Canada sent a letter to health care professionals on April 11, 2002,advising them:

Not to use Tutoplast Dura manufactured by Tutogen Medical GmbH in anysurgical procedure, as it is no longer licensed for sale in Canada. Toplace any remaining stocks of Tutoplast Dura in a secure location so thatit can no longer be used and immediately inform the manufacturer ordistributor who sold the product.

Individuals who want more information on the recall may leave a message onthe Medical Devices Hotline at 1-800-267-9675. A Health Canada officialwill return the call.

Last Updated: 2003-09-24

TSS


Terry S. Singeltary Sr. wrote:

I was amazed at the comment the doctor made about this in an article yesterday. i had to send a note to him.....tss

snip...

Dr. Dow said he doubted that the woman had died of an infected brain patch. And while there is a theoretical risk that the disease could be spread through instruments contaminated with prion proteins from a patient with CJD, he added to my knowledge there has been no proven case of a neurosurgical instrument contaminated with protein from a patient with CJD causing infection in another patient.

snip...

end


http://www.theglobeandmail.com/services/site/help.html#webstaff



what do you call this;

1: J Neurol Neurosurg Psychiatry 1994 Jun;57(6):757-8

Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery.

Gibbs CJ Jr, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC.

Laboratory of Central Nervous System Studies, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.

Stereotactic multicontact electrodes used to probe the cerebral cortex of a middle aged woman with progressive dementia were previously implicated in the accidental transmission of Creutzfeldt-Jakob disease (CJD) to two younger patients. The diagnoses of CJD have been confirmed for all three cases. More than two years after their last use in humans, after three cleanings and repeated sterilisation in ethanol and formaldehyde vapour, the electrodes were implanted in the cortex of a chimpanzee. Eighteen months later the animal became ill with CJD. This finding serves to re-emphasise the potential danger posed by reuse of instruments contaminated with the agents of spongiform encephalopathies, even after scrupulous attempts to clean them.

PMID: 8006664 [PubMed - indexed for MEDLINE]


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8006664&dopt=Abstract



7 CJD cases possible in N.B., officials say Brain-wasting ailment confirmed in woman who died in July, after she had neurosurgery

RICHARD FOOT CanWest News Service

Thursday, September 25, 2003 ADVERTISEMENT

Click here to find out more!

New Brunswick health officials have warned seven former hospital patients they may have contracted Creutzfeldt-Jakob disease during neurosurgery in Moncton, N.B., following the death of a woman this summer from the rare but fatal brain-wasting illness.

The woman died on July 31, about six weeks after undergoing neurosurgery at Moncton Hospital, where doctors noticed she was showing symptoms of the disease.

On Monday, autopsy results of her brain tissue confirmed she died of classical Creutzfeldt-Jakob disease, or CJD.

Only about 30 Canadians are diagnosed each year with classical CJD, which is a related but separate illness from the human form of mad cow disease, called variant-CJD.

"I want to make it very clear that this is not a case of mad cow disease,'' Gordon Dow, the hospital's chief of infectious diseases, said yesterday in Moncton.

How the woman contracted classical CJD remains a mystery. It's also unclear what specific type of infection she had.

If she died of sporadic CJD, her death poses no risk to the seven other patients. However, officials cannot rule out the chance she died of a less common form called iatrogenic CJD.

This is contracted when the disease is mistakenly passed from one person to another, through shared surgical instruments or through brain tissue transplants. The woman may have been infected during a brain tissue transplant on her spinal cord in 1992, when doctors implanted a tissue graft taken from the brains of human cadavers.

The type of implant used in 1992, known as Tutoplast dura mater, was banned by Health Canada last year because of concerns that it could transmit CJD.

The woman returned to hospital for a second operation in June this year, and died shortly afterwards. The instruments used in her operation have since been incinerated, but of the seven patients warned in the wake of the woman's death, two may have been exposed to those instruments before they were destroyed. Five others received similar brain tissue transplants in the early 1990s.

© Copyright 2003 Montreal Gazette


http://canada.com/national/story.asp?id=AD81755E-B1B4-4F27-ACCE-E6D809057C60


Terry S. Singeltary Sr. wrote:

Brain-wasting disease confirmed in N.B. woman

By LUMA MUHTADIE Globe and Mail Update

A New Brunswick woman died in hospital from Creutzfeldt-Jakob disease, health officials in Moncton announced on Wednesday.

Officials stressed that the case of so-called “classical” CJD cannot spread from person to person, and is not connected to the variant of the disease, which has been linked to mad cow or bovine spongiform encephalopathy.

“This is not a case of mad cow disease,” Gordon Dow, chief of infectious diseases at Moncton Hospital, told the press conference.

However, health officials said that tests were inconclusive as to whether the disease developed spontaneously in the 55-year-old woman (as it does in about 30 Canadians a year) or whether it was iatrogenic, meaning it resulted from an infection acquired during a medical procedure.

In 1992, doctors in Moncton grafted a patch made from tissue taken from a human corpse onto the woman's brain. She returned to the Moncton Hospital in June for a secondary neurosurgical operation, and in a follow-up consultation on June 18, possible CJD was diagnosed. She died on July 31 and the diagnosis of CJD was confirmed through an autopsy on Monday.

Health Canada banned the use of brain-tissue patches taken from human corpses last year due to CJD fears.

Dr. Dow said he doubted that the woman had died of an infected brain patch. And while there is a theoretical risk that the disease could be spread through instruments contaminated with prion proteins from a patient with CJD, he added “to my knowledge there has been no proven case of a neurosurgical instrument contaminated with protein from a patient with CJD causing infection in another patient.”

He said it would be very useful to know if the patient represented a sporadic form of CJD, in which case there would be “absolutely no risk to anybody else” or if she acquired the disease from the graft she received in 1992, “whereby potentially, other patients could have been exposed to the same graft.”

As a safety measure, the Moncton Hospital quarantined all neurosurgical and spinal instruments in the region, later narrowing the quarantine to only those instruments used in the woman's more recent operation.

The hospital also searched the charts of all patients who received graft surgery within one year on either side of the woman's original surgery -– or from 1991 to 1993 -– to identity all potential recipients of the same graft. Seven individuals were found and informed that they were at a small risk of infection.

CJD is a degenerative disease of the central nervous system that initially alters the personality or makes social interaction difficult, but quickly progresses into problems with speech, memory and vision. It eventually leads to motor problems such as stiffness, paralysis and twitching.

“During this rapid deterioration, patients quickly become confined to bed in a mute, paralyzed state -- probably in a semi-comatose state -- with very little insight or understanding ... or sensation of their illness and subsequently die,” Dr. Dow said.

It generally takes six months from the onset of symptoms until death. There is currently no treatment available for CJD.


http://www.theglobeandmail.com/servlet/story/RTGAM.20030924.wcreu0924/BNStory/Front


spontaneous my @ss..... how can these people continue to believe that 85%+ of all CJDs happen from nothing (a spontaneous happening without route and source). this is total BSeee and they cannot prove this. it is only wishful thinking by scientist and there politicians that advocate this myth $$$

TSS

Terry S. Singeltary Sr. wrote:

######## Bovine Spongiform Encephalopathy #########

New Brunswicker reported dead of Creutzfeldt-Jakob Last Updated Wed, 24 Sep 2003 12:25:17

MONCTON - A New Brunswick resident has died of Creutzfeldt-Jakob disease after brain surgery, CBC has learned.

Sources tell CBC News that this case was not the CJD variant caused by eating tainted beef and is not related to bovine spongiform encephalopathy, or mad cow disease.

Diagnosis of the disease cannot be confirmed until after death.

Public health authorities are expected to hold a news conference later Wednesday to release more details.

* FROM APRIL 13, 2002: Health Canada bans 'brain patch' linked to brain disease



From: TSS (216-119-130-124.ipset10.wt.net)Subject: BRAIN PATCH STILL IN USE $ (re-dura/CJD) $ LESS THAN ONE MONTH TO GO FOR COSMETICS/BSE/BeijingDate: March 27, 2002 at 6:04 pm PST

POSTED AT 2:08 AM EST Tuesday, March 26[space]Brain patch still in use despite risk[space][space] Advertisement[space]

By CAROLYN ABRAHAM From Tuesday's Globe and Mail

Canadian patients still receive brain-tissue patches taken from human corpses, despite a World Health Organization call to ban them because of the risk of transmitting a fatal brain-wasting disease similar to bovine spongiform encephalopathy (mad-cow disease).

The WHO recommended in 1997 that grafts of human dura, tissue harvested from the outer lining of cadaver brains, should be used only if a surgeon has no other means to patch and close an incision.

But based on a recent survey, the Canadian Neurosurgical Society estimates that surgeons stitch these human-tissue patches into the brains of 200 patients a year.

Scientists, meanwhile, fear that the incurable Creutzfeldt-Jakob disease can contaminate these tissue grafts, especially since the infection is known to survive extreme sterilization measures. Grafts are produced by companies that collect the dura from cadavers.

One type, the German-made Lyodura, a brand that is no longer in production, has been linked to 115 CJD deaths worldwide, four of them in Canada over the past decade.

"There are so few things that we know can transmit CJD, why the hell not just eliminate one possibility?" said Neil Cashman, a neurologist at the University of Toronto Centre for Neurodegenerative Disease.

Dr. Cashman, also a member of the CJD National Surveillance Team, said the benefits of using these tissue grafts in brain operations are not worth the potential risks.

Britain banned their use in 1989. Japan, where more than half the Lyodura-linked deaths have occurred, halted its use in 1997. But in Canada, as in the United States, there have been no similar restrictions.

Health Canada spokesman Ryan Baker said, however, that federal officials are now considering whether there should be.

"Health Canada is currently reviewing the potential risks of human-derived dura substitutes," Mr. Baker said.

No government official would speak about the use of the brain patches because Health Canada is being sued by the family of a 14-year-old boy who died of CJD in 1999 after receiving a Lyodura implant in 1988. Warnings that the product could be tainted with CJD had been published a year earlier.

According to Mr. Baker, there are seven licensed products on the market to patch the tough outer membrane of patients' brains after an operation. Four are synthetic and two are derived from bovine heart tissue. Only one, he said, comes from human cadavers ? a product called Tutoplast that is made by New Jersey-based Tutogen Medical Inc.

Rick Moulton, president of the Canadian Neurosurgical Society, said Health Canada contacted his organization last fall trying to find out how many patients receive the human dura patches and how brain surgeons would react to banning them.

"We actually support a complete ban on all human dura [grafts]," Dr. Moulton said. "In part because there is no way to test the product for CJD and there is no way to test the patient who receives it."

The society represents 130 of the approximately 170 neurosurgeons in Canada.

Dr. Moulton, also head of the division of neurosurgery at St. Michael's Hospital in Toronto, said the "gold standard" is to patch the dura with the patient's own tissue, taken from the skull or thigh.

Paul Brown, a senior investigator with the U.S. National Institute of Neurological Disorders and an expert on CJD and its related diseases, said some surgeons have felt that "none of the alternatives are as good as human dura."

He also said that manufacturers who have a clean record feel they should not be punished for the cases that have been linked to one company.

Dr. Brown explained certain procedures can reduce risks, such as ensuring that no brain tissue is collected from a donor who suffered neurological problems, that specimens are not pooled in one container to avoid contaminating others, and that the tissue undergoes special and proper sterilization.

CJD, usually a rare disorder that hits one in a million elderly people, strikes about 26 people a year in Canada. It can develop sporadically, with no explanation, it can be the result of a genetic mutation and it can be spread to the brain through medical procedures, such as tissue implants or contaminated surgical tools.

CJD is also linked to the neurodegenerative BSE, in which misshapen proteins devour the brain, leaving the tissue resembling a sponge after death.

Public Citizen, the national U.S. group founded by consumer advocate Ralph Nader, petitioned the U.S. Food and Drug Administration last August for a complete ban on the use of donated human dura tissue in surgery.

http://www.globeandmail.com/servlet/RTGAMArticleHTMLTemplate/C/20020326/wxlyod?hub=homeBN&tf=tgam%252Frealtime%252Ffullstory.html&cf=tgam/realtime/config-neutral&vg=BigAdVariableGenerator&slug=wxlyod&date=20020326&archive=RTGAM&site=Front&ad_page_name=breakingnewshtml&cf=tgam/realtime/config-neutral&vg=BigAdVariableGenerator&slug=wxlyod&date=20020326&archive=RTGAM&site=Front&ad_page_name=breakingnews


POSTED AT 3:07 AM EST Wednesday, March 27[space]Patients want answers on brain patch


By CAROLYN ABRAHAM
From Wednesday's Globe and Mail

Anxious patients who underwent brain surgery in the past dozen years are trying to find out if they received a brain tissue patch that has since been linked to a lethal, neurodegenerative disease.

Calls to doctors, hospitals and The Globe and Mail indicate that while there is no way to tell whether a patient received a tissue graft contaminated by the brain-wasting Creutzfeldt-Jakob disease, people still want to know if they are at risk.

"I have received calls from families whose members received a Lyodura [brain-tissue] transplant who also want to know what they can do. But the answer is, there is no answer," said Neil Cashman, a neurologist at the University of Toronto's Centre for Neurodegenerative Diseases.

Unless a person has actually begun to develop symptoms of CJD, such as trembling, loss of balance and dementia, no examination can reveal if they may be infected, said Dr. Cashman, who is also a member of the CJD National Surveillance effort.

Still, Health Canada is recommending that "anyone who received Lyodura or anyone who has concerns about their surgery should consult their physician," said Health Canada spokesman Ryan Baker.

But Mr. Baker added, "If we hear about a case of CJD, we will trace it to its origins."
Lyodura, processed from the brain coverings of human cadavers and produced by the German multinational medical supply giant B. Braun Melsungen until 1996, has been associated with 115 deaths in 11 countries ? including four in Canada.

The caseload has raised questions about the safety and sources of tissues harvested from human corpses for medicinal use, and the abilities of the health system to protect patients.
Hundreds of Canadians received Lyodura patches in the 1980s when surgeons stitched closed the dura, the brain's outer lining. But how many are at risk remains a mystery because no one knows which lots might have been infected with CJD, a condition that can incubate for 30 years.
One man, for example, who read on the weekend about the risks associated with Lyodura, learned from a Montreal hospital this week that he had in fact received this brand of tissue implant in 1988.

The man, who asked not to be identified, said hospital officials are now digging in their archives to determine which lot his Lyodura came from. The man said the hospital had also received the same request from another concerned patient.

Health Canada issued a recall of two lots of Lyodura in 1987 that had been linked to a CJD death in the United States. But U.S. health authorities warned later that year that the risk of CJD was not limited to any particular lot number, but applied to all Lyodura tissue grafts produced before 1987.

This is because the U.S. officials had found that, unlike other companies, B. Braun had been collecting dura brain matter from corpses and pooling all the tissue in one container, increasing the risk that one CJD-tainted specimen could contaminate all the others.

The investigation also learned that the company had no records on individual donors, making it impossible to trace the source of a possible infection.

Then it was reported in 1994 that the company had paid hospital autopsy workers $18 for each brain membrane harvested from a cadaver. German officials were quoted as saying that the tissues were sometimes collected without permission of the donor's families or hospital administrators.

However, Ermias Belay, a medical epidemiologist following the Lyodrua cases for the U.S. Centers for Disease Control, noted, "Not everyone who got Lyodura will get CJD. The risk is not 100 per cent."

In Canada, at least one family has settled out of court after filing a suit against B. Braun and others in connection to Lyodura. The family of Dominique Roy-Regimbald, a 14-year-old who died in 1999 after receiving the tissue graft in 1988, now has a suit before Quebec provincial court.

Other people with relatives who died of CJD after undergoing brain surgery are also haunted by questions.

Marianne Pope, whose 62-year-old mother died of CJD in May, 1991, contacted The Globe this week, saying she and her sister, brother and father were looking for answers.

Their mother, Margaret Sandercott, had undergone surgery at a London, Ont., hospital in November, 1988, to remove a tumour in her inner ear. They are now trying to find out from records whether she received a human tissue graft, or Lyodura, in the process.

"She lost all brain function less than three years after that operation," said Ms. Pope. "We've always been pretty convinced that she somehow contracted it through the operation.
"We feel there is way more of this out there than people realize."


http://www.globeandmail.com/servlet/RTGAMArticleHTMLTemplate/C/20020327/wxlyod?hub=homeBN&tf=tgam%252Frealtime%252Ffullstory.html&cf=tgam/realtime/config-neutral&vg=BigAdVariableGenerator&slug=wxlyod&date=20020327&archive=RTGAM&site=Front&ad_page_name=breakingnewsaca


Last updated at: (Beijing Time) Tuesday, March 26, 2002

BSE-related Cosmetics' Sale BannedChinese establishments that sell imported cosmetics which might spread mad cow disease have less than one month to clear their shelves of the potentially deadly products.


Chinese establishments that sell imported cosmetics which might spread mad cow disease have less than one month to clear their shelves of the potentially deadly products.

The Ministry of Health and the State General Administration of Quality Supervision and Inspection and Quarantine issued a statement early this month to ban the import and sale of such cosmetics before April 20.

Enterprises urged to withdraw products immediately At present, many shops still stock cosmetics containing cattle or sheep brain tissues, nerve tissue, internal organs, placenta, blood or their extracts from dozens of countries and regions where mad cow disease (bovine spongiform encephalopathy, or BSE) has been found.

Enterprises that have already imported cosmetic products containing such components are urged to immediately report them to the health authorities and withdraw.

Some large department stores claim they have already withdrawn the imported cosmetics.
In North Star Shopping Centre, only Lan Ono, a cosmetic brand from Australia which is famous for its wool oil cosmetics and is free of mad cow disease, is on sale.

Some cosmetics still flourishingHowever, in many small and medium-sized markets in Beijing and other cities, such cosmetics are reportedly still flourishing.

Some market managers claim they are waiting for a list of the banned cosmetics before clearing their shelves, as they do not know which ones should be pulled.

Consumers are also waiting for such a list to know which cosmetics to avoid.

The Ministry of Health will distribute a list. However, it will not be until after April 20, according to Zhang Yinfa, a ministry official.

The ministry will also check a list of cosmetics it previously approved to see which of them contain suspected tissues, he added.

"It will be a hard task because there are nearly 10,000 imported cosmetics already approved in China,'' said Zhang.

To some, the ban will not make much difference to consumers and enterprises.
For example, Meng Jun, deputy manager of the cosmetics sale department in Beijing Xidan Plaza, said the majority of marketable cosmetics are made of plant tissues -- a fashion in the cosmetic industry -- and, therefore, the ban will not have a great influence on the sale of cosmetics.

Consumers should remain cautiousBefore the list comes out, consumers should remain cautious when buying cosmetics, and check products' contents, experts suggest.

In China, cosmetics imported legally and sold have Chinese characters displaying their contents and usage.

Since the first case of mad cow disease was detected in Britain in 1985, BSE cases have cropped up in many European countries, including Ireland, Switzerland, France, Belgium, Luxembourg, the Netherlands, Germany, Portugal, Denmark, Italy, Spain, the Principality of Liechtenstein, the Slovak Republic, Finland and Austria.

China Bans Cosmetics from Countries Suffering from 'Mad-Cow' DiseaseA bulletin released jointly by the Ministry of Health and the State General Administration for Quality Supervision and Inspection and Quarantine noted that the cosmetics containing the material extracted from brains, nerve cells, inner organs, placentas and blood of cows and sheep which came from countries or regions suffering from "mad-cow" disease will be banned to import and sell.

Cosmetics containing the material extracted from brains, nerve cells, inner organs, placentas and blood of cows and sheep which came from countries or regions suffering from "mad-cow" disease will be banned to import and sell, noted a bulletin released jointly by the Ministry of Health and the State General Administration for Quality Supervision and Inspection and Quarantine. In Detail


http://english.peopledaily.com.cn/200203/26/eng20020326_92835.shtml


TSS



To: Mad Cow USA madcow@lists.iatp.org
From: flounder9@verizon.net
Date: 2006-06-01 15:20:59
Subject: Fw: Brief Report: Investigation into Recalled Human Tissue for Transplantation --- United States, 2005--2006


----- Original Message -----

From: "Terry S. Singeltary Sr."
To:
Sent: Wednesday, May 31, 2006 4:13 PM
Subject: Brief Report: Investigation into Recalled Human Tissue forTransplantation --- United States, 2005--2006


##################### Bovine Spongiform Encephalopathy#####################


MMWR Brief Report: Investigation into Recalled Human Tissue forTransplantation --- United States, 2005--2006Posted: 5/30/2006


Brief Report: Investigation into Recalled Human Tissue forTransplantation --- United States, 2005--2006


On September 29, 2005, a human tissue-processing company discoveredinaccuracies in donor records forwarded from a tissue-recovery firm andnotified the Food and Drug Administration (FDA). An FDA investigationdetermined that the recovery firm, Biomedical Tissue Services, Ltd. (BTS)(Fort Lee, New Jersey), recovered tissues from human donors who might nothave met donor eligibility requirements and who were not screened properlyfor certain infectious diseases. In October 2005, BTS and the fiveprocessors* that had received the tissues, working with FDA, issued a recallfor all tissues recovered by BTS. The continuing FDA investigationdetermined that information for some donors (e.g., cause, place, or time ofdeath) was not consistent with death certificate data obtained from thestates where the deaths occurred. The investigation also determined that BTShad failed to recover tissues in a manner that would prevent contaminationor cross-contamination and failed to control environmental conditionsadequately during tissue recovery. These failures were violations of theCurrent Good Tissue Practice Rules? (effective May 25, 2005), which requiremanufacturers to recover, process, store, label, package, and distributehuman cells, tissue, and cellular and tissue-based products (HCT/Ps) toprevent introduction, transmission, or spread of communicable diseases. InJanuary 2006, FDA ordered BTS to cease manufacturing and to retain allHCT/Ps.
The tissues recovered by BTS had been sent to five processors, whodistributed them through one or more sub-distributors or directly toclinicians and health-care facilities. CDC learned that, during June2002--October 2005, approximately 25,000 BTS-recovered tissue products weredistributed to all 50 states and internationally. Most of these tissueallografts were bone or demineralized bone matrix; others included skin andsoft tissue (e.g., tendons or fascia lata). Before distribution, tissueswere disinfected by tissue processors to reduce or eliminate contaminationwith bacteria, fungi, or viruses.


During September--October 2005, the five tissue processors recalled allproducts that had been produced from BTS tissues. Each of the processors andrelated distributors issued letters to consignees (i.e., health-carefacilities or clinicians) to notify them of the recall and request return ofunused products. The letters included a recommendation by FDA and CDC thattransplant recipients be notified of the recall and offered access totesting for the communicable diseases for which donor screening is required:human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis Cvirus (HCV), and syphilis.


In March 2006, FDA determined that, in some instances, blood samplessubmitted for disease screening had not come from the persons from whom thelinked tissues had been obtained. This finding cast doubt on the bloodsample--screening status of the tissue donors, and FDA and CDC issued anupdate§ that strongly recommended health-care providers offer patientsaccess to or referral for testing for HIV, HBV, HCV, and syphilis. CDCrecommendations¶ for testing persons who received BTS tissues call forpatients whose tissue implants have been in place >6 months to be offeredthe following tests: HIV antibody, antibody to hepatitis B core antigen,antibody to hepatitis C virus, a non-treponemal syphilis test (i.e., rapidplasma reagin [RPR] or Venereal Disease Research Laboratory [VDRL]), and atreponemal syphilis test (i.e., Treponema pallidum particle agglutination[TP-PA] or any enzyme-linked immunosorbent assay [ELISA] test). Patientswhose tissue implants have been in place <6 href="mailto:mmwrq@cdc.gov">mmwrq@cdc.gov.


Date last reviewed: 5/25/2006


http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5520a6.htm



Body snatchers tied to allograft firms?

Alleged New York-area ring investigated for selling parts to corpse tissue harvesters.

October 7, 2005: 2:54 PM EDTBy Aaron Smith, CNN/Money staff writer


NEW YORK (CNN/Money) - A Brooklyn funeral home and a New Jersey company that harvests body parts from corpses are being investigated for their alleged roles in a body snatching ring that sold parts to companies specializing inmedical grafts, sources close to the investigation said Friday.

The Brooklyn district attorney's office declined to comment on the investigation. But sources close to the investigation acknowledged that it has been going on for about one and a half years, focusing on Michael Mastromarino of Biomedical Tissue Services Ltd. of Fort Lee, N.J., who allegedly harvested body parts illegally from the Daniel George funeral home in Brooklyn.
The firms that bought the allegedly black-market tissue have not been accused of any wrong doing. Human tissue is usually obtained from non-profittissue banks. In the U.S., it's illegal to buy and sell human tissue.

Wendy Crites-Wacker, spokeswoman for Regeneration Technologies (down $0.66to $7.28, Research), a company in Alachua, Fla., said her company has severed all ties with Biomedical Tissue Services, their former source for some of the body parts used to make medical grafts, or allografts.

"We had previously terminated the relationship with Biomedical Tissue Services and we are cooperating with the appropriate authorities on this issue," said Crites-Wacker, who declined to say when the termination took place.

Crites-Wacker also said that her company's BioCleanse process, in which bones and tendons are sterilized through a melange of chemicals, temperatureand pressure, ensures that its products are safe.

Two other allograft companies have been identified as customers ofBiomedical Tissue Services: LifeCell Corp. (down $2.82 to $17.33, Research),of Branchburg, N.J. and Tutogen Medical Inc. (down $0.15 to $4.06, Research)of West Paterson, N.J.

LifeCell Corp. had issued a Friday statement saying it had voluntarily recalled some human tissue products after questions were raised about Biomedical Tissue Services.

"Specifically, the company recalled all lots of product that were produced using tissue from Biomedical Tissue Services (BTS)," LifeCell said in a release.

LifeCell, which markets products made from human tissues that are used in surgical procedures, said it recalled certain AlloDerm, Repliform and Graft Jacket products on Sept. 30.
LifeCell's stock price slid about 5 percent this morning, and a Piper Jaffray analyst attributed the slump to a New York Daily News story that first reported on the investigation.

"We believe this morning's weakness in LifeCell's shares is related to a news article that alleges LifeCell inadvertently received tissue from an illegal body-snatching ring," said Raj Denhoy of Piper Jaffray, in a written report.

LifeCell said in the statement all other tissues supplied by Biomedical Tissue Services remain "on hold until the discrepancies in the donor documentation can be resolved."

Denhoy said that LifeCell did not appear to do anything illegal and that"LifeCell itself was the victim of fraud," referring to allegations that Biomedical Tissue Services forged death certificates and family consent forms.

Denhoy said that LifeCell receives tissue from 30 sources, "so the loss of one will likely not impact the underlying business," though increased regulatory scrutiny could drive down the stock price.

"While LifeCell and the other tissue companies appear to have done nothing wrong, this event could increase regulatory and media scrutiny of the business," said Denhoy, who rates the company market perform. "We recently downgraded LifeCell shares on competitive concerns and today's revelations may pressure the stock further."

Eric Franz, the attorney representing funeral home owners Debora Johnson and Robert Nelms, said his clients "did not participate in any criminal conduct whatsoever."

Attempts to reach Mastromarino and his company Biomedical Tissue Services were unsuccessful. The Daily News reported that Mastromarino declined to comment.

Regeneration Technologies produces heart valves, bone and tendon implants and bone paste, which is used to plug holes. LifeCell specializes in AlloDerm, a "dermal matrix" made from human skin that is used in grafts. Tutogen focuses on bone and dental implants.

--from staff and wire reports

http://money.cnn.com/2005/10/07/news/midcaps/corpse/?section=money_latest


Order to Cease Manufacturing and to Retain HCT/Ps

January 31, 2006

CERTIFIED MAILRETURN RECEIPT REQUESTED

Michael Mastromarino, D.D.S.CEO & Executive Director of OperationsBiomedical Tissue Services, Ltd.2125 Center Avenue, Suite 300Fort Lee, NJ 07024-5874

Dear Dr. Mastromarino:

The Food and Drug Administration (FDA or the agency) conducted an inspection of your establishment, Biomedical Tissue Services, Ltd. (BTS or Establishment), at 2125 Center Avenue, Suite 300, Fort Lee, New Jersey07024, which manufactures human cells, tissues, and cellular and tissue-based products (HCT/Ps), between October 4 and 27, 2005. At the conclusion of the inspection, the FDA investigators issued you a FormFDA-483, Inspectional Observations. In addition to the inspection, the agency conducted a concurrent investigation of several funeral homes that provided you with potential donors of HCT/Ps for recovery. Our review of the information and records examined and collected during the inspection and investigation reveal that significant violations of Title 21, Code ofFederal Regulations (21 CFR), Part 1271, issued under the authority ofSection 361 of the Public Health Service Act (PHS Act) [42 U.S.C. 264],exist at BTS. The agency has determined that these deviations, because of their serious nature, constitute a danger to health. This Order to Cease Manufacturing and to Retain HCT/Ps relates exclusively to conduct occurring on or after May 25, 2005, the effective date of these regulations. We note that the FDA retains authority to pursue other actions and remedies.
Therefore, pursuant to 21 CFR 1271.440(a)(1) and (3), both you individually, and your Establishment, 1) must immediately cease all manufacturing until compliance with the regulations in 21 CFR Part 1271 has been achieved, and2) must retain all HCT/Ps recovered on or after May 25, 2005 that are inyour possession until they are disposed of as agreed by the agency or until the safety of the HCT/P is confirmed. Pursuant to 21 CFR 1271.3(e),"Manufacture" means, but is not limited to, any or all steps in the recovery, processing, storage, labeling, packaging, or distribution of anyHCT/P, and the screening or testing of the HCT/P donor.

Deficiencies noted include, but are not limited to, the following:
You failed to implement the standard operating procedures (SOP or SOPs) that you have established for all steps that you perform in determining donor eligibility, as required by 21 CFR 1271.47(a), and you failed to review the certificate of death for each donor, a relevant medical record, regarding risk factors for, or clinical evidence of, relevant communicable disease agents and diseases, as required by 21 CFR 1271.75(a). More specifically,your standard operating procedure entitled "Donor Identification" requiresthat, when recovering HCT/Ps at a funeral home, you review the death certificate to confirm the eligibility of the donor. However, you recovered HCT/Ps from at least eight donors, obtained from --- different funeral homes, located in ------ different states, in which you failed to review valid death certificates. The documents purporting to be the certificates of death for these donors were collected from BTS during our inspection, are not authentic death certificates issued by the state, and are inaccurate. For example:

You confirmed the eligibility of donor ------------, who donated HCT/Ps at afuneral home in ----------. The donor is listed on the BTS version of the certificate of death as being 63 years of age, having died of acutemyocardial infarction due to coronary artery disease, at ----pmon ------------, whereas the State of ---------------issued certificate of death lists this donor as being 69 years of age, having died of multi-organ failure, due to liver dysfunction, which in turn was due to thrombosis, at ----pm on ------------------;

You confirmed the eligibility of donor --------------, who donated HCT/Ps ata funeral home in ----------------. The donor is listed on the BTS version of the certificate of death as being 44 years of age, having died of blunt trauma in a motor vehicle accident, at ----am on ----------------, where as the State of -----------------issued certificate of death lists this donoras being 48 years of age, having died of congestive cardiac failure due to atherosclerotic cardiovascular disease, at ----am on ------------------;

You confirmed the eligibility of donor -------------, who donated HCT/Ps at a funeral home in ---------------. The donor is listed on the BTS version of the certificate of death as being 70 years of age, having died of cardio-pulmonary arrest due to acute myocardial infarction, at ---- pmon ------------------, whereas the State of ---------------------issued certificate of death lists this donor as being 74 years of age, having died of complications from the intravenous administration of medication due to aradical resection of a -----------------------------------------------------------------, at ----pm on ---------------------;

You confirmed the eligibility of donor ------------------, who donatedHCT/Ps at a funeral home in ---------------. The donor is listed on the BTS version of the certificate of death as having died of cardio-pulmonaryarrest due to atherosclerotic heart disease, at ----pm on -----------------, whereas the State of -------------issued certificate of death lists this donor as having died of cardio-pulmonary asystole due to sepsis and shock, at ----pm on --------------;

You confirmed the eligibility of donor ---------------, who donated HCT/Psat a funeral home in ----------------------. The donor is listed on the BTS version of the certificate of death as being 45 years of age, having died of blunt trauma due to a motor vehicle accident, at ----pm on ---------------, whereas the State of ----------------------issued certificate of death lists this donor as being 41 years of age, with a cause of death which was undetermined pending additional studies, at ----pm on -------------------;

You confirmed the eligibility of donor -------------, who donated HCT/Ps ata funeral home in -------------. The donor is listed on the BTS version ofthe certificate of death as having died of cardio-pulmonary arrest due toacute myocardial infarction, at ----pm on -----------------, whereas theState of ------------------issued certificate of death lists this donor as dying of probable ventricular fibrillation due to -------------------failure, as a consequence of -------------------- disease, at ----amon ----------------------;

You confirmed the eligibility of donor -------------, who donated HCT/Ps ata funeral home in ------------. The donor is listed on the BTS version ofthe certificate of death as being 58 years of age, having died of acutemyocardial infarction, at ----am on ----------, whereas the State of ---------------------issued certificate of death lists this donor as being 50 years of age, having died of diabetes mellitus and hypertension due to cardio-vascular disease, at ----pm on ---------------------------; and
You confirmed the eligibility of donor --------------, who donated HCT/Ps ata funeral home in ----------------. The donor is listed on the BTS version of the certificate of death as being 63 years of age, having died of acutemyocardial infarction, at ----pm on ------------, whereas the State of -------------issued certificate of death lists this donor as being 79 years of age, having died of pneumonia due to a myocardial infarction, at ----pm on -----------------.
You failed to implement the SOPs that you have established for all steps that you perform in determining donor eligibility, regarding your assessment of risk factors for, or clinical evidence of, relevant communicable disease agents and diseases, as required by 21 CFR 1271.47(a).

Furthermore, you failed to create and maintain accurate records, as required by 21 CFR1271.55(d)(2) and 21 CFR 1271.270(a).More specifically, your "Documenting the Recovery" SOP requires that, if the donor had been admitted to a health care facility immediately prior to death, you were to document the date and reason for admission; check the appropriate boxes regarding availability of donor history, physical, and discharge summary; check the appropriate box regarding surgeries; check the appropriate boxes regarding availability of lab results (including blood cultures, x-rays, and lung biopsies); and check the appropriate boxes regarding documentation of HIV, Hepatitis and Tuberculosis infection. However, your Medical Evaluation forms fordonors -----------------, ---------------, -------------------, -------------, ---------------, and -------------------- (who donated HCT/Psin ---------- different funeral homes located in ---------- different states), do not contain any of this information. Instead, you incorrectly stated that these donors were ? not admitted to a health care facility immediately prior to death?,? which statements are contradicted by the state-issued certificates of death for each of these donors.

You failed to create and maintain accurate records, as required by 21 CFR1271.55(d)(2) and 21 CFR 1271.270(a). More specifically:

The Medical Evaluation forms created and maintained by you for the following six donors are inaccurate in that you state that the donors were ? not admitted to a health care facility immediately prior to death?.? In so doing, you also failed to adhere to the following SOPs:

Documenting theRecovery SOP; Quality Assurance Audit of Donor Records SOP; QualityAssurance Check-Off Form; and Audit Check List. These six donors donated HCT/P at -----different funeral homes, located in -------- different states. More specifically:

the State of --------------issued certificate of death for donor ----------------- states that at the time of her death she was a patient at ------------------- Hospital;the State of ------------issued certificate of death for donor ------------------ states that at the time of his death he was a hospital inpatient at ---------;

the State of --------------issued certificate of death for donor ----------states that at the time of his death he was a patient at --------------------- Hospital;

the State of ----------------issued certificate of death for donor ---------- states that at the time of her death she was a patient at ------------- Hospital;

the State of ---------------------issued certificate of death for donor ---------- states that at the time of his death he was a patientat -------------- Hospital;

and the State of ---------------issued certificate of death for donor --------------- states that at the time of her death she was a patient in the emergency room of ----------------- Hospital.
The records created and maintained by you for donor --------------- are inaccurate in that you state in your Certifying Physician Interview formthat the donor was a 44 year old male who died as a result of a blunt traumato the head region in a motor vehicle accident;

your Circumstances of Death form states that the donor was a 44 year old male who was involved in amotor vehicle accident, sustained blunt trauma, and expired at the scene of the accident prior to medical intervention; and your Donor Physical Assessment form includes an incorrect schematic of the donor, showing fractures to the anterior and posterior portions of the skull, together with bruises or contusions to the anterior and posterior portions of the neck. These records are contradicted by the State of --------------------issued certificate of death, which states that the donor died of natural causes (congestive cardiac failure, resulting from atherosclerotic cardiovasculardisease), at his home, at the age of 48. The only other significant condition which is listed as contributing to the death of the donor in theState of --------------issued certificate of deathis -----------------------. In creating and maintaining these inaccurate records, you have also failed to adhere to your "Documenting the Recovery"SOP, your "Quality Assurance Audit of Donor Records" SOP, your Audit CheckList, and your Quality Assurance Check-Off form.

The records created and maintained by you for donor ---------------- are inaccurate in that you state in your Certifying Physician Interview form that the donor was a 45 year old female who suffered blunt trauma in a motor vehicle accident, and died at the scene of the accident prior to medical intervention; your Circumstances of Death form states that the donor was a 45 year old female who was involved in a motor vehicle accident, sustained blunt trauma to the head region, and expired prior to medical intervention;

and your Donor Physical Assessment form includes an incorrect schematic of the donor, showing fractures to the anterior and posterior portions of the skull, together with bruises or contusions to the anterior and posterior portions of the neck. These records are contradicted by the State of --------------issued certificate of death, which states that the donor died at her home, at the age of 41, was -----, and with an undetermined cause of death, pending additional studies. There were no other significant conditions listed as possibly contributing to the death of the donor in the state-issued certificate of death. In creating and maintaining these inaccurate records, you have also failed to adhere to your "Documenting theRecovery" SOP, your "Quality Assurance Audit of Donor Records" SOP, your Audit Check List, and your Quality Assurance Check-Off form.

The records created and maintained by you for donor ------------- are inaccurate and incomplete in that your Certifying Physician Interview form for this donor fails to indicate the cause of death; your Circumstances of Death form for this donor incorrectly states that the donor was a 70 year old female, and fails to indicate the cause of death;

your Medical/Social History Interview form incorrectly states that the donor never received an organ transplant; and your Donor Physical Assessment form for this donor fails to show on the schematic that the donor had a surgical procedure to her ------------------------ immediately prior to her death, and also fails to show that the donor had undergone a ------ transplant. These records are contradicted by the State of ------------issued certificate of death, which states that the immediate cause of death of this donor was due to complications related to the intravenous administration of medication due to a ------------------------------------------------------------------------------------------------------. The donor is also listed on the State of ----------------issued certificate of death as having undergone a status post-cadaver -------- transplant for ------------- disease, and as having died at the age of 74. In creating and maintaining these inaccurate records, you have also failed to adhere to your "Quality Assurance Audit of Donor Records" SOP, your "Documenting the Recovery" SOP, your Audit Check List,and your Quality Assurance Check-Off form.

The records created and maintained by you are inaccurate as concerns the identity of the funeral home from which donors -------, ----------------, and ----------------------were obtained and at which HCT/P recovery procedures were performed for these donors. In your Donor Demographics forms for these donors you state that their recovery location was a funeral home in -----------, -------------, and you also state that the director of the funeral home provided you with a positive identification of these three donors. However, in an affidavit provided to the agency by the director of the funeral home, while he estimates that his funeral homes have provided between --- and ---- donors to BTS, they did not provide BTS with these three donors. In creating and maintaining these inaccurate records, you have also failed to adhere to your "Quality Assurance Audit of Donor Records"SOP, your "Documenting the Recovery" SOP, your Audit Check List, and your Quality Assurance Check-Off form.
You failed to implement the SOPs you established for donor eligibility determinations specifically for documenting and confirming the identity ofthe donors' next of kin, including your Donor Medical Social History Interview SOP, your Quality Control Review of Donor Records SOP, your Quality Assurance Audit of Donor Records SOP, your Audit Check List, and your Quality Assurance Check-Off form, all as required by 21 CFR 1271.47(a), and you failed to create and maintain accurate records, as required by 21CFR 1271.55(d)(2) and 21 CFR 1271.270(a), in that you have inaccurately and incompletely recorded the donors' next of kin information.

Morespecifically:

The records created and maintained by you for donor ------------ are inaccurate and incomplete in that your information on the donor's spouse differs from that found in the State of -------------issued certificate of death. More specifically:

while your Consent for Donation of Anatomical Gifts form for this donor lists the donor's spouse as the consenting next of kin, the donor's spouse is incorrectly listed as another individual, residing at an entirely different address than the donor;

while your Medical/Social History Interview form for this donor lists the interviewee as the donor's spouse, the interview form incorrectly identifies the donor's spouse and residential address;

your Circumstances of Death form for this donor also incorrectly identifies the spouse; and the BTS version of the certificate of death for this donor is incomplete in that it does not list any surviving spouse, and does not indicate whether the donor was married.
The records created and maintained by you for donor ------------- are inaccurate and incomplete in that your information on the donor's spouse differs from that found in the State of --------------issued certificate of death. More specifically:

while your Consent for Donation of Anatomical Gifts form for this donor lists the donor's spouse as the consenting next of kin, the donor's spouseis incorrectly listed as another individual, residing at an entirely different address than the donor;

while your Medical/Social History Interview form for this donor lists the interviewee as the donor's spouse, the interview form incorrectly identifies the donor's spouse and residential address;

your Circumstances of Death form for this donor also incorrectly identifies the spouse;

andthe BTS version of the certificate of death for this donor is incomplete in that it does not list any surviving spouse, and does not indicate whether the donor was married.

You failed to implement the SOPs you established for donor eligibility determinations, as required by 21 CFR 1271.47(a), and to assure the timely refrigeration of donors and recovery of HCT/P, as required by 1271.180(a). You failed to recover HCT/P in a manner that does not cause contamination or cross-contamination during recovery, to adequately control environmental conditions, and to provide proper conditions for operations, all as requiredby 21 CFR 1271.145, 21 CFR 1271.195(a)(1), and 21 CFR 1271.215. Furthermore, you failed to create and maintain accurate records, as required by 21 CFR1271.55(d)(2) and 21 CFR 1271.270(a).Your SOPs require that donors be refrigerated within ----- hours and that HCT/P excision begin within ----- hours post cardiac asystole. However, you did not meet these standards for the following donors:

your Donor Demographics form for donor ------------- states that the donor was "? refrigerated within --- hours and tissue excision began within ----hours post cardiac asystole" and that the donors refrigeration time was at ----am on -----------, which, according to the State of --------------------issued certificate of death's time of death (----pmon ----------------), is more than 33 hours post-cardiac asystole. Also, according to your Tissue Recovery Log form for this donor, HCT/P excision of the donor began at ----pm on --------, almost 48 hours post-cardiacasystole. As a result, your Donor Demographics form is inaccurate; and
your Donor Demographics form for donor ---------------states that the donor was "?refrigerated within ----hours and tissue excision began within ----hours post cardiac asystole" and that the donors refrigeration time was at --------------------------------------------, which, according to theStateof -------------------------------------------------------------------------------------------------issued certificate of death(---------------------------------------------), is almost 48 hours post-cardiac asystole. Also, according to your Tissue Recovery Log form for this donor, HCT/P excision of the donor began at ----pm on -------------, more than 54 hours post-cardiac asystole. As a result, your Donor Demographics form is inaccurate.
You failed to implement SOPs you established to assure that HCT/P recovery takes place in a suitable environment, as required by 21 CFR 1271.180(a). You failed to recover HCT/Ps in a manner that does not cause contamination or cross-contamination during recovery, and you failed to adequately control environmental conditions and to provide proper conditions for operations,all as required by 21 CFR 1271.145, 21 CFR 1271.195(a)(2), and 21 CFR1271.215. Furthermore, you failed to create and maintain accurate records,as required by 21 CFR 1271.55(d)(2) and 21 CFR 1271.270(a). Your SOP requires that the HCT/P recovery site ensure a maintained and controlled,closed airflow system so that there is no direct access to the outside ofthe building. However, you recovered HCT/P from donors ----------and ------------ at a funeral home in ------------, ---------- that is not equipped with any refrigeration units in which to hold the deceased. The embalming room where HCT/P recovery took place was equipped with an exhaust fan that delivered air to the adjacent garage/outside. There was no air filtration system in the room. Moreover, you recorded in your Nonstandard Tissue Recovery Site Assessment form for these donors that the recovery site ensured a maintained and controlled, closed airflow system so that there was no direct access to the outside of the building.
You failed to implement SOPs you established for donor eligibility determinations, specifically to confirm whether an autopsy was performed, as required by 21 CFR 1271.47(a). In particular, your Quality Control Review of Donor Records SOP requires that "[t]he team leader will assure a physical exam was performed and the information documented on the recovery paper work is included in the donor chart?" and your Physical Assessment of a Cadaveric Donor SOP requires that the team leader physically check the donor in their entirety. Furthermore, you failed to create and maintain accurate records,as required by 21 CFR 1271.55(d)(2) and 21 CFR 1271.270(a). Your Donor Demographics forms for donors -------- and ----------------------- stat that no autopsies had been performed on these donors, and the Donor Physical Assessment forms for these donors provide schematics of the donors which fail to show that autopsies had been performed. These documents are contradicted by the State of ----------------issued certificates of death for these donors, which confirm not only that autopsies were performed on these two donors, but also that the autopsy findings were available to complete the cause of death. The fact that an autopsy had been performed should have been obvious to you upon your physical assessment of the donors at the time of HCT/P recovery.The above-identified deficiencies are not intended to be an all-inclusive list of violations by you and your Establishment. Nevertheless, they indicate serious noncompliance with many of the regulations under 21 CFRPart 1271, which are designed to protect against the risks of communicable disease transmission. Of particular concern are the serious deficiencies involving:

1/ your failure to create and maintain accurate records;

2/ your failure to implement SOPs for all steps in determining donor eligibility;

3/ your failure to recover HCT/Ps in a manner that does not cause contamination or cross-contamination during recovery; and

4/ your failure to adequately control environmental conditions. These deficiencies involve donors from numerous funeral homes located in different states. Based on the fore going, the agency finds that there are reasonable grounds to believe that HCT/Ps manufactured by you are violative because they were manufactured in contravention of the regulations under 21CFR Part 1271 and, therefore, the conditions of manufacture of the HCT/Ps do not provide adequate protections against the risks of communicable disease transmission. Moreover, these deficiencies, including your failure to createand maintain accurate records, are so serious and widespread that FDA finds there are reasonable grounds to believe that they present a danger to public health.

This letter confirms the telephone conversation on January 31, 2006, in which notice was given that, pursuant to 21 CFR 1271.440(a)(3), you individually, and your Establishment,

1) must immediately cease all manufacturing, as defined in 21 CFR 1271.3(e), until compliance with the regulations in 21 CFR Part 1271 has been achieved, and

2) must retain allHCT/Ps recovered on or after May 25, 2005 that are in your possession until they are disposed of as agreed by the agency or until the safety of the HCT/P is confirmed. Instructions were given at that time not to recover or ship HCT/Ps. Neither you, nor your Establishment, can resume operations without prior written authorization from FDA. Any shipment of HCT/Ps inviolation of this order constitutes a violation of section 368 of the PHSAct [42 U.S.C. § 271], for which criminal penalties may be imposed.

Within five (5) working days from the receipt of this Order to Cease Manufacturing, you may request a hearing on the matter in accordance with 21CFR Part 16 (copy attached), to Mary A. Malarkey, Director, Office of Compliance and Biologics Quality, Center for Biologics Evaluation and Research, 1401 Rockville Pike, HFM-600, Rockville, MD 20852 (telephone:301-827-6190). Failure to request a hearing within the specified time period constitutes a waiver of the right to a hearing. You may also wish to inform yourself with respect to the agency's guidelines regarding electronic media coverage of its administrative proceedings, which can be found at 21 CFRPart 10, Subpart C.


Sincerely,


----- signature -----


Jesse L. Goodman, M.D., M.P.H.DirectorCenter for Biologics Evaluation and Research
Effective Date: 31 January Time: 11:25 AM Eastern

Updated February 1, 2006

http://www.fda.gov/cber/compl/bts013106.htm




TSE i.e. CJD and the legal stealing of tainted tissue


http://www.rense.com/general62/don.htm



http://creutzfeldt-jakob-disease.blogspot.com/2008_01_01_archive.html



http://mad-cow.org/~tom/dec99_news.html#bbb




TSS


#################### https://lists.aegee.org/bse-l.html####################




http://lists.iatp.org/listarchive/archive.cfm?id=119823




From: TSS
Subject: Dubious transplant recipients sue companies
Date: March 4, 2006 at 5:52 pm PST
Dubious transplant recipients sue companies

By PENNY BROWN ROBERTSAdvocate staff writer Published: Mar 4, 2006
Hundreds of Louisianians may have body parts transplanted inside them that were looted from corpses — some riddled with cancer or infected with syphilis or hepatitis.

A class-action lawsuit made public Friday in Baton Rouge federal court alleges that a New York medical supply company sold illegal — and unscreened — tissue and bone to Our Lady of the Lake Regional Medical Center and other unnamed hospitals in the state. Darrel Bourque of Gonzales says surgeons notified him in January that tissue transplanted in his neck during spinal surgery a year ago came from that supply company — Biomedical Tissue Services.

They urged the petrochemical industry supervisor to undergo blood testing to see if the transplanted tissue was infected with syphilis, HIV or hepatitis.

Although the tests haven’t shown anything, Bourque said in an interview Friday that he’s worried that, “There’s still the possibility something could have been there.”

“I have a lot of depression and a lot of anger. I don’t really know what the future holds,” Bourque said. “I’m worried about whether or not I’ll still be able to get insurance coverage for further illnesses that may come about.”

The lawsuit estimates the defective tissue has been implanted in hundreds of Louisiana patients since 2002. In addition to damages, it seeks to establish a comprehensive medical monitoring program and treatment of any future disease or complication related to the implants.

In an advisory issued Friday, the U.S. Food and Drug Administration “strongly” recommends health-care providers inform patients who received tissue implants from Biomedical Tissue Services that they “may be at increased risk for communicable disease transmission and to offer them testing. While FDA believes the risks from these tissues are low … the actual infectious risk is unknown.”

Baton Rouge lawyer Philip Bohrer said Friday the class-action lawsuit is intended to protect Louisiana victims from the potential “long-term consequences of what’s happened to them.”
Several patients outside the state who got transplants of the tissue in question already have tested positive for hepatitis and syphilis, according to news reports.

“I believe unfortunately that many people in our community may be victims of this practice,” Bohrer said. “The people who received this contaminated tissue are at risk for the rest of their lives, and initial blood test or screening cannot rule out future diseases, such as cancer, leukemia or other diseases with long latency periods that may have been in the tissue they received.”
Biomedical Tissue Services owners Michael Mastromarino and Joseph Nicelli and others are accused of secretly carving up bodies from funeral parlors and city morgues in three states and forging death certificates and organ-donor consent forms to make it appear as if the bones, skin, tendons, heart valves and other tissues were removed legally.

Some of the corpses were those of people who had not given consent; others didn’t meet federal donor eligibility requirements because they were infected with syphilis, AIDS or hepatitis or had cancer or heart disease. Among the cadavers they allegedly raided for parts was that of former PBS “Masterpiece Theatre” host Alistair Cook, who died of cancer in 2004 at the age of 95.
Last month, the FDA shut down Biomedical Tissue Services. Those involved have pleaded innocent to charges of enterprise corruption, body stealing and opening graves, unlawful dissection, forgery and other counts.

Staten Island lawyer, Mario Gallucci — who is representing Mastromarino and Biomedical Tissue Services — said Friday he was not aware of the Louisiana lawsuit.

Mastromarino “finds it unfortunate but does sympathize with all of these people who received the tissue,” Gallucci said. “He is just as taken aback as all these people are that he was misled. Hopefully, the distribution companies have done what they were supposed to do in sterilization, processing and release of this tissue. Dr. Mastromarino is traumatized by the prospect that his life’s work may have been tainted by the processing of this tissue.”

According to prosecutors, Mastromarino is a former dentist and oral surgeon who went into the tissue harvesting business after losing his license. He was sued for malpractice by several patients — one of whom claimed he deserted them in the middle of surgery.

Also named as defendants in the Louisiana lawsuit are Florida-based Regeneration Technologies and Memphis-based Medtronic Sofamor Danek USA, which allegedly distributed the millions of dollars worth of tissue, bone and organs. The lawsuit alleges the companies violated industry standards, their own internal safety and testing procedures, and possibly state and federal laws.
The lawsuit does not blame Our Lady of the Lake Regional Medical Center, other hospitals or any local surgeons, saying none of them was aware that the body parts “consisted of the stolen human tissue obtained by BTS, or that RTI failed to follow its own safety protocols.”

Our Lady of the Lake Regional Medical Center spokeswoman Catherine Harrell said Friday that 27 of its patients are known to have gotten such transplants. She said the hospital bought the tissue in question from Tennessee-based SpinalGraft Technologies.

Harrell said that once the hospital was notified of a nationwide recall of the tissue, it “immediately” returned its remaining supply to the manufacturer.

The hospital also notified surgeons of the situation “so that the physicians could communicate with their patients about the situation and really answer any questions the patients had.”
She said the doctors should have notified all their patients by now.

The American Association of Tissue Banks estimates there are more than 1 million tissue transplants annually in the United States. The FDA began regulating the billion-dollar industry in 1993 and now has strict regulations requiring examination of the cadaver, testing for disease-causing agents, interviews with the donor family and reviews of medical records, lab test results, coroner and autopsy reports and other relevant records.

In 2005, the agency added screening for diseases such as syphilis, West Nile, SARS and the neurological condition Creutzfeldt-Jakob to tests already required for HIV and hepatitis.
The Louisiana case has been assigned to U.S. District Judge Frank Polozola. No hearing dates have been set.


http://www.2theadvocate.com/news/2406461.html



25 Apr 2002 :
Column WA58 Bovine Embryos and Live Cattle: Imports from North America
The Earl of Caithness asked her Majesty's Government:

When the ban on the importation of embryos and live cattle from North America will be lifted; and [HL3912] What is the scientific evidence for the imposition of a ban on the importation of embryos and live cattle from North America. [HL3913]

Lord Whitty: Her Majesty's Government have not imposed a ban on imports of bovine embryos and live cattle from North America.

The European Parliament and European Council introduced legislation in May last year laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (TSEs). The legislation was introduced in response to the recommendations of the Office International des Epizooties (OIE—the international animal health organisation) and advice from the Commission's scientific comittees. The legislation (and the transitional measures which came into effect in October last year) includes requirement that imports into the EU of bovine embryos and live cattle must be accompanied by certification confirming that the feeding of ruminants with protein derived from mammals has been banned and that the ban has been effectively enforced. Some exporting countries, such as Canada and the USA, are currently unable to meet these new requirements.


http://www.publications.parliament.uk/pa/ld199900/ldhansrd/pdvn/lds02/text/20425w04.htm


BSE: US Export of Specified Risk Material
Lord Kennet asked Her Majesty's Government:


Whether the United States contends that under the provisions enforceable by the World Trade Organisation the European Union may not ban the import into Europe from the United States of "specified risk material" (that is, material at possible risk of BSE infection).

Lord Donoughue: Yes. But their position on the Specified Risk Material legislation is based on the assumption that the United States can safely be regarded as a "BSE free" country. Their case for such treatment has not been accepted by the EU Commission's Scientific Veterinary Committee.
http://www.publications.parliament.uk/pa/ld199798/ldhansrd/vo971215/text/71215w02.htm
Baroness Masham of Ilton: My Lords, as blood products which infected haemophiliacs with HIV came from the USA, is the Minister confident that something else nasty may not come again from imported blood from the USA? Is he aware that there are ways of cleaning blood to make it safer? I know that that is done in Vienna, in Austria. Will the Minister look into that? Following the question asked by the noble Lord, Lord Clement-Jones, about people using their own blood, I am sure that, when this Statement goes out into the wider community, people will want to know that information.


http://www.publications.parliament.uk/pa/ld199900/ldhansrd/pdvn/lds03/text/31217-09.htm


However, the Bio Products Laboratory who produce plasma products did export surplus products, under the Income Generation Regulations for the NHS, and used the income for the benefit of the health service.[21]


http://www.publications.parliament.uk/pa/cm200001/cmselect/cmpubacc/207/20703.htm#n21


43. Do you sell any of it abroad at all?(Mr Gorham) No. The only circumstances in which we would export blood would be if there was an approach to the British Government and the British Government felt that it was appropriate to support an international emergency or something like that. We do supply the British Forces. We occasionally help out our colleagues in Wales and Scotland and they would reciprocate with us if that was appropriate. At the moment it is more or less totally contained within the United Kingdom.


http://www.publications.parliament.uk/pa/cm200001/cmselect/cmpubacc/207/1012904.htm


Blood and Blood Products

Mr. Hinchliffe: To ask the Secretary of State for Health what estimate he has made of the number of persons who have been inoculated with blood or blood products over the past three years in the United Kingdom. [61681]

Ms Jowell [holding answer 2 December 1998]: It is estimated that about one million people in the United Kingdom receive blood and blood products every year.


http://www.parliament.the-stationeryoffice.co.uk/pa/cm199899/cmhansrd/vo990210/text/90210w02.htmstationeryoffice.co.uk/pa/cm199899/cmhansrd/vo990210/text/90210w02.htm


Human vaccine prepared in animal brains


http://www.mad-cow.org/00/nov00_late_news.html#fff


http://www.whale.to/v/singeltary7.html


http://www.mad-cow.org/00/may00_news.html


http://www.mad-cow.org/00/jul00_dont_eat_sheep.html#hhh


RECALLS AND FIELD CORRECTIONS: BIOLOGICS -- CLASS I_______________________________PRODUCTHuman Tissue for Transplantation, Recall # B-0432-6:a) Tricortical Wedge (R) 1.5 x 2.5 cm,Freeze Dried Irradiated;b) Tricortical Wedge ( L ) 1.7 x 3.0 cm,Fresh Frozen Irradiated;c) Cancellous Crushed 60.0 cc, Freeze Dried,Irradiated;d) Cancellous Crushed 30.0 cc Freeze Dried,Irradiated;e) Achilles Tendon OA ( R ) Fresh FrozenIrradiated;f) Achilles Tendon OA ( L ) Fresh FrozenIrradiated;g) Lumbar;h) Cancellous Crushed 30.0 cc Fresh Frozen,IrradiatedCODEa) Tissue 04091-002;b) Tissue 04113-003;c) Tissues 04091-008, 04101-008, 04103-002,04103-003, 04105-003;d) Tissues 04091-005, 04091-006, 04091-007,04101-006, 04101-007, 04102-004, 04102-005,04104-003, 04104-004, 04104-005, 04105-002,04109-003, 04109-004, 04120-004, 04124-003,04124-004, 04138-002, 04138-003, 04140-002,04143-002, 04143-003, 04146-001, 04152-001;e) Tissues 04101-003, 04123-004;f) Tissues 04101-004, 04123-003;g) Tissues 03049-001, 03051-001, 04091-001,04102-001, 04103-001, 04104-001, 04105-001,04106-001, 04107-001, 04108-001, 04109-001,04113-001, 04120-001, 04122-001, 04123-001,04124-001;h) Tissue 04108-002RECALLING FIRM/MANUFACTURERRecalling Firm: Central Texas Regional Blood & Tissue Center, Austin, TX, bytelephone on October 4, 2005, and by letter dated October 11, 2005.Manufacturer: Biomedical Tissue Services, Fort Lee, NJ, firm initiatedrecall is ongoing.REASONHuman tissues, procured from donors without adequate donor eligibilitydeterminations, were distributed.VOLUME OF PRODUCT IN COMMERCE51 allograftsDISTRIBUTIONTX and COPRODUCTHuman Corneal Tissues for Transplantation, Recall # B-0380-6CODETissues: CI044108 OD and CI044108 OSRECALLING FIRM/MANUFACTURERMichigan Eye Bank, Ann Arbor, MI, by letter dated November 22, 2005, and byfacsimile dated November 28, 2005. Firm initiated recall is complete.REASONHuman Corneas, collected from an ineligible donor, were distributed.VOLUME OF PRODUCT IN COMMERCE2 tissuesDISTRIBUTIONMI, CA and Germany_______________________________PRODUCTa) Red Blood Cells Leukocytes Reduced,Recall # B-0617-6;b) Red Blood Cells (Apheresis) Leukocytes Reduced(distributed as split product), Recall # B-0618-6;c) Platelets Leukocytes Reduced, Recall # B-0619-6;d) Fresh Frozen Plasma, Recall # B-0620-6;e) Cryoprecipitated AHF, Recall # B-0621-6;f) Plasma Cryoprecipitate Reduced, Recall # B-0622-6;g) Recovered Plasma, Recall # B-0623-6CODEa) Unit numbers: 1136792, 1040212, 1011245;b) Unit numbers: 1048247-1, 1048247-2;c) Unit numbers: 1040212, 1011245;d) Unit number: 1136792;e) Unit numbers: 1040212, 1011245;f) Unit number: 1040212;g) Unit number: 1011245RECALLING FIRM/MANUFACTURERHoxworth Blood Center, Cincinnati, OH, by letter dated September 6, 2005.Firm initiated recall is complete.REASONBlood products, collected from a donor considered to be at increased riskfor variant Creutzfeldt-Jakob Disease (vCJD), were distributed.VOLUME OF PRODUCT IN COMMERCE12 unitsDISTRIBUTIONOH and FL_______________________________END OF ENFORCEMENT REPORT FOR MARCH 1, 2006###http://www.fda.gov/bbs/topics/enforce/2006/ENF00941.htmlPRODUCTRecovered Plasma, Recall # B-0643-6CODEUnit numbers: R170537, R165863, and R158308RECALLING FIRM/MANUFACTURERPuget Sound Blood Center, Seattle, WA, by facsimile on October 7, 2003. Firminitiated recall is complete.REASONBlood products, which were collected from an unsuitable donor based on riskfactors for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.VOLUME OF PRODUCT IN COMMERCE3 unitsDISTRIBUTIONAustriaEND OF ENFORCEMENT REPORT FOR FEBRUARY 22, 2006###http://www.fda.gov/bbs/topics/enforce/2006/ENF00940.htmlPRODUCTa) Product is 1.0 cc Regenaform® RT. SINGLE PATIENTUSE ONLY. Recall # Z-0481-06;b) OPTEFORM Allografts of varying sizes. SINGLE PATIENTUSE ONLY. Recall # Z-0482-06;c) Product is OPTEFORM Allograft Paste of varying sizes.SINGLE PATIENT USE ONLY. Recall # Z-0483-06;d) OPTEFORM® RT Moldable Allograft of varying sizes.SINGLE PATIENT USE ONLY. Recall # Z-0484-06;e) Osteofil + RT Allograft Paste in varying sizes.SINGLE PATIENT USE ONLY. Recall # Z-0485-06;f) Osteofil Allograft Paste (Bio) of varying sizes.SINGLE PATIENT USE ONLY. Recall # Z-0486-06;g) Osteofil IC Syringeable of varying sizes. SINGLEPATIENT USE ONLY. Recall # 0487-06;h) Osteofil ICM Moldable Strip of varying sizes.SINGLE PATIENT USE ONLY. Recall # Z-0488-06;i) Osteofil RT, ICM Allograft Paste of varying sizes.SINGLE PATIENT USE ONLY. Recall # Z-0489-06;j) OSTEOFIL® DBM Paste of varying sizes. SINGLEPATIENT USE ONLY. Recall # Z-0490-06;k) OsteoPack 3 FZ 22cc. SINGLE PATIENT USE ONLY.Recall # Z-0491-06;l) Regenafil IC. SINGLE PATIENT USE ONLY.Recall # Z-0492-06;m) REGENAFORM RT Allograft Paste, 1cc. SINGLEPATIENT USE ONLY. Recall # Z-0493-06;n) Product is REGENAFORM® Allograft Moldable Blocks,of varying sizes. SINGLE PATIENT USE ONLY.Recall # Z-0494-06;o) Product is RTI Allograft Paste of varying sizes.SINGLE PATIENT USE ONLY. Recall # Z-0495-06;p) Product is REGENAFIL® Allograft Paste, Syringe,0.5cc. SINGLE PATIENT USE ONLY. Recall # 0496-06;q) Product is 1.0cc flowable paste from donorapproved for distribution in Italy. SINGLEPATIENT USE ONLY. Recall # Z-0497-06;r) Product is OPTEFIL Allograft Paste of varyingsizes. SINGLE PATIENT USE ONLY. Recall# Z-0498-06;s) Product is OPTEFIL Allograft Paste, Syringeof varying sizes. SINGLE PATIENT USE ONLY.Recall # Z-0499-06;t) Product is OPTEFORM® Allograft Full Disc,5 x 90mm, 32cc, Frozen. SINGLE PATIENT USEONLY, Recall # Z-0500-06;u) Product is 2.0 cc Opteform® RT. SINGLEPATIENT USE ONLY. Recall # Z-0501-06CODE2879130 2879131 2879132 2879133 2879134 2879135 2879136 2879137 28791382879139 2879350 2879351 2879352 2879353 2879354 2879355 2879440 28794412879442 2879443 2879444 2879445 2879446 2879447 2879448 2879449 28794502879451 2879452 2879453 2879454 2879455 2879456 2879457 2879458 28794592886780 2886781 2886782 2886783 2886784 2886785 2886786 2886787 28867882886789 2886950 2886951 2886952 2886953 2886954 2886955 2886956 28869572886958 2886959 2962280 2962281 2962282 2962283 2962284 2962285 29622862962287 2962288 2962289 2963820 2963821 2963822 2963823 2963824 29638252963826 2963827 2963828 2963829 2963910 2963911 2963912 2963913 29639142963915 2963916 2963917 2963918 2963919 2963990 2963991 2963992 29639932963994 2963995 2963996 2963997 2963998 2963999 2965900 2965901 29659022965903 2965904 2965905 2965906 2965907 2965908 2965909 2965910 29659112965912 2965913 2965914 2965915 2965916 2965917 2965918 2974861 29748622974863 2974864 2974865 2974866 2974867 2974868 2974869 2974870 30218273021829 3021830 3021831 3021832 3021833 3021834 3021836 3021877 30218783021882 3021883 3021885 3023281 3023282 3023283 3023284 3023285 30232863023287 3023288 3023289 3030571 3030572 3030573 3030574 3031471 30314733031474 3031475 3031476 3031477 3031478 3031479 3031480;0756898 0756899 0774572 0829702 0829703 0829704 0829705 0829706 08297570829758 0829759 0829760 0829761 0849054 0849055 0849056 0849057 08490580849144 0849145 0849146 0849147 0849148 0849159 0849160 0849161 08491620849163 0849230 0849231 0849232 0849233 0849234 0850462 0850463 08504690850470 0850471 0852636 0852637 0852638 0852639 0852640 1483739 14837401483741 1483742 1494117 1494118 1494119 1494122 1494240 2121702 21217032121704 2121705 2121706 2121907 2121908 2121909 2121910 2121911 21219222121923 2121924 2121925 2121926 2125258 2125339 2125340 2125341 21253422125343 2147725 2147727 2147825 2147827 2147829 2147905 2147906 21479072147908 2147909 2147930 2147931 2147932 2147933 2147980 2147981 21479822147983 2147984 2147995 2147996 2147997 2147998 2147999 2151766 21517672151768 2151769 2151770 2151781 2151782 2151783 2151784 2151785 21518272151828 2151829 2151830 2151966 2151967 2151968 2151969 2151970 21531172153118 2153119 2153120 2153346 2153347 2153348 2153349 2153350 21533592153360 0843158 0843159 0843160 0843161 0843162 2124913 2124914 21249682124969 2124971 2124972 2135208 2135209 2135210 2135211 2135212 21352732135274 2135275 2135276 2135277 2135284 2135285 2135286 2135287 21353082135309 2135310 2135311 2135312 2135318 2135319 2135320 2135478 21424362142437 2142438 2142439 2145001 2145002 2145003 2145004 2145005 21451312145132 2145133 2145134 2145135 2161531 2161532 2161533 2161534 21616862161687 2161688 2161689 2161690 2166675 2166676 2188866 2188969 21889702188971 0837098 0837099 0837100 0837101 0837102 0837477 0837478 08374790837480 2040067 2040068 2040069 2174843 2174844 2174845 2174846 21748472995331 2995332 2995333 2995334 2997901 2997902 2997903 2997904 29979052997906 2997907 2997908 2997909 2997910;3043561 3043562 3043563 3043564 3043565 3043566 3043567 3043568 30435693043570 3047041 3047042 3047043 3051158 3051159 3051160 3051193 30511943051195 3051196 3051197 3051198 3051199 3051491 3051493 3051495 30514973050703 3050705 3050706 3050710 3056760 3060591 3027677 3027678 30276793044581 3044582 3044583 3044584 3044585 3044586 3044587 3044588 30445893044590 3044931 3044932 3044933 3044934 3044935 3044936 3044937 30449383044939 3044940 3044941 3044942 3044943 3044944 3044945 3044946 30449473044948 3044949 3044950 3045571 3045572 3045573 3045574 3045575 30455763045941 3045942 3045943 3045944 3045946 3045947 3045948 3045949 30463413046342 3046343 3046344 3046345 3046346 3046347 3046348 3046349 30463503046531 3046532 3046533 3046534 3046535 3046536 3046537 3046538 30465393046540 3046621 3046622 3046623 3046624 3046625 3046626 3046627 30466283046629 3046630 3046661 3046662 3046663 3046664 3046665 3046666 30466673046668 3046669 3046670 3046671 3046672 3046673 3046674 3046675 30466763046677 3046678 3046679 3046680 3046731 3046732 3046733 3046734 30467353046736 3046737 3046738 3046739 3046740 3046831 3046832 3046833 30468343046835 3046836 3046837 3046838 3046839 3046840 3046971 3046972 30469733046974 3046975 3046976 3046977 3046978 3046979 3046980 3046981 30469823046983 3046984 3046985 3046986 3046987 3046988 3046989 3046990 30474013047402 3047403 3047404 3047405 3047406 3047407 3047408 3047409 30474103051101 3051102 3051103 3051104 3051105 3051161 3051162 3051163 30511643051165 3051166 3051167 3051168 3051169 3051170 3051221 3051222 30512233051224 3051226 3051227 3051228 3051229 3051230 3051231 3051232 30512333051234 3051235 3051236 3051237 3051238 3051239 3051240 3051241 30512423051243 3051244 3051245 3051246 3051247 3051248 3051249 3051250 30512713051272 3051273 3051274 3051275 3051276 3051277 3051278 3051279 30512803051381 3051382 3051383 3051384 3051385 3051386 3051387 3051388 30513893051390 3051422 3051423 3051424 3051425 3051426 3051427 3060550 30605513060552;2613431 2613432 2613433 2613434 2613435 2613436 2613437 2613438 26134392613440 2613901 2613902 2613903 2613904 2613905 2613906 2613907 26148812614882 2614883 2614884 2614885 2614886 2614887 2614888 2614889 26148902653106 2653107 2653108 2654250 2654251 2654252 2654253 2654254 26542552654256 2654257 2654258 2654259 2699840 2699841 2699842 2699843 24852312485232 2485233 2485234 2485235 2485236 2485237 2485238 2485239 24852402595521 2595522 2595921 2595922 2595923 2595924 2595925 2595926 25959272595928 2595929 2595930 2978531 2978532 2978533 2978534 2978535 29785362978537 2978538 2978539 2978540 2983613 2983614 2983615 2983616 29838312983832 2983842 2983843 2983844 2984801 2984802 2984803 2984804 29848052984806 2984807 2984808 2984809 2984810 2985721 2985722 2985723 29857242985725 2985726 2985727 2985728 2985729 2985730 2985791 2985792 29857932985794 2985795 2985796 2985797 2985798 2985799 2985800 2985911 29859122985913 2985914 2985915 2985916 2985917 2985918 2985919 2985920 29859912985992 2985993 2985994 2985995 2985996 2985997 2985998 2985999 29860002986841 2986842 2986843 2986844 2986845 2986846 2986847 2986848 29868492986850 2986861 2986862 2986863 2986864 2986865 2986866 2986867 29868682986869 2986870 2987907 2987908 2999921 2999922 2999923;2488121 2488122 2488123 2488124 2488125 2488126 2488127 2488128 24881302497251 2497252 2497253 2497253 2497254 2497255 2497256 2497257 24972582497259 2497260 2497361 2497362 2497363 2497364 2497365 2497366 24973672497368 2497369 2497370 2501782 2501783 2501784 2501785 2501786 25017872501788 2501789 2501790 2501791 2501791 2501832 2501833 2501834 25018352501836 2501837 2501838 2501839 2501840 2501841 2501872 2501873 25018742501875 2501876 2501877 2501878 2501879 2501880 2501881 2502191 25021922502193 2502194 2502195 2502196 2502197 2502198 2502199 2502200 25598512559852 2559853 2559854 2559855 2559856 2559857 2559858 2559859 25599512559952 2559953 2559954 2559955 2559956 2559957 2559958 2559959 25599602559991 2559992 2559993 2559994 2559995 2559996 2559997 2559998 25599992560000 2560071 2560072 2560073 2560074 2560075 2560076 2560077 25600782560079 2560080 2560221 2560222 2560223 2560224 2560225 2560226 25602272560228 2560229 2560230 2560273 2560274 2560275 2560276 2560277 25602782560279 2560280 2560471 2560472 2560473 2560474 2560475 2560476 25604772560478 2560479 2560480 2561641 2561642 2561643 2561645 2561646 25616472561648 2561649 2561650 2561841 2561842 2561843 2564571 2564572 25645732564574 2564575 2564576 2564577 2564578 2564579 2564580 2564591 25645922564593 2564594 2564595 2564596 2564598 2564599 2564600 2565581 25655822565583 2565584 2565585 2565586 2565587 2565588 2565589 2565971 25659722565973 2565974 2565975 2565976 2565977 2565978 2565979 2565980 26133512613352 2613353 2613354 2613355 2613356 2613358 2613359 2613461 26134622613463 2613465 2613466 2613467 2613468 2613469 2613470 2613524 26135252613526 2613527 2613528 2613529 2613908 2613909 2613910 2613931 26139322613933 2613934 2613935 2613936 2613937 2613938 2613939 2613940 26139712613972 2613974 2613975 2613976 2613977 2613978 2613979 2613980 26143712614372 2614373 2614374 2614375 2614376 2614377 2614551 2614552 26145532614554 2614555 2614556 2614558 2614591 2614592 2614593 2614594 26145952614596 2614597 2614599 2614891 2614892 2614893 2614894 2614895 26148962614899 2614900 2614982 2614984 2614989 2614990 2616221 2616222 26162232616224 2616227 2616228 2616229 2616230 2616491 2616492 2616493 26164942616495 2616496 2616497 2616500 2620221 2620223 2620225 2620227 26202292620271 2620272 2620276 2620277 2620278 2620279 2620280 2689161 26891632689165 2689166 2689168 2689169 2689371 2689372 2689373 2689374 26893752689376 2689378 2690294 2690295 2690297 2690299 2690300 2690301 26903032692921 2692922 2692923 2692926 2692927 2692928 2692929 2692939 27131972713198 2713199 2713200 2713202 2713203 2713228 2713230 2713231 27132322713234 2713235 2713236 2713388 2713389 2713390 2713391 2713392 27133932713394 2713395 2713396 2713427 2713428 2713429 2713430 2713431 27134332713434 2713435 2713436 2718753 2718754 2718755 2718756 2718758 27187602718791 2718793 2718794 2718795 2718796 2718798 2718800 2718931 27189322718934 2718935 2718936 2718937 2718940 2718961 2718962 2718965 27189692718970 1901774 1901775 1901776 1901777 1901778 1901779 1901780 19017811901782 1901783 1901804 1901805 1901806 1901807 1901808 1901809 19018101901811 1901812 1901813 1909226 1909227 1909228 2679851 2679852 26892602689261 2689262 2689263 2689264 2689265 2689266 2689267 2689268 26892692692940 2692941 2692942 2692943 2692944 2692945 2692946 2692947 26929482692949;1700271 1700272 1700273 1700274 1700275 1700276 1700277 1700278 17002791700280 1879091 1879092 1879093 1879094 1879095 1879096 1879097 18790981879099 1879100 1907051 1907052 1907053 1907054 1907055 1907056 19070571907058 1907059 1907060 1907141 1907142 1907143 1907144 1907145 19071461907147 1907148 1907149 1907150 1951240 1951241 1951242 1951243 19512441951245 2436853 2436854 2436855 2436856 2436857 2436858 2436859 24368602436861 2436862 2442511 2442512 2442513 2442514 2442515 2442516 24425172442518 2442519 2442520 2442581 2442582 2442583 2442584 2442585 24425862442587 2442588 2442589 2442590 2443901 2443902 2443903 2443904 24439052443906 2443907 2443908 2443909 2443910 2444551 2444552 2444553 24445542444555 2444557 2444558 2444559 2444560 2446181 2446182 2446183 24461842446185 2446186 2446187 2446188 2446190 2446491 2446492 2446493 24464942446495 2446496 2446497 2446498 2446499 2446500 2446851 2446852 24468532446854 2446855 2446856 2446857 2446858 2446859 2446860 2446911 24469122446913 2446914 2446915 2446916 2446917 2446918 2446919 2446920 24469512446952 2446953 2446954 2446955 2446956 2446957 2446958 2446959 24469602446971 2446972 2446973 2446974 2446975 2446976 2446977 2446978 24469792446980 2446981 2446982 2446983 2446984 2446985 2446986 2446987 24469882446989 2446990 2456961 2456962 2456963 2456964 2456965 2456966 24569672456968 2456969 2456970 2822090 2822091 2822092 2822093 2822094 28220952822096 2822097 2822098 2822099 2822460 2822461 2822462 2822463 28224642822465 2822466 2822467 2822468 2822469 2823610 2823611 2823612 28236132823614 2823615 2823616 2823617 2823618 2823619 2823850 2823851 28238522823853 2823854 2823855 2823856 2823857 2823858 2823859 2824090 28240912824092 2824093 2824094 2824095 2824096 2824097 2824098 2824099 28243202824321 2824322 2824323 2824324 2824325 2824326 2824327 2824328 28243292158083 2184601 2184602 2184603 2184604 2184605 2184606 2184607 21846082184609 2184610 2190451 2190452 2190453 2190454 2190455 2190471 21904722190473 2190474 2190475 2190476 2190477 2190478 2190479 2190480 28350232835029 2839737 2158050 2158051 2158052 2158053 2158054 2158055 21580562158057 2158058 2158059 2158060 2158061 2158062 2158063 2158064 21580652158066 2158067 2158068 2158069 2158070 2158071 2158072 2158073 21580742158075 2158076 2158077 2158078 2158079 2158080 2158081 2158082 26144762614477 2614478 2614479 2614729 2614730 2616471 2616472 2616473 26164742616475 2616476 2616477 2616478 2616479 2616480 2622781 2622783 26227842622785 2622786 2622787 2622788 2622789 2622790 2700000 2700001 27000022700003 2700004 2700005 2700006 2700007 2700008 2700009 2713098 27130992713100 2713101 2713102 2713103 2713104 2713105 2713106 2713307 27133082713309 2713310 2713311 2713312 2713313 2713314 2713315 2713316 27201732720174 2720175 2720176 2720177 2720178 2720179 2720180 2720181 27201822732530 2732531 2732532 2732533 2732534 2732535 2732536 2732537 27325382732539 2732690 2732691 2732692 2732693 2732694 2732695 2732696 27326972842690 2842691 2842692 2842693 2842694 2842695 2842696 2842697 28426982842699 2844190 2844191 2844193 2847760 2847763 2847766 2847767 28485142848515;2250274 2250275 2250276 2443591 2443592 2443593 2443594 2443595 24449412444942 2444943 2444944 2444945 2444946 2444947 2444948 2444949 24449502446231 2446232 2446233 2446234 2446235 2446236 2446237 2446238 24462392446240 2000898 2000899 2000900 2000901 2000902 2000903 2000952 20009532000954 2000955 2000956 2000957 2000958 2000959 2000960 2000961 20009622000963 2000964 2000965 2000966 2000967 2000968 2000969 2250269 2250270;2511671 2511672 2511673 2511674 2511675 2511676 2511677 2511678 26144712614472 2614473 2614474 2614475 2614721 2614722 2614723 2614724 26147252614726 2614727 2614728 2730530 2730531 2730532 2730533 2730534 27305352730536 2730537 2742463 2742464 2742465 2742466 2746363 2746364 27463652746366 2746367 2746368 2746369 2747870 2764991 2764992 2764993 27649942764995 2764996 2764997 2764998 2764999 2766699 2766700 2766701 27667022766703 2766704 2924612 2924613 2924730 2924731 2924732 2924733 29247342924735 2924736 2924737 2924738 2924739 2184631 2184633 2184634 21846352184636 2184637 2184638 2184639 2184640 2185751 2185752 2185753 21857542185755 2185756 2185757 2185758 2185759 2185760 2275371 2275372 22753732275374 2275375 2275376 2275377 2275378 2275379 2275380 2277521 22775222277523 2277524 2277525 2277526 2277527 2277528 2697923 2697924 26979252697926 2697927 2697928 2697929 2699572 2699573 2699574 2699575 26995762699577 2699732 2699733 2699734 2699735 2699736 2699737 2699738 27013922701393 2703640 2703961 2703962 2703963 2703964 2703965 2703966 27039672730383 2730384 2730385 2730386 2730387 2730388 2749681 2749682 27496832749684 2749685 2749686 2749687 2749688 2754459 2754460 2754461 27544622754463 2788895 2788896 2788897 2894236 2924780 2924781 2924782 29247832924784 2924785 2924786 2924787 2924788 2924933 2926150 2926151 29261522926153 2926154 2926155 2926156 2926157 2926158 2926159 2945532 29455332945534 2945535 2945536 2945537 2945538 2946230 2946231 2946232 29462332946234 2946235 2946236 2946237 2946238 2946239 2946350 2946351 29463522946353 2946354 2946355 2946356 2946357 2946358 2946359 2955822 29558232955824 2955825 2955826 2955827 2955828 2955829 2959010 2959011 29590122959013 2959014 2959015 2959016 2959017 2959018 2959019 2964612 29646132964614 2985046 2985048 2985049 2985112 2985113 2985114 2985115 29851162985117 2985118 2985119 2985120 2985393 3003673 3003674 3003675 30036763003677 3003678;1942724 1942725 1942726 1942727 1942728 1942729 1942730 1942731 19427321942733 2348778 2348779 2348780 2348782 2348783 2348786 2348787 23535812353582 2353583 2353584 2353585 2353586 2353587 2353588 2353589 23558912355892 2357191 2357192 2357194 2357195 2357197 2357199 2357200 23573522357353 2357354 2357355 2357356 2357357 2357358 2357359 2555281 25552822555283 2555284 2555285 2555286 2702230 2702231 2702232 2707030 27070312707032 2707033 2707034 2707035 2707036 2707037 2707038 2707039 27070802707081 2707082 2707083 2707084 2707085 2707086 2707087 2707088 27070892736580 2736582 2736583 2736584 2745510 2745511 2745512 2745513 27455142745515 2745516 2745517 2745518 2745519 2745810 2745811 2745812 27458132745815 2745816 2745817 2790531 2792751 2792752 2792753 2792754 27927552792756 2801580 2801581 2819213 2819214 2819215 2819216 2819217 28192182819219 2822200 2822201 2822202 2822203 2822204 2822205 2822206 28222072822208 2822209 2822690 2822691 2822692 2822693 2822694 2822695 28226962822697 2822698 2822699 2825260 2825261 2825262 2825263 2827850 28285302828531 2828532 2828533 2828534 2828535 2828536 2828537 2828538 28285392828970 2828971 2828972 2828973 2828974 2828975 2828976 2829000 28290012829002 2829003 2829004 2829005 2829006 2829007 2829008 2829009 28414212841422 2841423 2841424 2841425 2841426 2841427 2858451 2858453 28584542858455 2858456 2858457 2858458 2862140 2862141 2862142 2862143 28621442862145 2862146 2862147 2862148 2862149 2867790 2867791 2867792 28677932867794 2879490 2879491 2879492 2879493 2879494 2879495 2879496 28794972879498 2879499 2891075 2892310 2892311 2892312 2892313 2892314 28923152898700 2898701 2898702 2898703 2898704 2898705 2898706 2898707 28987082898709 2898750 2898751 2898752 2898753 2898754 2898756 2898757 29021102902111 2902112 2902113 2902114 2902115 2902116 2902117 2916110 29161112916112 2916113 2916114 2916115 2916116 2916117 2916118 2916119 29245102924511 2924970 2924971 2924972 2924973 2924974 2924975 2924976 29249772924978 2927580 2927581 2927582 2927583 2927584 2927585 2927586 29275872927588 2927589 2927990 2927991 2927992 2927993 2927994 2928200 29282012928202 2928203 2928204 2928205 2928206 2928207 2928208 2928209 29284502928451 2928452 2928453 2928454 2928455 2928456 2928457 2928458 29284592946140 2946141 2946142 2946143 2946144 2946145 2946146 2946147 29461482946180 2946181 2946182 2946183 2946184 2946185 2946186 2946187 29461882946189 2949810 2949811 2950032 2950033 2950034 2950035 2950036 29500372950290 2950292 2950293 2950294 2950295 2950296 2950297 2950298 29502992954658 2954659 2954660 2954661 2954662 2954663 2954664 2954665 29546662954667 2954908 2954909 2954910 2954911 2954912 2954913 2954914 29549152954916 2954917 2955246 2955248 2955249 2955250 2955251 2955252 29552532960350 2960351 2960352 2960353 2960354 2960355 2960356 2960357 29603582960359 2962920 2962921 2962922 2962923 2962924 2962925 2962926 29629272962928 2962929 2964790 2964791 2964792 2964793 2964794 2964795 29647962964797 2964798 2964799 2965980 2965981 2965982 2965983 2965984 29659852965986 2965987 2965988 2965989 2974871 2974872 2974875 2974877 29748782974879 2974881 2974883 2974884 2974885 2974889 2974890 2983839 29839152985681 2985682 2985683 2985684 2985685 2985686 2985687 2985688 29856892985690 2987041 2987042 2987043 2987044 2987045 2987046 2987047 29870482987049 2987050 2987269 2987270 2987271 2987272 2987273 2987274 29872752987276 2987277 2987561 2987562 2987563 2987564 2987565 2987566 29875672993431 2997361 2997362 2997363 2997364 2997365 2997366 2997367 29973682997369 2997370 2997631 2997632 2997633 2997634 2997635 2997636 29976372997638 2997639 2997640 2997752 2997753 2997754 2997931 2997932 29979352997936 2997937 2997938 2997939 3003851 3003852 3004091 3004092 30040933004094 3004095 3004096 3004097 3004098 3004099 3004100 3004431 30044323004433 3004434 3004435 3004436 3004437 3004438 3004439 3004440 30055913005592 3005593 3005594 3005595 3005596 3005597 3005598 3005599 30056003007581 3007582 3007583 3007584 3007585 3007586 3007587 3007588 30075893007590 3007621 3007622 3007624 3007625 3007626 3007627 3007628 30076293007630 3013741 3013742 3013743 3013744 3013746 3013747 3013748 30137493013750 3013781 3013782 3013784 3013785 3013786 3013787 3013788 30137903013961 3013962 3013963 3013964 3013965 3013966 3013967 3013968 30139693013970 2880362 2880363 2880364 2880365 2880366 2880367 2880368 29089942910330 2910331 2910332 2910333 2910334 2910335 2910336 2910337 29103382910339 2927630 2927631 2927633 2927634 2927635 2927636 2927637 29276382927639 2927910 2927911 2927912 2927914 2927915 2927916 2962764 29627662649790 2649791 2649792 2649793 2649794 2649795 2649796 2649797 26497982649799 2654240 2654241 2654242 2654243 2654244 2654245 2654246 26542472654248 2654249 2663020 2663021 2663022 2663023 2663024 2663025 26630262663027 2663028 2663029 2663141 2663142 2663143 2663144 2663170 26631712663172 2663173 2663174 2663175 2663176 2663177 2663178 2663179 26795902679592 2679593 2679594 2679595 2679596 2679597 2679598 2679599 26891902689191 2689192 2689193 2689194 2689195 2689196 2689197 2689198 26891992690374 2690375 2691490 2691491 2725370 2725371 2725372 2725373 27253752725376 2725377 2725378 2725379 2726260 2726261 2726264 2726265 27262662729450 2729451 2729452 2729453 2729454 2729455 2729456 2729457 27307202730721 2730722 2730725 2730727 2730729 2730760 2730761 2730762 27307642730765 2730766 2730767 2730768 2732600 2732601 2732603 2732604 27326052732607 2732608 2732609 2732870 2732871 2732874 2732876 2732878 27329002732901 2732902 2732903 2732905 2732906 2732907 2732908 2732909 27390502739051 2739052 2739053 2739054 2739055 2739056 2739057 2739058 27390592745750 2745751 2745752 2745753 2745754 2745755 2745756 2745757 27457582745759 2745980 2745981 2745982 2745983 2745984 2745985 2745986 27481802748181 2748182 2748183 2748184 2748185 2748187 2748188 2748189 27482002748201 2748202 2748203 2748204 2748205 2748206 2748207 2748208 2748209;2819000 2819001 2819002 2819003 2819004 2819005 2819006 2819007 28190082819009 2819080 2819081 2819082 2819083 2819084 2819085 2819086 28190872819088 2819089 2819470 2819471 2819472 2819473 2819474 2819475 28194762819477 2819478 2819479 2820000 2820001 2820002 2820003 2820004 28200052820110 2820111 2820112 2820113 2820114 2820115 2820116 2820117 28201182820119 2820210 2820211 2820212 2820213 2820214 2820215 2820216 28202172820218 2820219 2820430 2820431 2820432 2820433 2820434 2820435 28204362820437 2820438 2820439 2820440 2820441 2820442 2820443 2820444 28204452820446 2820447 2820448 2820449 2820480 2820481 2820482 2820483 28204842820485 2820486 2820487 2820488 2820489 2821340 2821341 2821342 28213432821344 2821345 2821346 2821347 2821348 2821349 2821350 2821351 28213522821353 2821354 2821355 2821356 2821357 2821358 2821359 2821480 28214812821482 2821483 2821484 2821485 2821486 2821487 2821488 2821489 28215002821501 2821502 2821503 2821504 2821505 2821506 2821507 2821508 28215092821936 2821937 2821938 2821939 2824520 2824521 2824522 2824523 28245242824525 2824526 2824527 2824528 2824529 2824802 2824803 2824804 28248052824806 2824807 2824808 2824809 2824810 2824811 2824812 2824813 28248142824815 2824816 2824817 2824818 2824819 2824820 2824821 2824822 28248232824824 2824825 2824826 2824827 2824828 2824829 2824830 2824831 28248822824883 2824884 2824885 2824886 2824887 2824888 2824889 2824890 28248912824982 2824983 2824984 2824985 2824986 2824987 2824988 2824989 28249902824991 2825360 2825361 2825362 2825363 2825364 2825365 2825366 28253672825368 2825369 2728210 2728211 2728212 2728213 2728214 2728215 27282162728217 2728218 2728219 2729190 2729191 2729192 2729194 2729195 27353902735391 2735392 2735393 2735394 2735395 2764520 2764521 2764522 27645232764524 2764525 2764526 2764527 2764528 2764529 2766656 2766657 27666592766660 2769420 2769421 2769422 2769423 2769424 2769425 2769426 27694272769428 2769429 2826080 2826082 2826083 2826084 2826087 2826088 28260892826190 2826191 2826192 2826194 2826196 2826198 2826199 2826220 28262212826222 2826223 2826224 2826225 2826226 2826227 2826228 2826320 28263212826322 2826324 2826326 2826327 2826329 2826400 2826401 2826402 28264032826404 2826406 2826408 2826409 2831060 2831061 2831063 2831065 28310672831340 2831342 2831344 2831345 2831346 2831348 2831350 2831353 28313542831355 2831357 2831358 2831359 2831420 2831421 2831422 2831423 28314242831425 2831426 2831427 2831429 2833250 2833253 2833254 2833323 28333242833325 2833328 2833329 2833380 2833381 2833382 2833383 2833384 28333862833388 2833389 2835290 2835291 2835293 2835296 2835297 2835298 28353002835302 2835303 2835304 2835305 2835306 2835307 2835308 2835691 28356922835695 2835696 2835698 2835699 2729620 2729621 2729622 2729623 27296242729625 2729626 2729627 2729628 2729629 2770951 2770952 2770953 27709542770955 2774620 2774621 2774622 2774623 2774624 2774625 2774626 27746272774628 2774629 2774881 2774882 2774883 2774884 2774885 2774889 27777602777761 2777762 2777763 2777764 2777765 2777766 2777767 2777768 27777692777790 2777791 2777792 2777793 2777794 2777795 2777796 2777797 27777982777799 2779040 2779041 2779042 2779043 2779044 2779045 2779046 27790472779048 2779049 2779490 2779491 2779492 2779493 2779494 2779495 27794962779497 2779498 2779499 2796951 2796952 2796953 2796954 2796955 27969562796957 2796958 2796959 2796960;2726001 2726002 2726003 2730281 2730282 2730283;2396521 2396522 2396523 2396524 2396525 2396526 2396527 2396528 23965292397301 2397302 2397303 2397304 2397305 2397306 2397307 2397308 23973092397310 2000878 2000879 2000880 2000881 2000882 2000883 2000884 20008852000886 2000887 2000888 2000889 2000890 2000891 2000892 2000893 20008942000895 2000896 2000897 2158322 2158324 2158325 2158326 2158327 2158329;3047051 3047052 3047053 3047054 3047055 3047056 3047057 3047058 30470593047060 3049351 3049352 3049353 3049354 3049355 3049356 3049357 30493583049359 3049360 3049421 3049422 3049423 3049424 3049425 3049426 30494273049428 3049429 3049430 3049471 3049472 3049473 3049474 3049475 30494763049477 3049478 3049479 3049480 3056740 3056817 3056818 3056819 30568203056981 3056982 3056983 3056984 3056985 3056986 3056987 3056988 30569893056990 3057141 3057142 3057143 3057144 3057145 3057146 3057147 30571483057149 3057150 3057161 3057162 3057163 3057165 3057166 3057167 30571683057169 3057170 3057241 3057242 3057243 3057244 3057245 3057246 30572483057249 3057250 3057251 3057252 3057253 3057254 3057255 3057256 30572573057258 3057259 3057260 3057281 3057282 3057283 3057284 3057285 30572863057287 3057288 3057289 3057290 3057915 3057917 3057918 3057919 30579203057921 3057922 3057923 3057924 3057985 3057986 3057987 3057988 30579893057990 3057991 3057992 3057993 3057994 3059151 3059152 3059153 30591543059155 3059156 3059157 3059158 3059159 3059160 3059521 3059522 30595233059524 3059525 3059526 3059527 3059528 3059529 3059530 3059621 30596223059623 3059624 3059625 3059626 3059627 3059628 3059629 3059630 30605743060575 3060576 3064501 3064502 3064503 3064504 3064505 3064506 30645073064508 3064509 3064510 3064561 3064562 3064563 3064564 3064565 30645663064567 3064568 3064569 3064570 3064761 3064762 3064763 3064764 30647653064766 3064767 3064768 3064769 3064770 3064781 3064782 3064783 30647853064786 3064787 3064788 3064789 3064790 3064821 3064822 3064823 30648243064826 3064827 3064828 3064829 3064830 3064881 3064882 3064884 30648853064886 3064887 3064888 3064889;2825210 2825211 2825212 2825213 2825214 2825215 2825216 2825217 28252182825219 2828500 2828501 2828502 2828590 2828591 2828592 2828593 28285942828595 2828596 2828597 2828598 2828599 2828600 2828601 2828602 28286032828604 2828605 2828606 2828607 2828608 2828609 2828640 2828641 28286422828643 2828644 2828645 2828646 2828648 2828649 2828820 2828821 28288222828823 2828824 2828825 2828826 2828827 2828828 2828829 2831070 28310712831072 2831073 2831074 2831075 2831076 2831077 2831078 2831079 28310902831091 2831092 2831093 2831094 2831096 2831097 2831098 2831099 28311502831151 2831152 2831153 2831154 2831155 2831156 2831157 2831158 28311592834480 2834481 2834482 2834483 2834484 2834485 2834486 2834487 28344882834489 2835022 2835110 2835111 2835112 2835113 2835114 2835115 28351162835117 2835118 2835119 2835320 2835321 2835322 2835323 2835324 28353252835326 2835327 2835328 2835329 2835720 2835721 2835722 2835723 28357242835725 2835726 2835727 2835728 2835729 2835730 2835731 2835732 28357332835734 2835735 2835736 2835737 2835738 2835739 2836030 2836031 28360322836033 2836034 2836035 2836036 2836037 2836038 2836039 2836130 28361312836132 2836133 2836134 2836135 2836136 2836137 2836138 2836139 28361502836151 2836152 2836153 2836154 2836155 2836156 2836157 2836158 28361592836490 2836491 2836492 2836493 2836494 2836495 2836496 2836498 28364992837000 2837001 2837002 2837003 2837004 2837005 2837006 2837007 28370082837009 2837050 2837051 2837052 2837053 2837054 2837055 2837056 28370572837058 2837059 2837060 2837061 2837062 2837063 2837064 2837065 28370662837067 2837068 2837069 2837090 2837091 2837092 2837093 2837094 28370952837096 2837097 2837098 2837099 2837170 2837171 2837172 2837173 28371742837175 2837176 2837177 2837178 2837179 2839620 2839621 2839622 28396232839624 2839625 2839626 2839627 2839628 2839629 2841890 2841891 28418922841893 2841894 2841895 2841896 2841897 2841898 2841899 2842080 28420812842082 2842083 2842084 2842085 2842086 2842087 2842088 2842089 28421702842171 2842172 2842173 2842174 2842175 2842176 2842177 2842178 28421792844150 2844151 2844152 2844153 2844154 2844155 2844156 2844157 28441582844159 2844160 2844161 2844162 2844163 2844164 2844165 2844166 28441672844168 2844169 2844240 2844241 2844242 2844243 2844244 2844245 28442462844247 2844248 2844249 2846312 2846313 2846314 2846315 2846316 28463172846318 2846319 2846320 2846321 2846432 2846433 2846434 2846435 28464362846437 2846438 2846439 2846440 2846441 2846452 2846453 2846454 28464552846456 2846457 2846458 2846459 2846460 2846461 2858100 2858101 28581022858103 2858104 2858105 2858106 2858107 2858108 2858109 2858230 28582312858232 2858233 2858234 2858235 2858236 2858237 2858238 2858239 28583102858311 2858312 2858313 2858314 2858315 2858316 2858317 2858318 28583192858978 2858979 2858980 2858981 2858982 2858983 2858984 2858985 28589862858987 2880020 2880021 2880022 2880023 2880024 2880025 2880026 28800272880028 2880029 2880090 2880091 2880092 2880093 2880094 2880095 28800962880097 2880098 2880099 2880400 2880401 2880402 2880403 2880404 28804052880406 2880407 2880408 2880409 2881910 2881911 2881912 2881913 28819142881915 2881916 2881917 2881918 2881919 2886799 2902808 2902809 29028102902811 2902812 2902928 2902929 2902930 2902931 2902932 2902933 29029342902935 2902936 2902937 2903090 2903091 2903092 2903093 2903094 29030952903096 2903097 2903098 2903099 2903190 2903191 2903192 2903193 29031942903195 2903196 2903197 2903198 2903199 2903340 2903341 2903342 29033432903344 2903345 2903346 2903347 2903348 2903349 2903360 2903361 29033622903363 2903364 2903365 2903366 2903367 2903368 2903369 2904130 29041312904132 2904133 2904134 2904135 2904136 2904137 2904138 2904139 29043502904351 2904352 2904353 2904354 2904355 2904356 2904357 2904358 29043592904440 2904441 2904442 2904443 2904444 2904445 2904446 2904447 29044482904449 2826060 2826061 2826062 2826063 2826064 2826065 2826066 28260672826068 2826069 2831010 2831011 2831012 2831013 2831014 2831015 28310162831017 2831018 2831019 2835650 2835651 2835652 2835653 2835654 28356552835656 2835657 2835658 2835659 2835810 2835811 2835812 2835813 28358142835815 2835816 2835817 2835818 2835819 2842840 2842841 2842842 28428432842844 2842845 2842846 2842847 2842848 2842849 2844080 2844081 28440822844083 2844084 2844085 2844086 2844087 2844088 2844089 2844480 28444812844482 2844483 2844484 2844485 2844486 2844487 2844488 2844489 28223742822375 2822376;2819380 2819382 2819383 2819384 2819386 2819387 2819388 2820151 28201532820154 2820156 2820157 2820158 2820159 2820281 2820282 2820283 28202842820285 2820286 2820287 2820288 2820289 2820341 2820343 2820520 28205212820523 2820525 2820526 2820527 2820528 2820529 2822391 2822392 28223932822394 2822395 2822396 2822397 2822398 2822840 2822841 2822844 28228452822846 2822847 2822849 2822860 2822861 2822862 2822863 2822864 28228652822867 2822868 2822869 2822990 2822991 2822992 2822995 2822997 28229982822999 2824351 2824356 2824358 2824359 2824972 2824974 2824976 28249772824980 2824981 2825230 2825231 2825233 2825234 2825235 2825236 28252382825239 2825310 2825312 2825313 2825314 2825315 2825317 2825318 28278412827842 2827843 2827844 2827846 2827847 2827848 2827849 2828930 28289312828932 2828934 2828935 2828936 2828937 2828938 2828939 2831133 28311352831136 2831139 2835180 2835182 2835183 2835184 2835185 2835186 28351882835189 2835471 2835479 2836210 2836211 2836212 2836214 2836215 28362162836218 2837142 2837143 2837144 2837145 2837147 2837148 2837149 28417402841741 2841742 2841743 2841744 2841746 2841747 2841748 2841811 28418122841813 2841816 2841819 2841822 2841824 2841825 2841829 2841860 28418632841864 2841865 2841869 2841980 2841981 2841984 2841988 2842860 28428612842863 2842864 2842865 2842866 2842867 2842868 2842869 2842880 28428812842883 2842884 2842885 2842889 2842901 2842903 2842905 2842909 19427151942716 1942717 1942719 1942720 1942721 1942722 2878543 2878544 28785452878546 2878548 2878549 1942714 2764410 2764411 2764412 2764413 27644142821780 2821781 2821782 2821783 2821784 2821785 2821786 2821787 28217882823650 2823651 2823652 2823653 2823654 2823655 2823656 2823657 28236582823659 2825130 2825131 2825132 2825133 2825134 2825135 2825136 28251372825138 2825139 2847641 2847643 2847649 2870100 2870101 2870102 28701032870104 2870105 2870106 2870107 2870108 2870109 2870454 2870455 24435162443520 2443741 2443745 2726490 2726491 2726492 2726493 2666749 26723302672332 2672390 2672391 2672393 2672394 2672395 2672396 2672397 26723982672399 2672400 2672401 2672402 2672403 2672404 2672405 2672406 26724072672409 2673830 2673831 2673832 2673833 2673834 2673835 2673836 26738392674111 2674112 2674113 2674114 2674116 2674117 2674118 2674119 27132272718751 2718752 2718757 2718759 2718792 2718933 2718938 2718963 27189672718968;2389280 2389281 2389282 2389283 2389284 2389285 2389286 2389287 23892882389289 2395001 2395002 2395003 2395004 2395005 2395006 2395007 23950082395009 2395010 2395021 2395022 2395023 2395024 2395025 2395026 23950272395028 2395029 2395030 2395141 2395142 2395143 2395144 2395145 23951462395147 2395148 2395149 2395150 2395301 2395302 2395303 2395304 23953052395306 2395307 2395308 2395309 2395310 2396221 2396222 2396223 23962242396225 2396226 2396227 2396228 2396229 2396230 2396321 2396322 23963232396324 2396325 2396326 2396327 2396328 2396329 2396330 2396371 23963722396373 2396374 2396375 2396376 2396377 2396378 2396379 2396380 23964012396402 2396403 2396404 2396405 2396406 2396407 2396408 2396409 23964102396421 2396422 2396423 2396424 2396425 2396426 2396427 2396428 23964292396430 2396531 2396532 2396533 2396534 2396535 2396536 2396537 23965382396539 2396540 2397051 2397052 2397053 2397054 2397055 2397056 23970572397058 2397059 2397060 2397071 2397072 2397073 2397074 2397075 23970762397077 2397078 2397079 2397080 2397321 2397322 2397323 2397324 23973252397326 2397327 2397328 2397329 2397330 2764320 2764321 2764322 27643232764324 2764325 2764326 2764327 2764328 2764329 2764370 2764371 27643722764373 2764374 2764375 2764376 2764377 2764378 2764379 2764460 27644612764462 2764463 2764464 2764465 2764466 2764467 2764468 2764469 28016002801601 2801602 2801603 2801604 2801605 2801606 2801607 2801608 28016092820250 2820251 2820252 2820253 2820254 2820255 2820256 2820257 28202582820259 2821120 2821121 2821122 2821123 2821124 2821125 2821126 28211272821128 2821129 2821210 2821211 2821212 2821213 2821214 2821215 28212162821217 2821218 2821219 2821230 2821231 2821232 2821233 2821234 28212352821236 2821237 2821238 2821239 2821470 2821471 2821472 2821473 28214742821475 2821476 2821477 2821478 2821479 2824610 2824611 2824612 28246132824614 2824615 2824616 2824617 2824618 2824619 2824772 2824773 28247742824775 2824776 2824777 2824778 2824779 2824780 2825290 2825291 28252922825293 2825294 2825295 2825296 2825297 2825298 2825299 2846352 28463532846354 2846355 2846356 2846357 2846358 2846359 2846360 2846361 28463822846383 2846384 2846385 2846386 2846387 2846388 2846389 2846390 28463912858000 2858001 2858002 2858003 2858004 2858005 2858006 2858007 28580082858009 2858040 2858041 2858042 2858043 2858044 2858045 2858046 28580472858048 2858049 2858080 2858081 2858082 2858083 2858084 2858085 28580862858087 2858090 2858091 2858092 2858093 2858094 2858095 2858096 28580972858098 2858099 2858350 2858351 2858352 2858353 2858354 2858355 28583562858357 2858358 2858359 2858440 2858441 2858442 2858443 2858444 28584452858446 2858447 2858448 2858449 2864468 2864469 2864470 2864471 28644722864473 2864474 2864475 2864476 2864477 2865860 2865861 2865862 28658632865864 2865865 2865866 2865867 2865868 2865869 2865883 2865884 28658852865886 2865887 2865888 2865889 2865950 2865951 2865952 2865953 28659542865955 2865956 2865957 2865958 2865959 2879030 2879031 2879032 28790332879034 2879035 2879036 2879037 2879038 2879039 2879040 2879041 28790422879043 2879044 2879045 2879046 2879047 2879048 2879049 2879060 28790612879062 2879063 2879064 2879065 2879066 2879068 2879069 2879080 28790812879082 2879083 2879084 2879086 2879087 2879088 2879140 2879141 28791422879143 2879144 2879145 2879146 2879147 2879148 2879149 2879240 28792412879242 2879243 2879244 2879245 2879246 2879247 2879248 2879249 28793702879371 2879372 2879373 2879375 2879376 2879377 2879378 2879379 28794302879431 2879432 2879433 2879434 2879435 2879436 2879437 2879438 28794392886750 2886751 2886752 2886753 2886754 2886755 2886756 2886757 28867582886759 2900930 2900931 2900932 2900933 2900934 2900935 2900936 29009372900938 2900939 2902040 2902041 2902042 2902043 2902044 2902045 29020462902047 2902048 2902049 3021777 3021778 3021779 3021780 3021781 30217823021783 3021784 3021785 3021786 3021917 3021918 3021919 3021920 30219213021922 3021923 3021924 3021925 3021926 3021947 3021948 3021949 30219503021951 3021952 3021953 3021954 3021955 3021956 3022871 3022872 30228733022874 3022875 3022876 3022877 3022878 3022879 3022880 3024038 30240393024040 3024041 3024042 3024043 3024044 3024045 3024046 3024047 30241783024179 3024180 3024181 3024182 3024183 3024184 3024185 3024186 30241873024188 3024189 3024190 3024191 3024192 3024193 3024194 3024195 30241963024197 3024731 3024732 3024733 3024734 3024735 3024736 3024737 30247383024739 3024740 3024741 3024742 3024743 3024744 3024745 3024746 30247473024748 3024749 3024750 3024921 3024922 3024923 3024924 3024925 30249263024927 3024928 3024929 3024930 3030584 3030585 3030586 3030587 30314213031422 3031423 3031424 3031425 3031426 3031427 3031428 3031429 30314303031441 3031442 3031443 3031444 3031445 3031446 3031447 3031448 30314493031450 2764189 2764250 2764251 2764252 2764253 2764254 2764255 27642562764257 2764258 2764259 2829290 2829291 2829292 2829293 2829294 28292952829296 2829297 2829298 2829299 2829360 2829361 2829362 2829363 28293642829365 2829366 2829367 2829368 2829369 2833436 2833437 2833438 28334392858220 2858221 2858222 2858223 2858224 2858225 2858226 2858227 28582282858229 2858299 2389490 2389491 2389492 2389493 2389494 2389495 23894962389497 2389498 2389499 2389500 2395281 2395282 2395283 2395284 23952852395286 2395287 2395288 2395289 2395290 2395291 2395292 2395293 23952942395295 2395296 2395297 2395298 2395299 2395300 2396021 2396022 23960232396024 2396025 2396026 2396027 2396028 2396029 2396030 2396481 23964822396483 2396484 2396485 2396486 2396487 2396488 2396489 2396490 23966112396612 2396613 2396614 2396615 2396616 2396617 2396618 2396619 23966202396811 2396812 2396813 2396814 2396815 2396816 2396817 2396818 23968192396820 2396831 2396832 2396833 2396834 2396835 2396836 2396837 23968382396839 2396840 2396981 2396982 2396983 2396984 2396985 2396987 23969882396989 2396990 2397021 2397022 2397023 2397024 2397025 2397026 23970272397028 2397029 2397030 2397031 2397032 2397033 2397034 2397035 23970362397037 2397038 2397039 2397040 2397041 2397042 2397043 2397044 23970452397046 2397047 2397048 2397049 2397050 2397081 2397082 2397083 23970842397085 2397086 2397087 2397088 2397089 2397090 2397121 2397122 23971232397124 2397125 2397126 2397127 2397128 2397129 2397130 2397271 23972722397273 2397274 2397275 2397276 2397277 2397278 2397279 2397280 23973112397312 2397313 2397314 2397315 2397316 2397317 2397318 2397319 23973202879410 2879411 2879412 2879413 2879414 2879415 2879416 2879417 28794182879419 2879420 2879421 2879422 2879423 2879424 2879425 2879426 28794272879428 2879429 2886920 2886921 2886922 2886923 2886924 2886925 28869262886927 2886928 2886929 2886940 2886941 2886942 2886943 2886944 28869452886946 2886947 2886948 2886949 2886970 2886971 2886972 2886973 28869742886975 2886976 2886977 2886978 2886979 3021736 3021776 3021837 30241523024154 3030705 3031791 3031793;2679850 2689160 2689162 2689164 2689167 2689370 2689377 2690296 26902982690302 2692920 2692925 2692931 2692932 2692933 2692934 2692935 26929362692937;3043361 3043362 3043364 3043365 3043366 3043367 3043368 3043369 30433703043441 3043443 3043445 3043446 3043471 3043472 3043473 3043475 30434763043477 3043479 3026931 3026932 3026934 3026935 3026937 3026939 30271813027185 3027187 3027189 3027462 3027463 3032194 3032196 3032200 30347713034776 3034777 3034779 3034780 3034851 3034852 3034853 3034854 30348553034857 3034858 3034859 3034860 3035411 3035412 3035414 3035415 30354163035417 3035418 3035420 3035951 3035952 3035953 3035954 3035959;2984056 2984062 2984064 2984065 2984067 2986825 2986827 2986829 29953212995322 2995323 2995324 2995325 2995326 2995327 2995328 2995329 29953302999692 2999693 2999694 2999695 2999696 2999697 2999698 2999699 29997002999924 2999925 2999926 2999927 2999928 2999929 2713387 2718732 27187362718737 2718738 2559751 2559752 2559753 2559754 2559755 2559756 25597572559758 2559759 2559760 2560031 2560032 2560033 2560034 2560035 25600362560037 2560038 2560039 2560040 2560271 2560272 2610521 2610522 26105232610524 2610525 2610526 2610527 2610528 2610529 2610530 2610541 26105422610543 2610544 2610545 2610546 2610547 2610548 2610549 2610550 26105812610582 2610583 2610584 2610585 2610586 2610601 2610602 2610603 26106042610605 2610606 2610607 2610608 2610609 2610610 2610611 2610612 26106132610614 2610615 2610616 2610617 2610618 2610619 2610620 2610761 26107622610763 2610764 2610765 2610766 2610767 2610768 2610769 2610770 26667402666741 2666742 2666743 2666744 2666745 2666746 2666747 2666748;2956993 2956994;2667541 2667542 2667543 2667548 2667981 2667983 2667984 2667985 26679872667988 2667989 2669552 2669553 2669554 2669556 2669559 2669633 26696362669639 2669640 2669965 2669967 2669968 2669969 2669981 2669983 2669985RECALLING FIRM/MANUFACTURERRegeneration Technologies, Inc., Alachua, FL, by letter on October 14, 2005.Firm initiated recall is ongoing.REASONThe tissue was collected from donors for whom there is no verifiableidentity or consent. The medical records and social histories of the donorscannot be ascertained. The devices which incorporate these donor bonetissues undergo processing, including sterilization, which has beenvalidated to inactivate and/or remove all viral diseases for which humantissue donors are tested.VOLUME OF PRODUCT IN COMMERCE5,320DISTRIBUTIONNationwide and InternationallyEND OF ENFORCEMENT REPORT FOR FEBRUARY 15, 2006###http://www.fda.gov/bbs/topics/enforce/2006/ENF00939.html_______________________________PRODUCTSource Plasma, Recall # B-0584-6CODEUnits VL53767, ZZ031076, ZZ030881, ZZ03046, VL151413, VL151144, VL50837RECALLING FIRM/MANUFACTURERBioLife Plasma Services LP, Shreveport, LA, by facsimile dated October 6,2003. Firm initiated recall is complete.REASONSource Plasma, collected from a donor who was at increased risk for variantCreutzfeldt-Jakob Disease (vCJD), was distributed.VOLUME OF PRODUCT IN COMMERCE7 unitsDISTRIBUTIONNCEND OF ENFORCEMENT REPORT FOR FEBRUARY 1, 2006###http://www.fda.gov/bbs/topics/enforce/2006/ENF00937.html_______________________________PRODUCTRed Blood Cells, Recall # B-0552-6CODEUnit number: 4426304RECALLING FIRM/MANUFACTURERFlorida's Blood Center, Inc., St. Petersburg, FL, by facsimile on July 8,2005. Firm initiated recall is complete.REASONBlood product, collected from a donor who may have been at increased riskfor new variant Creutzfeldt-Jakob Disease (nvCJD), was distributed.VOLUME OF PRODUCT IN COMMERCE1 unitDISTRIBUTIONFLEND OF ENFORCEMENT REPORT FOR JANUARY 25, 2006###http://www.fda.gov/bbs/topics/enforce/2006/ENF00936.htmlRECALLS AND FIELD CORRECTIONS: BIOLOGICS -- CLASS I_______________________________PRODUCTHuman Tissue for Transplantation, Recall # B-0322-6a) Alloquent CC Allograft (8, 9 & 10 mm);b) Achilles Tendon;c) Cancellous Bone 4-10 mm (15 & 30 cc);d) Patella Tendon-Hemi;e) Iliac Crest Wedge (14-17mm, 11-13mm,<10mm, href="mhtml:%7B33B38F65-8D2E-434D-8F9B-8BDCD77D3066%7Dmid://00000055/!x-usc:http://deposit.ddb.de/cgi-bin/dokserv?idn=993774407&dok_var=d1&dok_ext=pdf&filename=993774407.pdf">http://deposit.ddb.de/cgi-bin/dokserv?idn=993774407&dok_var=d1&dok_ext=pdf&filename=993774407.pdf


http://www.gtp.org.tw/Files/Download/2008613134233.pdf


Wednesday, January 02, 2008

Risk factors for sporadic Creutzfeldt-Jakob disease


http://creutzfeldt-jakob-disease.blogspot.com/2008/01/risk-factors-for-sporadic-creutzfeldt.html


Sunday, December 16, 2007

Risk factors for sporadic Creutzfeldt-Jakob disease


http://creutzfeldt-jakob-disease.blogspot.com/2007/12/risk-factors-for-sporadic-creutzfeldt.html


Monday, December 31, 2007

Risk Assessment of Transmission of Sporadic Creutzfeldt-Jakob Disease in Endodontic Practice in Absence of Adequate Prion Inactivation


http://creutzfeldt-jakob-disease.blogspot.com/2007/12/risk-assessment-of-transmission-of.html


New Jersey mayors and rabbis arrested in money laundering probea.. Daniel Nasaw in Washington b.. guardian.co.uk, Thursday 23 July 2009 17.31 BST c..

Two New Jersey mayors and more than two dozen political figures and religious leaders were arrested today as part of a massive international money laundering scheme that includes illegal traffic in human body parts.Among those arrested following a two-year investigation were Hoboken mayor Peter Cammarano III, Secaucus Mayor Dennis Elwell, Jersey City deputy mayor Leona Beldini, officials in the state capital and several rabbis. Federal law enforcement officials this morning also were searching the offices of the New Jersey state department of consumer affairs. Details of the charges were sparse today. The Wall Street Journal reported that the investigation included a probe of an international body-part trafficking ring. One of the people arrested is accused of dealing in human organs. State legislator Daniel Van Pelt was accused of taking $10,000 in bribes from a government informant to facilitate a real estate development, the Asbury Park Press reported. Many of the arrested come from a gritty, urban area of New Jersey directly across the Hudson River from New York City that in recent years has attracted young professionals driven out of New York by high real-estate prices.The detained clergymen came from a enclaves of Syrian Jews in New Jersey and in Brooklyn, New York. Their connection to the politicians was unclear Thursday morning.One northern New Jersey man arrested in the wide-ranging investigation, Levy Izhak Rosenbaum, was charged with conspiring to traffic human organs, the Record newspaper of Bergen County reported.Cammarano, Hoboken mayor, was apparently unaware he was sought in the probe, spending yesterday evening tending bar at a Hoboken festival and celebrating his 32nd birthday. "I would like to thank everyone today for the birthday wishes," he wrote on Twitter about 1am on Wednesday. "Hope everyone had a great time at the opening night for St Ann's feast."


http://www.guardian.co.uk/world/2009/jul/23/new-jersey-corruption-money-laundering


Mayors, rabbis arrested in NJ corruption probeThu Jul 23, 2009 3:17pm EDT

NEW YORK (Reuters) - Two northern New Jersey mayors, several rabbis and other politicians were arrested on Thursday in a federal investigation into public corruption and international money laundering, U.S. authorities said.Among the approximately 30 people arrested were Hoboken Mayor Peter Cammarano, who took office 23 days ago, Secaucus Mayor Dennis Elwell, state Assemblyman Daniel Van Pelt and Jersey City Deputy Mayor Leona Beldini, according to the U.S. Attorney's Office in Newark.Also arrested in the money-laundering investigation were several rabbis in New York and New Jersey, the federal prosecutor's office said.The international money-laundering was "high volume," it said.Local television showed images of rabbis and the two mayors taken into federal custody in Newark, New Jersey.No further details were immediately available from authorities. A news conference was scheduled for later on Thursday.Court appearances for those arrested were to begin in the early afternoon.(Reporting by Ellen Wulfhorst; editing by Mohammad Zargham)

http://www.reuters.com/article/newsOne/idUSTRE56M3QU20090723


Feds Target Politicians and Rabbis in Massive Corruption, Money-Laundering Case in New Jersey and New YorkAtlanta, Ga. 7/23/2009 03:24 PM GMT (TransWorldNews - Top Story) Federal authorities have arrested at least 30 people, including mayors, rabbis and politicians, in New Jersey and New York as part of a corruption and money-laundering investigation.Those arrested included Hoboken Mayor Peter Cammarano and Secaucus Mayor Dennis Elwell.According to federal authorities several rabbis in the two states were also detained.There have been reports that suggest some of those arrested on Thursday were involved in organ trafficking, having accepted cash payments to locate organs for those in need of transplants. ###


http://www.transworldnews.com/NewsStory.aspx?id=104213&cat=5


Saturday, January 26, 2008

CJD HGH BODY SNATCHERS


http://creutzfeldt-jakob-disease.blogspot.com/2008/01/cjd-hgh-body-snatchers.html



THE LEGAL TRADING AND SELLING OF BODY PARTS AND TSEs i.e. THE BODY SNATCHERS


http://disc.server.com/discussion.cgi?disc=167318;article=2864;title=CJD%20WATCH


http://disc.server.com/discussion.cgi?disc=7498;article=2818;title=CJD%20Voice%20Discussion%20Group


http://lists.iatp.org/listarchive/archive.cfm?id=119823


STOLEN BODY PARTS


http://www.google.com/search?hl=en&q=stolen+body+parts&btnG=Search



Friday, August 07, 2009

CJD Human Cornea Tissue, Recall END OF ENFORCEMENT REPORT FOR AUGUST 5, 2009


http://creutzfeldt-jakob-disease.blogspot.com/2009/08/cjd-human-cornea-tissue-recall-end-of.html



Update: Creutzfeldt-Jakob Disease Associated with Cadaveric Dura Mater Grafts --- Japan, 1979--2003
MMWR Weekly December 5, 2003 / 52(48);1179-1181



http://www2.niddk.nih.gov/AboutNIDDK/CommitteesAndWorkingGroups/HGH_CJD_Dec_11_2003_TAB_A.htm



Thursday, October 23, 2008

Creutzfeldt-Jakob Disease Associated with Cadaveric Dura Mater Grafts - Japan, 1979-2008 : UPDATE


http://creutzfeldt-jakob-disease.blogspot.com/2008/10/creutzfeldt-jakob-disease-associated.html


http://www.wellsphere.com/cjd-article/medical-procedures-and-risk-for-sporadic-creutzfeldt-jakob-disease-japan-1999-2008-warning-to-neurosurgeons-and-ophthalmologi/641229



Thursday, January 29, 2009

Medical Procedures and Risk for Sporadic Creutzfeldt-Jakob Disease, Japan, 1999-2008 (WARNING TO Neurosurgeons and Ophthalmologists) Volume 15, Number 2-February 2009 Research



http://creutzfeldt-jakob-disease.blogspot.com/2009/01/medical-procedures-and-risk-for.html



Wednesday, August 12, 2009

Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt-Jakob disease


http://creutzfeldt-jakob-disease.blogspot.com/2009/08/unique-clinicopathological-features-and.html



Sunday, May 10, 2009

Meeting of the Transmissible Spongiform Encephalopathies Committee On June 12, 2009 (Singeltary submission)



http://tseac.blogspot.com/2009/05/meeting-of-transmissible-spongiform.html



Tuesday, August 11, 2009

Characteristics of Established and Proposed Sporadic Creutzfeldt-Jakob Disease Variants


http://creutzfeldt-jakob-disease.blogspot.com/2009/08/characteristics-of-established-and.html



TSS>>>>>>>>>>>> * FROM MAY 9, 2001: Possible Creutzfeldt-Jakob case reported in
>>> Windsor>>>>>> Classical CJD, which occurs naturally in a small number of people, can>>> be transmitted by transplants of human tissue.>>>>>> The disease affects the central nervous system.>>>>>> It occurs in the world population at a rate of about one case per>>> million people per year – about 30 cases are diagnosed each year in>>> Canada. Most cases die within months.>>>>>> Written by CBC News Online staff>>>>>> http://www.cbc.ca/stories/2003/09/24/moncton030924>>>>>> it would be most interesting how this hospital has handled the>>> quarantining>>> of the surgical instruments and the operating/surgical arena after this>>> surgery>>> and the finding of CJD in the patient. were the instruments used on>>> this>>> victim used on any other persons and can they trace all tools ???>>>>>> TSS>>>>>>

########### http://mailhost.rz.uni-karlsruhe.de/warc/bse-l.html>>> ############>>>>>>>>>